Advanced Magnetic Resonance Imaging of Osteoarthritis by MacKay, James
  
 
ADVANCED MAGNETIC RESONANCE IMAGING 
OF OSTEOARTHRITIS 









This dissertation is the result of my own work and includes nothing which is the 
outcome of work done in collaboration except as declared in the Preface and specified 
in the text. 
It is not substantially the same as any that I have submitted, or, is being concurrently 
submitted for a degree or diploma or other qualification at the University of 
Cambridge or any other University or similar institution except as declared in the 
Preface and specified in the text. I further state that no substantial part of my 
dissertation has already been submitted, or, is being concurrently submitted for any 
such degree, diploma or other qualification at the University of Cambridge or any 
other University or similar institution except as declared in the Preface and specified in 
the text. 
It does not exceed the prescribed word limit for the Degree Committee for Clinical 
Medicine & Veterinary Medicine. 
Dr James MacKay  
Advanced Magnetic Resonance Imaging of Osteoarthritis 
 ii 
ABSTRACT 
This thesis examines the potential utility of magnetic resonance (MR) quantitative 
imaging biomarkers (QIBs) of knee osteoarthritis (OA) for rapid assessment of 
treatment efficacy in experimental medicine studies. 
The development of treatments able to modify disease in OA is hampered by an 
inability to evaluate treatment response over a timeframe relevant to clinical trials. 
There are particular challenges in the experimental medicine setting due to the small 
numbers of participants and short follow-up duration relative to the expected time 
course of OA development and progression. Multiple MR QIBs of OA exist which may 
help address the problem of early evaluation of treatment response. However, their use 
in early phase studies has remained limited. Possible reasons for this include 
incomplete characterisation of the performance of QIBs in this setting and lack of 
head-to-head comparison of candidate QIBs to determine which would be optimal.  
This thesis aims to address these shortcomings and provide new information on the 
likely utility of MR QIBs in the setting of experimental medicine studies, as well as 
their potential for improving our general understanding of OA pathophysiology. 
I start by examining the reliability and ability to discriminate between OA and healthy 
knees of cartilage compositional MR imaging in a systematic review and meta-analysis.  
I then describe the development and validation of a novel semi-automatic surface-
based method for analysing articular cartilage composition and morphology at the 
knee which may offer improved responsiveness and spatial localisation of change.  
Moving to QIBs of subchondral bone, I evaluate the association between measures of 
subchondral bone architecture derived from MR texture analysis and OA progression 
in the Osteoarthritis Initiative. The remainder of the thesis describes a prospective 
observational study where the utility of MR QIBs of synovium, subchondral bone and 
cartilage in experimental medicine studies is assessed.  
In summary, this thesis will inform decisions regarding the use of MR-based QIBs in 
future longitudinal and interventional studies. Their inclusion in experimental 
medicine studies may allow early assessment of treatment efficacy at a structural level 
and improve efficiency of treatment development pipelines. 
  iii 
ACKNOWLEDGEMENTS 
My Z and a bit years of PhD research have been the most challenging but also the most 
enjoyable and rewarding of my career to date. There are many people who are 
responsible for making this the case, too many to acknowledge individually. However, 
there are some deserving of special mention. 
I consider myself extremely lucky to have undertaken my PhD under the supervision of 
Professor Fiona Gilbert. As well as guiding my research, she has taught me a lot about 
how to develop a successful research career and has provided an example of what 
outstanding research leadership looks like. The co-supervision of Professor Andrew 
McCaskie has been invaluable, particularly the key clinical insights that he has 
provided into the challenges of treating osteoarthritis. His vision for musculoskeletal 
research in Cambridge is inspiring and he has been a pleasure to work with. 
Professor Andoni Toms in Norwich has been an excellent mentor throughout my 
research career to date. I owe him a debt of gratitude for starting me on my 
radiological research journey as a young registrar. It has been great to be able to 
bounce ideas off someone external to my project during my PhD, and I can always 
count on him to spot at least one grammatical error or formatting faux pas in anything 
I send him to review. 
My PhD was funded by the Addenbrooke’s Charitable Trust and the Experimental 
Medicine Initiative (EMI). I am grateful to both parties for enabling me to undertake 
this work. Through the EMI, I have had the pleasure of meeting and working with 
many excellent people within GlaxoSmithKline including Rob Janiczek, Alex Morgan-
Roberts, Jon Larkin, Danielle Gerlag and Duncan Richards. They have helped me to 
navigate the industry/academia border and I have learned a lot by doing so. 
I was fortunate to have access to additional advice and guidance through the EMI from 
Professor Ian Wilkinson, and I thank him for his support. I would also like to 
acknowledge the assistance of Nicola White, the EMI programme manager, who has 
been very helpful throughout. 
The dynamic contrast enhanced (DCE) MR work described in this thesis was 
performed in collaboration with BiOxyDyn. I would like to thank Faezeh Sanaei and Jo 
  iv 
Naish for their hard work on the data analysis (and for answering my many questions), 
and to Prof Geoff Parker for his valuable input. 
I am fortunate to now be able to call many of my colleagues within the Department of 
Radiology friends, and I hope to keep in touch on both an intellectual and a personal 
level in years to come. Special mention must go to Josh Kaggie and Martin Graves, 
whose MR physics expertise has been invaluable and whose general good humour 
means that they are always a pleasure to be around. Dimitri Kessler arrived as a new 
PhD student towards the end of my PhD and it has been a pleasure helping him to 
embark upon his journey. The departmental administrative staff have also been 
wonderful. In particular, Candice Anderson and Sarah Perkins have shown incredible 
patience and understanding in dealing with my many questions and requests and have 
helped to keep me organised. I will miss the friendly and welcoming environment 
which they have created. 
Research is at its best as a collaborative endeavour, and I have been lucky to 
collaborate with some excellent people during my PhD. Special thanks are reserved for 
Stephen McDonnell and Wasim Khan in the Division of Trauma & Orthopaedics and 
Graham Treece and Tom Turmezei in the Department of Engineering. Simon White of 
the MRC Biostatistics Unit was also very helpful in providing initial guidance to my 
prospective study. 
On that note, I am incredibly grateful to the participants in this prospective study who 
willingly gave up their time to lie in our MR scanner and have their knees imaged on 
multiple occasions. One of the most rewarding parts of my PhD was getting to know 
them and understanding how their OA was affecting their lives. Their frustration at the 
lack of effective treatment options will continue to be a real motivator for me in my 
future work. 
Finally, the support of my friends and family has been unwavering throughout this 
PhD.  
My parents provided me with an outstanding education and encouraged me to ask 
questions from an early age, something which has no doubt led me to embrace a career 
in research. I am very grateful to them for this.  
  v 
Hazel was born about two-thirds of the way into this PhD. While her arrival and the 
subsequent months have felt something like being at the centre of a whirlwind, she has 
brought untold joy to my life. At times during my PhD it has felt like the work is all-
encompassing but one little smile from her and I am reminded of what is truly 
important.  
Eilbhe has been my rock and teammate since long before embarking on my PhD. 




  vi 
PUBLICATIONS ARISING FROM THIS THESIS 
MacKay JW, Low SBL, Smith TO, Toms AP, McCaskie AW, Gilbert FJ. Systematic 
review and meta-analysis of the reliability and discriminative validity of cartilage 
compositional MRI in knee osteoarthritis. Osteoarthr Cartil. =>?`;=b(@):??d>–??f=. 
MacKay JW, Kapoor G, Driban JB, et al. Association of subchondral bone texture on 
magnetic resonance imaging with radiographic knee osteoarthritis progression: data 
from the Osteoarthritis Initiative Bone Ancillary Study. Eur Radiol. =>?`;=`(??):db`g–
db@f. 
PRESENTATIONS ARISING FROM THIS THESIS 
Oral 
)*+, 
‘Utility of MRI quantitative biomarkers in experimental medicine studies of knee OA’. 
International Workshop on Osteoarthritis Imaging (IWOAI), Prince Edward Island, 
Canada. 
‘Cartilage compositional MRI: does it have a role in defining early OA’ [invited]. 
Osteoarthritis Research Society International annual congress (OARSI), Toronto, 
Canada. 
)*+- 
‘Physiology of joint tissues in osteoarthritis’ [invited]. International Society for 
Magnetic Resonance in Medicine annual meeting (ISMRM), Paris, France. 
)*+/ 
‘Association between MRI subchondral bone texture and radiographic OA progression: 
Data from the Osteoarthritis Initiative Bone Ancillary Study’. IWOAI, Sydney, 
Australia 
‘High resolution ZD modelling of cartilage surfaces at the knee using clinical magnetic 
resonance imaging data’. IWOAI, Sydney, Australia. 
  vii 
Poster 
)*+, 
‘Cartilage imaging for experimental medicine studies: b-month changes in morphology 
and composition can be detected by ZD cartilage surface mapping of knee magnetic 
resonance imaging data’. OARSI, Toronto, Canada. 
)*+- 
‘Repeatability and discrimination validity of cartilage imaging biomarkers for 
experimental medicine studies of knee OA’. OARSI, Liverpool, UK. 
*‘Dynamic contrast enhanced MR imaging in early stage knee osteoarthritis: A test-
retest repeatability study’. ISMRM, Paris, France. 
)*+/ 
‘Systematic review of the reliability and discriminative validity of cartilage 
compositional MRI in knee osteoarthritis’. IWOAI, Sydney, Australia. 
**‘ZD modelling of cartilage surfaces at the knee using clinical magnetic resonance 
imaging data’ . ISMRM, Hawaii, USA. 
* First author & presenter: Dr Faezeh Sanaei, BiOxyDyn, Manchester, UK. I was second author, co-wrote the 
abstract and critically reviewed the final poster design. 
** Presented by Dr Josh Kaggie (second author) as I was unable to attend the conference. 
  
  viii 
TABLE OF CONTENTS 
Declaration ............................................................................................................................ i 
Abstract ................................................................................................................................ ii 
Acknowledgements ............................................................................................................ iii 
Publications arising from this thesis ................................................................................. vi 
Presentations arising from this thesis ............................................................................... vi 
Table of Contents.............................................................................................................. viii 
List of Figures ...................................................................................................................... xi 
List of Tables ..................................................................................................................... xiii 
Commonly used abbreviations ......................................................................................... xv 
Key collaborator contributions ....................................................................................... xvii 
Chapter ?:  Introduction ....................................................................................................... ? 
     ?.? Knee osteoarthritis ..................................................................................................... = 
     ?.= Imaging of knee osteoarthritis .................................................................................. d 
     ?.Z Experimental medicine ............................................................................................. ?Z 
     ?.d Thesis aims................................................................................................................ ?b 
Chapter =:  Systematic Review and Meta-analysis of the Reliability and Discriminative 
Validity of Cartilage Compositional MRI in Knee Osteoarthritis .................................... ?` 
     =.? Introduction .............................................................................................................. ?@ 
     =.= Methods................................................................................................................... =Z 
     =.Z Results ..................................................................................................................... =` 
     =.d Discussion ............................................................................................................... Zf 
Chapter Z:  ZD Cartilage Surface Mapping – Validation in Cadaveric Knees ................. fb 
     Z.? Introduction ............................................................................................................. f` 
     Z.= Methods ................................................................................................................... b> 
     Z.Z Results ...................................................................................................................... bb 
     Z.d Discussion ............................................................................................................... b` 
  ix 
Chapter d:  Association of Subchondral Bone Texture on Magnetic Resonance Imaging 
with Radiographic Knee Osteoarthritis Progression – Data from the Osteoarthritis 
Initiative Bone Ancillary Study .......................................................................................... g? 
     d.? Introduction ............................................................................................................. g= 
     d.= Methods .................................................................................................................. gd 
     d.Z Results ..................................................................................................................... ` > 
     d.d Discussion ............................................................................................................... ` f 
Chapter f:  The Advanced Magnetic Resonance Imaging of Osteoarthritis (AMROA) 
Study – Core Methodology & Results ................................................................................ @? 
     f.? Introduction ............................................................................................................. @= 
     f.= Methods ................................................................................................................... @d 
     f.Z Results.................................................................................................................... ?>> 
     f.d Discussion ............................................................................................................. ?>b 
Chapter b:  Dynamic Contrast Enhanced Magnetic Resonance Imaging of Synovitis in 
the AMROA Study ............................................................................................................. ??Z 
     b.? Introduction ............................................................................................................ ??d 
     b.= Methods ..................................................................................................................??b 
     b.Z Results .................................................................................................................... ?== 
     b.d Discussion .............................................................................................................. ?=` 
Chapter g:  Magnetic Resonance Imaging of Subchondral Bone in the AMROA Study
 ........................................................................................................................................... ?Z` 
     g.? Introduction ............................................................................................................ ?Z@ 
     g.= Methods .................................................................................................................. ?d? 
     g.Z Results..................................................................................................................... ?df 
     g.d Discussion .............................................................................................................. ?f= 
Chapter `:  ZD Cartilage Surface Mapping – Implementation in the AMROA Study ... ?f` 
     `.? Introduction ............................................................................................................ ?f@ 
     `.= Methods ..................................................................................................................?b? 
  x 
     `.Z Results .................................................................................................................... ?bg 
     `.d Discussion .............................................................................................................. ?gd 
Chapter @:  Conclusions ................................................................................................... ?g@ 
     @.? Contributions to knowledge ................................................................................. ?`> 
     @.= Future directions ................................................................................................... ?`Z 
     @.Z Conclusions ............................................................................................................?`d 
References ......................................................................................................................... ?`f 
 
  
  xi 
LIST OF FIGURES 
Figure Description Page 
?.? Illustration of the changes in cartilage morphology occurring with increasing degradation.  d 
?.= Schematic illustration of radiographic joint space width measurement ` 
?.Z Illustration of stages of OA development and progression ?= 
?.d Illustration of experimental medicine paradigm ?d 
=.? PRISMA flow chart demonstrating process for selection of included studies =g 
=.= Summary of reliability data =@ 
=.Z Summary forest plot for discrimination data Z= 
Z.? Dissected cadaveric femur showing exposure of the articular cartilage surface b? 
Z.= Cadaveric femur loaded into acrylic holder for HRpQCT b? 
Z.Z Outline of initial steps in ZD-CaSM pipeline b= 
Z.d Outline of HRpQCT thickness measurement process bd 
Z.f Comparison of agreement between ZD-CaSM and HRpQCT and manual segmentation of HRpQCT bg 
Z.b Schematic illustration of the tibial plateau demonstrating major ligamentous and meniscal attachment sites b` 
d.? Study timeline for image assessments as part of the Osteoarthritis Initiative Bone Ancillary Study gd 
d.= 
Example coronal-oblique ZD FISP MR image demonstrating ROI 
placement in the medial tibial and medial femoral subchondral 
bone 
gg 
d.Z Flow diagram for selection of study participants `? 
d.d Boxplot demonstrating the association between subchondral bone composite texture score and radiographic progression `= 
d.f 
Example coronal ZD FISP MR images through the medial 
tibiofemoral compartment of radiographic progressors and non-
progressors at the initial timepoint 
`d 
f.? Fixed flexion radiographic technique using SynaFlexer frame @f 
f.= Study visit schedule for AMROA ?>> 
f.Z Percentage of subregions in each group with change in MOAKS score over b-months and ?-year  ?>f 
b.? ZD rendering of synovial regions of interest ??g 
b.= Example of shuffle transform of pre and post contrast images ??@ 
b.Z Baseline DCE-MR QIB values ?=Z 
b.d b-month and ?-year changes in DCE-MR QIBs ?=f 
b.f b-month changes in Ktrans and MOAKS synovitis score ?=b 
  xii 
Figure Description Page 
b.b Example images from participants with significant changes in Ktrans at b-months ?=g 
g.? Coronal =D T?w FSE image with example ROIs for texture analysis ?d= 
g.= Subchondral bone area measurement pipeline ?dZ 
g.Z Baseline subchondral bone area values ?dg 
g.d Baseline subchondral bone texture values ?dg 
g.f Dot plots and example images for most responsive subchondral bone QIBs at b-months and ?-year ?d@ 
`.? Outline of cartilage composition measurement process ?bZ 
`.= Overview of spatial normalisation procedure for ZD-CaSM ?bd 
`.Z Vertexwise assessment of b-month change in cartilage morphology and composition ?bb 
`.d Average vertexwise differences between OA and HV groups at baseline for each parameter ?g> 
`.f 
Baseline and b-month follow-up thickness and compositional 
data for a single representative OA participant displayed on 
canonical femoral and tibial surfaces 
?g= 
`.b Individual b-month and ?-year %SC data for each parameter ?gZ 
`.g 
Average OA group b-month change in femoral dGEMRIC, with 
focal region of statistical significance (p < >.?) demonstrated 
close to the medial femoral sulcus 
?gZ 
@.? Use of AMROA data to inform Bayesian analysis of experimental medicine study data. ?`= 
@.= Translational gaps in imaging biomarker development ?`Z 
 
  
  xiii 
LIST OF TABLES 
Table Description Page 
?.? Kellgren-Lawrence grading of OA g 
?.= Commonly used semiquantitative MR grading systems for knee OA ?> 
=.? Summary of discrimination between subjects with OA and controls for included compositional techniques Zd 
Z.? Results of Bland-Altman analysis for comparison of MR and HRpQCT thickness values bb 
d.? Subject characteristics at initial timepoint and ?=-?` month follow-up `> 
d.= Association between texture features and case vs control status, and classification performance `Z 
f.? Description of QIBs included in AMROA study @Z 
f.= AMROA study MR protocol @g 
f.Z Baseline demographic characteristics of included study participants ?>? 
f.d KOOS scores for OA and HV participants ?>? 
f.f Number of OA participants with symptomatic improvements at b-months and ?-year visits ?>= 
f.b Results of radiographic analyses in OA participants ?>Z 
f.g Summary of baseline MOAKS data ?>d 
b.? Anatomical definition of synovial regions of interest ??` 
b.= RMSCVs and SDDs for DCE-MR biomarkers ?== 
b.Z Adjusted mean b-month and ?-year changes in DCE-MR QIBs ?=d 
b.d Number of participants with b-month and ?-year changes greater in magnitude than the SDD ?=d 
b.f Confusion matrix demonstrating concordance between changes in Ktrans and MOAKS synovitis score ?=b 
g.? RMSCVs and SDDs for subchondral bone biomarkers ?db 
g.= Adjusted mean b-month and ?-year changes in subchondral bone QIBs ?f> 
g.Z Number of participants with b-month and ?-year changes greater in magnitude than the SDD ?f? 
`.? Signal equations and thresholds for implausible values for cartilage compositional methods in this study ?b= 
`.= Number of analysable participants at each timepoint for each cartilage parameter ?bg 
`.Z Inter-observer reproducibility data for ZD-CaSM and conventional manual segmentation ?b` 
`.d One month test-retest repeatability data for ZD-CaSM ?b@ 
`.f Baseline surfacewise standardised mean difference values for each parameter at each surface ?g? 
  xiv 
Table Description Page 
@.? Comparison of QIBs included in AMROA study across domains of interest. ?`? 
  xv 
COMMONLY USED ABBREVIATIONS 
=D =-dimensional 
ZD Z-dimensional 
ZD-CaSM ZD Cartilage Surface Mapping 
ZT Z Tesla 
AMROA Advanced MR imaging of osteoarthritis 
ANCOVA Analysis of covariance 
AUC Area under the receiver operating characteristic curve 
BML Bone marrow lesion 
CI Confidence interval 
DCE-MR Dynamic contrast enhanced magnetic resonance (imaging) 
dGEMRIC Delayed gadolinium enhanced MR imaging of cartilage 
DICOM Digital Imaging and Communications in Medicine 
DMOAD Disease modifying OA drug 
DMOAT Disease modifying OA treatment 
EM Experimental medicine 
FDA Food and Drug Administration 
FNIH Foundation of the National Institutes for Health 
FSA Fractal signature analysis 
FSE Fast spin echo 
gdCA Gadolinium based contrast agent 
HRpQCT High resolution peripheral quantitative computed tomography 
HV Healthy volunteer 
IAUCb> Area under the time-concentration curve at b>s 
ICC Intraclass correlation coefficient 
IQR Interquartile range 
IW Intermediate-weighted 
JSN Joint space narrowing 
JSW Joint space width 
KL Kellgren-Lawrence grade 
KOOS Knee injury and osteoarthritis outcome score 
Ktrans Volume transfer coefficient between the plasma and the extracellular extravascular space 
LASSO Least absolute shrinkage and selection operator (regression) 
MOAKS MRI Osteoarthritis Knee Score 
MR(I) Magnetic resonance (imaging) 
  xvi 
OA Osteoarthritis 
OAI Osteoarthritis Initiative 
OARSI Osteoarthritis Research Society International 
OMERACT Outcome measures in rheumatology 
QIB Quantitative imaging biomarker 
RMSCV Root-mean-square average coefficient of variation 
ROI Region of interest 
SBA Subchondral bone area 
SD Standard deviation 
SDD Smallest detectable difference 
SMD Standardised mean difference 
SPGR Spoiled gradient echo 
SPM Statistical parametric mapping 
STV Synovial tissue volume 
T? MR longitudinal relaxation time constant 
T?rho MR longitudinal relaxation time constant in the presence of a radiofrequency field  
T= MR transverse relaxation time constant 
TA Texture analysis 
ve Proportion of extracellular extravascular space  
VEP Volume of enhancing pannus 
vp Proportion of blood plasma volume 
  
  xvii 
KEY COLLABORATOR CONTRIBUTIONS 
Chapter 3 – Systematic review and meta-analysis… 
Dr Samantha Low performed initial screening to identify potentially eligible studies 
per inclusion and exclusion criteria in duplicate with me. Dr Low also double-checked 
the data extraction for included studies. 
Dr Toby Smith and Prof Andoni Toms provided important systematic review expertise 
to guide my efforts. 
Chapter ? – ?D cartilage surface mapping validation… 
Dr Graham Treece and Dr Tom Turmezei provided training in the software used for ZD 
cartilage surface mapping, helped to design the validation experiment and provided 
critical feedback on the results. 
Chapter B – Association of subchondral bone texture… 
Dr Geeta Kapoor performed duplicate texture analysis for inter-observer 
reproducibility assessment. 
Chapter E – Dynamic contrast enhanced… 
I performed the image analysis jointly with Dr Faezeh Sanaei and Dr Jo Naish at 
BiOxyDyn. Specifically, I created the manual regions of interest which were then 
incorporated into the BiOxyDyn DCE analysis pipeline. I reviewed the resulting 
parameter maps and performed subsequent data analysis using the parameters 
outputted from the BiOxyDyn pipeline. 
Chapter F – ?D cartilage surface mapping implementation… 
Dr Graham Treece and Dr Tom Turmezei provided training in the software used for ZD 
cartilage surface mapping and provided critical feedback on the results. 
Dr Tom Turmezei performed duplicate ZD-CaSM and manual segmentation for inter-
observer reproducibility assessment. 





  2 
?.? KNEE OSTEOARTHRITIS 
G.G.G Epidemiology & current treatment options 
Osteoarthritis (OA) is the commonest cause of pain and loss of function in the adult 
population, affecting an estimated `.gf million individuals in the UK(?). Although 
traditionally considered a disease of the elderly, people of working age (under bf years 
old) make up =/Z of this total, and in =>?b (the latest year for which data are available) 
OA was the commonest reason for claiming disability living allowance in the UK(?,=). 
The prevalence of OA is expected to increase over the next few decades given the rising 
ageing population and increasing prevalence of obesity which are both important risk 
factors for developing OA(Z). The commonest joint involved is the knee, which is the 
focus of this thesis(?). 
The term ‘osteoarthritis’ refers to a clinical syndrome of joint pain associated with 
various structural abnormalities. Knee OA (and indeed OA in general) is a 
heterogeneous condition with distinct OA phenotypes increasingly being described(d). 
These involve variations in underlying aetiology (e.g. post-traumatic OA), joint 
structures involved (e.g. atrophic vs hypertrophic OA) and natural history (e.g. rapidly 
progressive OA).  The conventional view of knee OA as primarily a cartilage disease 
has been thoroughly debunked, and it is now recognised to be a disease of multiple 
joint structures including bone, synovium, ligaments, menisci, capsule and juxta-
articular muscle as well as cartilage(f). 
Current treatment options for knee OA depend on stage of disease. Total knee 
arthroplasty (TKA) and unicompartmental knee arthroplasty (UKA) are effective 
treatments for end-stage knee OA(b,g). However, these options are less suitable earlier 
in the disease process due to limited lifespan of the prostheses and associated 
functional limitations making joint replacement less acceptable to younger patients 
wishing to maintain relatively high degrees of physical activity. The mainstay of 
treatment for individuals with earlier disease is non-pharmacological, including 
lifestyle modification (particularly weight loss) and physiotherapy. Previously, knee 
arthroscopy with or without partial meniscectomy was commonly performed in 
patients with earlier stages of OA. However, recent randomised controlled trial 
evidence has suggested that arthroscopy offers little benefit over conservative 
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treatment although it should be noted that the generalisability of these results is 
disputed(`–?>). Recent guidelines from the British Association for Surgery of the Knee 
(BASK) have aimed to clarify situations in which knee arthroscopy may be an 
appropriate treatment in the presence of OA. These guidelines introduced the concept 
of the ‘meniscal target’ lesion, based on the presence or absence of displaced meniscal 
tear or displaced meniscal tissue. In patients with mild-to-moderate knee OA, BASK 
guidelines suggest that arthroscopy may be appropriate in the presence of a target 
lesion and following an appropriate period of conservative treatment(??). 
Pharmacological options in early OA are limited at present to symptomatic relief with 
oral analgesics (which are often accompanied by undesirable side effects) and short-
acting intra-articular treatments (mainly corticosteroids). At present, there is no 
treatment for early disease that has conclusively demonstrated disease modifying 
properties, i.e. the ability to prevent or reverse progression of OA. There is therefore a 
large group of individuals experiencing debilitating symptoms but not yet suitable for 
knee replacement surgery for whom no effective pharmacological treatment exists(?=).  
G.G.3 Pathophysiology of OA 
Pathological changes in knee OA include degeneration of articular cartilage and 
meniscus, alterations in subchondral bone, synovial inflammation, ligamentous 
degradation and changes in periarticular muscles(?Z). The typical description of OA as 
a disease of ‘wear and tear’ is now recognised to be outdated, with current concepts 
viewing OA onset as being caused by an imbalance between normal wear and repair 
processes(?d). 
Normal articular cartilage exists to provide a surface for smooth, friction-free 
movement. It acts in concert with the subchondral bone to transmit loads applied to 
the joint. The superficial layers secrete lubricin, a lubricating component of the 
synovial fluid. The only cell type found in healthy articular cartilage is the chondrocyte 
which plays a crucial role in cartilage homeostasis(?f).  
In OA, cartilage alterations at the microscopic and molecular level include a 
phenotypic shift with chondrocyte clustering and hypertrophy, increased catabolic 
activity with proteases causing degradation of the cartilage matrix, and eventual 
chondrocyte senescence or apoptosis. This proceeds as a ‘vicious circle’ with 
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senescent/apoptotic chondrocytes stimulating further chondrocyte activation, 
secretion of pro-inflammatory and catabolic mediators and further matrix 
degradation(?b). These microscopic level changes directly link to the macroscopic 
changes that are seen on imaging (Figure ?.?). An initial increase in protease activity 
leads to a reduction in proteoglycan concentration. This reduces the amount of bound 
water within the cartilage and causes a net increase in water mobility, reducing the 
cartilage’s load bearing capacity. As matrix degradation progresses, damage to the 
collagen lattice allows further increase in water mobility with associated reduction in 
load-bearing function(?g). At this point, the damage is already irreversible as there is 
minimal cartilage collagen synthesis in humans after adolescence [HEINEMEIER 
=>?b].  
Figure +.+ 
Illustration of the changes in cartilage morphology occurring with increasing degradation. The theoretical 
sensitivity of different imaging modalities to detect each stage of degradation is displayed as dark grey bars at the 
top of the figure. Reproduced from (?g). 
 
The subchondral bone forms a biomechanical couple with the overlying articular 
cartilage. Its main function is to absorb and respond to load, as well as providing 
  5 
nutrients to the deeper layers of articular cartilage. Normal subchondral bone 
homeostasis consists of a balance between bone formation and bone resorption. Each 
of these processes is associated with a specific cell type, the osteoblast (formation) and 
osteoclast (resorption). In response to a stimulus (e.g. increased or reduced loading), 
the subchondral bone trabecular surfaces are ‘activated’. This activation involves both 
osteoclasts and osteoblasts. Osteoblasts deposit osteoid which is mineralised via 
deposition of calcium hydroxyapatite to form mature trabecular bone. Osteoclasts then 
selectively resorb this, followed by further osteoblast-mediated bone deposition(?`). 
This coupled osteoblast-osteoclast activity allows tightly controlled remodelling of 
trabecular network, permitting the bone to adapt to its local loading conditions per 
Wolff’s law(?@). 
Co-ordination of bone formation and bone resorption is lost in OA. Initially there is a 
state of increased bone turnover with an increase in both processes. However, because 
the bone is being formed at a supraphysiological rate, mineralisation cannot keep up 
and the new bone formed has inferior material properties. This explains the 
observation that subchondral bone volume fraction increases, but with paradoxically 
reduced stiffness(=>). It is unclear what the initiating event for this state of increased 
bone turnover is. Proposed aetiologies include biomechanical (increased loading 
and/or altered loading pattern) and biological (local or systemic inflammation) factors. 
Reduced load-bearing capacity of the subchondral bone will have a direct knock-on 
effect on the load-bearing overlying articular cartilage, increasing the shear and strain 
forces that it experiences(?`). As well as the adverse mechanical effects on articular 
cartilage, vascular invasion through the osteochondral junction causes dysregulation of 
normal bone-cartilage molecular ‘crosstalk’ and promotes cartilage breakdown(=?). 
Concurrent or closely sequential changes in subchondral bone and overlying articular 
cartilage have been observed in animal models(==). 
Closely linked to the described changes in bone and cartilage are alterations in the 
synovium. Normal synovium is a thin layer of connective tissue which seals the joint 
cavity from adjacent tissues. In health, the major cell type is the synovial fibroblast. Its 
principle function is to secrete and regulate the composition of synovial fluid. Synovial 
fluid lubricates the joint via molecules such as lubricin and hyaluronic acid, and is the 
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major source of nutrients to the superficial layers of articular cartilage (deep layers also 
receive nutrition from the subchondral bone)(=Z). 
Synovial changes in OA are characterised by an influx of leucocytes (particularly 
macrophages and T-lymphocytes), hypertrophy and hyperplasia of the synovial lining 
layer and angiogenesis(=d). The triggering event for these changes is debated, but 
likely relate to the production of an increased amount of joint debris (e.g. due to 
increased cartilage breakdown), or an abnormal response to normal amounts of joint 
debris due to ‘priming’ of synovial immune cells by local or systemic factors. Inflamed 
synovium produces both proteolytic enzymes and pro-inflammatory mediators (e.g. 
cytokines) which promote the expression of proteolytic enzymes within chondrocytes, 
leading to cartilage damage(=f). In addition, activated synovial macrophages have 
been shown to play a key role in osteophyte formation in animal models(=b).   
?.= IMAGING OF KNEE OSTEOARTHRITIS 
G.3.G Plain radiography 
Plain radiographs have traditionally formed the basis of radiological diagnosis and 
classification of knee OA. These have the advantage of being cheap and quick to 
perform. Although there is an associated ionising radiation dose, this is minimal (< ? 
µSv, less than one day of ‘background’ radiation in the UK). Classification of OA on 
plain radiographs is most often performed using the Kellgren-Lawrence (KL) 
system(=g). This categorises radiographs into normal, doubtful OA, mild OA, 
moderate OA, and severe OA classes based on the presence of osteophytes, joint space 
narrowing, and subchondral bone attrition (Table ?.?).  
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Table +.+ 
Kellgren-Lawrence grading of osteoarthritis 
Grade Description 
> Normal 
? Doubtful - Possible osteophytic lipping, minor joint space narrowing (JSN) 
= Mild – Definite osteophyte, little to no JSN 
Z Moderate – Definite JSN + osteophytes, early subchondral sclerosis +/- early subchondral bone deformity 
d Severe – Severe JSN, large osteophytes, severe sclerosis + definite bone deformity 
 
The Osteoarthritis Research Society International (OARSI) grading system is a 
modification of the KL system (=`). This scores joint space narrowing, osteophytes and 
subchondral sclerosis separately and allocates distinct scores for the medial and lateral 
compartments. Qualitative grading systems such as KL and OARSI have the advantage 
of being quick to perform and easy to interpret. However, inter-observer agreement is 
suboptimal and neither system is responsive to change(=@). The KL system in 
particular has the shortcoming of assuming a linear progression of disease involving 
development of osteophytes prior to joint space narrowing. In fact, a large number of 
patients will develop joint space narrowing prior to radiographic osteophyte 
development. Such patients do not fit neatly into the KL classification system(Z>). 
Quantitative methods of radiographic assessment have also been developed. 
Measurement of tibiofemoral joint space width (JSW) is probably the best established 
of these. This can be performed using manual measurements, but the advent of 
automated techniques has improved the reliability of JSW measurement and has 
enabled the rapid assessment of JSW in both large epidemiological studies and clinical 
trials(Z?). Until recently, JSW measurement was the only approved imaging metric 
accepted by the United States (US) Food and Drug Administration (FDA) for use in 
clinical trials(Z=). There are two main types of JSW measurement used by researchers. 
Most widely used is minimum JSW (minJSW), which reflects the smallest distance 
between the femoral and tibial subchondral bone for a given tibiofemoral 
compartment (i.e. medial or lateral). Fixed location measurements of JSW are also 
used, which are measurements taken at a consistent location in the medial to lateral 
dimension normalised to the size of the knee using a co-ordinate system as 
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demonstrated in Figure ?.=(ZZ). Fixed location JSW has demonstrated superior 
responsiveness to minJSW although both measures are still commonly used(Zd). 
Measurement of JSW has the advantages inherent to plain radiographic methods of 
low cost and accessibility, with the additional benefit over qualitative techniques of 
improved sensitivity to change and improved reliability with automated methods. 
However, JSW measurement also has several disadvantages. First, differences in knee 
positioning between individuals or within the same individual over time can confound 
measurement. To some extent this can be overcome using standardised positioning 
protocols and assistive devices(Zf). Second, JSW is a composite measure reflecting 
both cartilage thickness and meniscal position(Zb,Zg). This lack of specificity can be 
troublesome, for example in determining whether a change in JSW is due to change in 
cartilage thickness or meniscal extrusion in a trial of a potential disease modifying OA 
treatment (DMOAT) targeting cartilage. Finally, JSW is relatively unresponsive when 
compared to magnetic resonance (MR) imaging-based measures, discussed in the next 
section(Z`). 
Figure +.) 
Schematic illustration of a posteroanterior knee radiograph. Red line indicates location of minJSW in the medial 
(M) and lateral (L) compartments. Dotted vertical black lines indicate boundaries of medial and lateral joint space 
used to derive co-ordinate system for fixed location JSW. Green line indicates measurement of fixed location JSW at 
x = >.==f, i.e. ==.f% of the distance between the medial and lateral vertical dotted lines. 
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Additional quantitative measures can also be derived from radiographs, for example 
fractal signature analysis (FSA) of subchondral bone. FSA quantifies the degree of self-
similarity of an image and provides an indirect measure of trabecular microstructure. 
This has demonstrated reasonable construct and predictive validity, and does not 
suffer from the same sensitivity to positioning as does JSW(Z@–d?). However, the 
output of FSA is complex and the biological meaning of the parameters derived from 
FSA is not always clear.  
G.3.3 Magnetic resonance imaging 
MR imaging has the substantial advantage over plain radiography of being able to 
directly visualise all joint tissues involved in the OA disease process, including 
subchondral bone, articular cartilage, ligament, meniscus, and synovium(?Z). 
Moreover, it has the ability to detect earlier stages of the disease before radiographic 
changes are apparent(d=). Despite this, the use of MR imaging in routine clinical 
practice for OA diagnosis and monitoring is not recommended due to the relatively 
high cost, limited influence on current management decisions and potential 
association with higher rates of arthroscopic intervention(dZ). 
However, in the research setting MR imaging is widely used and recommended(dd). 
Two general approaches to MR-based assessment of OA-related abnormalities exist: 
semiquantitative and quantitative. Semi-quantitative grading systems typically divide 
the knee into anatomical subregions then grade various pathologies (e.g. cartilage 
defects, bone marrow lesions – BML) in each subregion according to an ordinal scale of 
severity (Table ?.=).  
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Table +.) 




publication Scored features (grades) 
WORMS =>>d 
Cartilage (>–b); BMLs (>–Z); subchondral cysts (>–Z); bone 
attrition (>–Z); effusion and synovitis (>–Z); periarticular 
cysts (>–Z); bursitides (>–Z); loose bodies (>–Z); 
osteophytes (>–g); meniscal tear (>–d); cruciate and 
collateral ligaments (>–?) 
   
BLOKS =>>` 
Cartilage size and depth (>–Z, plus extent of any cartilage 
loss at specified point); BMLs (>–Z, for each lesion); 
osteophytes (>–Z); effusion (>–Z); meniscal extrusion (>–
Z); synovitis (in Hoffa's fat pad >–Z and at f additional sites 
>–?); meniscal status (>–? for intrameniscal signal, tears, 
maceration, meniscal cyst, each scored individually); 
ligaments (>–?); periarticular cysts/bursitis (>–?); loose 
bodies (>–?) 
   
MOAKS =>?? 
Cartilage size and depth (>–Z); BMLs (>–Z, for each 
lesion); osteophytes (>–Z); effusion-synovitis (>–Z); Hoffa 
synovitis (>–Z); meniscal extrusion (>–Z); meniscal status 
(>–?, for intrameniscal signal, tears, maceration, meniscal 
cyst, hypertrophy; scored individually); ligaments (>–?); 
periarticular cysts/bursitides (>–?, scored individually); 
loose bodies (>–?) 
Abbreviations: WORMS – Whole Organ MRI score, BLOKS – Boston-Leeds Osteoarthritis of the Knee Score, 
MOAKS – MRI Osteoarthritis Knee Score 
The most widely used scoring method at present is the MOAKS (MRI Osteoarthritis 
Knee Score) system(db). This was designed to harmonise existing scoring methods, 
particularly BLOKS (Boston-Leeds Osteoarthritis of the Knee Score) and WORMS 
(Whole Organ MRI score), while addressing some of their shortcomings(dg,d`). Many 
of the semiquantitative MR features graded by MOAKS have a stronger association 
with symptoms than do plain radiographic measures(d@,f>). This is particularly true 
for synovitis and BML. Moreover, semiquantitative MR features have improved 
responsiveness to change than do radiographic measures(f?–fZ). Semiquantitative 
scoring systems typically use standard clinical MR pulse sequences and so are widely 
applicable, illustrated by their successful implementation in several large observational 
and interventional studies(fd,ff). However, there are limitations associated with their 
use. Most important, they are less responsive than quantitative MR measures for 
assessing comparable features(f?,fb). For example, quantitative cartilage thickness 
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measurements are more responsive than semiquantitative cartilage scores. Second, 
they are inherently subjective in nature and therefore subject to inter-observer 
error(db). Finally, the ordinal nature of the data plus the multiple different features 
scored across multiple subregions makes statistical analysis complex both to perform 
and interpret(fg). 
Quantitative approaches to MR imaging can overcome some of these shortcomings. 
Such approaches can be broadly divided into morphological and physiological 
categories. Morphological approaches involve quantification of the volume, area, 
thickness or position of various joint tissues. One of the best-established of these 
measures is quantification of cartilage thickness. This is usually achieved via expert 
manual segmentation although automated and semi-automated methods are 
increasingly providing viable alternatives. Quantitative imaging of cartilage has helped 
to provide new insights into OA pathogenesis and the influence of various risk factors 
on disease progression(f`–b?). Due to the high spatial resolution required for 
quantitative analysis of cartilage, dedicated MR sequences are required. Typically, 
these are Z-dimensional gradient echo-based sequences with fat suppression and either 
fluid suppression (e.g. spoiled gradient echo, SPGR) or fluid excitation (e.g. dual-echo 
in steady-state, DESS) to optimise contrast resolution between subchondral bone, 
articular cartilage and synovial fluid. Although these are not part of most clinical MR 
knee protocols, they are product sequences (i.e. they do not require a specialised 
research agreement for access) on all major MR vendors and so can be implemented 
widely. Another morphological quantitative approach is the measurement of 
subchondral bone area and shape. OA has long been associated with changes in bone 
shape on plain radiographs(b=). However, the assessment of bone area and shape 
using ZD MR data has provided rich new information on the nature of these 
changes(bZ). Head-to-head comparison with quantitative cartilage morphology has 
demonstrated superior responsiveness for subchondral bone area(bd). This can be 
quantified using the same MR sequences used for cartilage morphology and so is 
similarly widely applicable. Both quantitative assessment of cartilage thickness and 
subchondral bone area have been implemented successfully in clinical trials(bf,bb). 
Physiological quantitative approaches are less widespread than their morphological 
counterparts. This is mostly due to a need for specialised MR pulse sequences (often 
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only accessible via a research agreement with a vendor and requiring MR physics 
support) and both technically demanding and time-consuming image analysis 
pipelines. Their promise lies in an ability to detect and quantify pre-morphological 
changes and thus the earliest stages of OA (Figure ?.Z).  
Figure +.D 
Illustration of stages of  OA development and progression. Compositional MRI methods offer the potential to detect 
the very earliest stages of disease before structural changes have become established. Adapted from (bg). 
 
From a clinical trials point of view, it also seems logical that physiological changes in 
response to treatment will occur earlier than morphological changes. The most 
established physiological imaging methods in OA research are cartilage compositional 
MR imaging techniques. Such techniques rely, directly or indirectly, on the fact that 
alterations in cartilage composition will lead to changes in MR relaxation mechanisms. 
These methods are the focus of chapter = of this thesis. Cartilage compositional MR 
techniques have been available for several decades but their use remains limited 
largely to the research setting. In common with other advanced imaging methods in 
OA, this likely reflects the fact that the results do not (at present) influence patient 
management(b`). Other physiological imaging approaches include dynamic contrast-
enhanced (DCE) MR imaging. DCE MR imaging quantifies tissue microvascular 
structure and function via pharmacokinetic modelling of dynamically acquired MR 
data following the administration of contrast agent. This was originally applied to 
assess tumour vascularity in oncology studies(b@). However, the technique is 
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potentially applicable to any disease in which tissue vascularity is altered. In OA, it has 
been applied to quantify the vascularity of both subchondral bone and 
synovium(g>,g?). Cross-sectional associations have been demonstrated between DCE 
parameters of both subchondral bone and synovium and osteoarthritis severity. DCE 
MR of the synovium has also demonstrated the ability to assess response to therapy 
with intra-articular steroid(g=). DCE MR imaging uses widely available MR pulse 
sequences, although the post-processing is complex(gZ). 
?.Z EXPERIMENTAL MEDICINE 
G.?.G Concept 
Experimental medicine is defined by the Medical Research Council as “investigation 
undertaken in humans, relating where appropriate to model systems, to identify 
mechanisms of pathophysiology or disease, or to demonstrate proof-of-concept 
evidence of the validity and importance of new discoveries or treatments”(gd). From a 
treatment development point of view, the purpose of experimental medicine studies is 
to move the point at which proof-of-concept (POC) or proof-of-mechanism (POM) can 
be demonstrated for a new drug (or other treatment) to earlier in the development 
process (Figure ?.d).  
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Figure +.E 
Comparison of traditional model of drug development (a) with experimental medicine paradigm (b). In (b), the aim 
is to improve confidence in novel treatments before the more expensive and time-consuming later phases of drug 
development. Abbreviations: CS – candidate selection, FHD – first human dose, FED – first efficacy dose, PD – 
product decision, POC – proof-of-concept, p(TS) – probability of success. Reproduced from (gf). 
 
The main impetus behind the development of the experimental medicine concept has 
been increasingly high rates of attrition late in the drug development pathway with 
associated cost implications for pharmaceutical companies(gf). The aim of the 
experimental medicine model is to allow candidate treatments which demonstrate 
early POC to be backed confidently with the required resource for subsequent stages in 
drug development. On the other hand, treatments which fail to demonstrate POC can 
be terminated early, reducing waste(gb). Experimental medicine activities rely on the 
availability of good biomarkers and surrogate outcome measures. The definitions of 
the terms ‘biomarker’ and ‘surrogate outcome’ overlap to some extent. A biomarker is a 
measured objective characteristic which is an indicator of normal biological processes, 
pathogenic processes, or a response to a therapeutic intervention. A surrogate outcome 
measure is defined as a marker that is thought to predict clinical benefit, but is not 
itself a measure of clinical benefit(gg). Biomarkers can be divided into different 
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categories, for example diagnostic biomarkers aim to discriminate between the disease 
state of interest and health whereas predictive biomarkers aim to predict the 
likelihood that a given individual will develop the disease state of interest following an 
exposure. Biomarkers can include laboratory measurements, physical signs and 
imaging features. 
G.?.3 Imaging biomarkers 
Imaging biomarkers are biomarkers measurements derived from medical images. 
Quantitative imaging biomarkers (QIBs) are a subset of imaging biomarkers where the 
biomarker is a measurement on a continuous, interval or ratio scale(g`). Categorical 
and qualitative imaging biomarkers are thus excluded from this definition.  
QIBs offer the potential to improve precision and reduce subjectivity of image analysis. 
Compared to qualitative imaging biomarkers, QIBs offer a larger dynamic range and 
improved sensitivity to change. The implementation of appropriate validated QIBs 
may allow the early demonstration of POC which is the raison d’être of experimental 
medicine. However, there are challenges specific to the implementation of QIBs 
compared with laboratory biomarkers. These include the fact that clinical imaging 
platforms are designed to provide diagnostic quality images for qualitative radiological 
interpretation, not to provide robust quantitative data. Moreover, QIBs often aim to 
reflect a complex biological process rather than a single molecule or analyte making 
straightforward biological validation impossible. 
Despite these drawbacks, QIBs are playing an increasingly important role in the drug 
development process. Collaborative efforts such as the FDA Critical Path Initiative and 
the creation of the FDA-NIH (National Institutes for Health) Biomarker Working 
Group have established standardised pathways for biomarkers from initial 
development and validation through to eventual regulatory acceptance(g@,`>). Several 
imaging biomarker-specific initiatives and guidelines have also been developed. These 
include an ‘imaging biomarker roadmap’ consensus document which, although written 
with oncological imaging biomarkers in mind, has broad applicability across disease 
areas(`?). A Quantitative Imaging Biomarkers Alliance has also been created, aiming to 
standardise QIB terminology and help ensure that correct and consistent statistical 
methods are applied in QIB studies(`=,`Z). 
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G.?.? Relevance to osteoarthritis 
Several putative disease modifying OA drugs (DMOADs) have failed in the late stages 
of drug development. As well as the associated resource implications, this has also 
discouraged further pharmaceutical industry investment in this area. The EM 
paradigm therefore has a significant contribution to make to future DMOAD 
development by providing early evidence of efficacy, thus ensuring that future 
treatments progress to late stage clinical trials with a greater likelihood of 
success(`d,`f).  
As described above, QIBs are likely to play an important role in EM studies of OA. 
There are particular reasons to prefer imaging biomarkers over blood/serum 
biomarkers in the setting of OA due to the lack of joint specificity of the latter. 
Moreover, there is increasing recognition that early changes in structure may be 
predictive of longer-term clinical outcomes. In EM studies, such clinical outcomes (e.g. 
patient reported outcome scores) are difficult to assess due to the large expected 
magnitude of placebo effect(`b). This has been recognised recently by the FDA with 
the prospect of obtaining accelerated approval for potential DMOADs based on an 
imaging-derived surrogate outcome, with subsequent post-approval studies to confirm 
benefit on clinical outcomes(`g).  As well as demonstrating early POC, QIBs may also 
contribute to decision making for later phase studies by informing outcome 
measurement and recruitment strategy (e.g. recruiting participants based on a QIB 
threshold). 
?.d THESIS AIMS 
More work is required for the promise of QIBs in EM studies to be realised. While 
several QIBs (particularly cartilage thickness) have been deployed successfully in large 
observational studies and large clinical trials, there is a relative paucity of evidence on 
their utility in the EM setting. This is important as the desirable performance 
characteristics are different in these two settings. For example, in later stage trials the 
multi-centre feasibility of QIBs is much more of a consideration than in EM studies 
which may be single-centre or, if multi-centre, involve only a small number of sites. 
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At present, this lack of evidence hinders the widespread use of QIBs for EM studies. 
Thus, the purpose of this thesis is to improve the understanding of MR-based QIBs of 
knee OA in general, and in particular provide new data on their performance 
characteristics for EM studies. 
In chapter =, I systematically review the literature on the assessment of cartilage 
composition using MR imaging, and provide a meta-analysis of reliability and 
discriminative validity of the various techniques described, pooling data from ?,@`@ 
persons. 
Chapter Z describes the development and validation of ZD Cartilage Surface Mapping 
(ZD-CaSM), a novel semi-automatic analysis pipeline for articular cartilage which 
overcomes some of the problems with existing methods described in chapter =. This 
validation is performed in five cadaveric knees.  
Moving from articular cartilage to subchondral bone, chapter d describes the 
application of texture analysis to ?== persons in the Osteoarthritis Initiative, a 
prospective multicentre observational study. I assess the association of subchondral 
bone texture on MR imaging with the radiographic worsening of OA over a Z-year 
period, as well as the ability of subchondral bone texture to predict this worsening.  
Chapters f to ` describe the Advanced Magnetic Imaging of Osteoarthritis (AMROA) 
study, a prospective observational clinical study involving => persons. Fourteen 
participants with mild-to-moderate knee osteoarthritis and six age-matched healthy 
controls underwent multiple knee MR examinations over a ?-year period. The aim of 
this study was to assess the performance characteristics of a number of QIBs which 
have the potential to contribute to decision making in EM studies. Reflecting the 
whole-organ concept of knee OA, QIBs of synovium, cartilage and subchondral bone 
were included. The test-retest repeatability, ability to discriminate between OA 
participants and healthy controls, and responsiveness to change over b-months and ?-
year were assessed. The results enable head-to-head comparison of the QIBs assessed 
and will be informative for their inclusion in future longitudinal and interventional 
studies. The thesis closes with a summary of the work performed with reflection on 
knowledge gained and directions for future work.
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CHAPTER 5: 
 
SYSTEMATIC REVIEW AND META-ANALYSIS 
OF THE RELIABILITY AND DISCRIMINATIVE 
VALIDITY OF CARTILAGE COMPOSITIONAL 








MacKay, J. W. et al. Systematic review and meta-analysis of the reliability and 
discriminative validity of cartilage compositional MRI in knee osteoarthritis. 
Osteoarthr Cartil =b, ??d>–??f= (=>?`). 
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Cartilage compositional MR techniques aim to quantify changes in 
the collagen and proteoglycan content of articular cartilage, 
offering the potential to detect very early degeneration.  Here I 
systematically review the literature on these techniques and 
perform meta-analysis to assess their reliability and ability to 
discriminate between subjects with OA and controls. I show that 
the techniques are generally reliable and – in some cases – able to 
discriminate between subjects with OA and controls. However, 
there are several limitations to the current literature leading to 
increased risk of bias, primarily the use of poorly matched control 
groups. Moreover, the magnitudes of the differences between OA 
subjects and controls using existing approaches are small. 
=.? INTRODUCTION 
3.G.G Background 
Breakdown of articular cartilage is an important feature of knee osteoarthritis (OA). 
The earliest changes in articular cartilage are alterations in the biochemical 
composition of the extracellular matrix (ECM), a network of collagen fibrils and 
glycoproteins. These compositional changes may predispose to the development of 
focal defects, which in turn may lead to more diffuse cartilage loss associated with 
established OA.  
Cartilage compositional MR imaging techniques such as T?rho relaxometry, T= 
relaxometry and delayed gadolinium enhanced MRI of cartilage (dGEMRIC) are 
sensitive to changes in cartilage ECM composition, and provide a way to detect 
degeneration before gross morphological changes become apparent.  This contrasts 
with conventional clinical MR imaging which can detect focal defects and diffuse 
cartilage loss but is limited in its ability to detect earlier changes in cartilage 
composition. Compositional MR imaging techniques may therefore allow 
identification of individuals suitable for intervention at an earlier stage, before 
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irreversible changes occur. They also have the potential to assess response to 
treatments designed to repair or regenerate cartilage or slow degradation(``). 
3.G.3 Cartilage compositional MRI techniques 
A detailed review of the relaxation mechanisms underpinning the different 
compositional methods is beyond the scope of this thesis. However, an outline of the 
main compositional methods currently in use is provided below. 
T?rho relaxation refers to longitudinal (spin-lattice) relaxation under the influence of a 
radiofrequency field. It is sensitive to interactions between restricted motion (i.e. 
bound) water molecules and adjacent macromolecules and is therefore sensitive to the 
macromolecular content of tissues(`@). In articular cartilage, T?rho has been shown to 
be sensitive to proteoglycan content, although the strength of reported correlation 
between T?rho relaxation times and proteoglycan content varies between 
studies(@>,@?). 
T= relaxation refers to transverse (spin-spin) relaxation.  It is sensitive to the ability of 
water molecules to move and exchange energy freely. For example, fluid-filled 
structures will tend to have high T= values due to the presence of freely mobile water 
molecules. In articular cartilage, T= has shown to be a non-specific marker of cartilage 
health, sensitive to changes in water content, collagen content and collagen 
orientation(@=–@d). As with T?rho, the strength of correlation between T= relaxation 
times and these measures varies between studies.  
dGEMRIC refers to the assessment of spin-lattice (T?) relaxation following the 
administration of gadolinium-based contrast agent (gdCA). dGEMRIC relies on the use 
of a negatively charged gdCA. Healthy articular cartilage has a bulk negative charge 
primarily due to the presence of negatively charged glycosaminoglycan (GAG) side 
chains of proteoglycans. In diseased cartilage, there is a decrease in GAG 
concentration, with a corresponding decrease in the bulk negative charge. Therefore, 
more negatively charged gdCA will be allowed to enter diseased cartilage than healthy 
cartilage, reflected in shorter T? relaxation times in areas of GAG-depleted 
cartilage(@f). For dGEMRIC to work, gdCA must be able to enter the joint and 
equilibrate between the synovial and articular cartilage compartments.  dGEMRIC 
achieves this via the intravenous administration of gdCA with eventual ‘leakage’ of 
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gdCA into the joint, a process typically encouraged by exercising the joint to be 
imaged. In order for gdCA to equilibrate between the synovial fluid and articular 
cartilage, a waiting period (typically @> minutes following intravenous gdCA) is needed 
between the administration of gdCA and acquisition of the dGEMRIC images(@b). 
dGEMRIC has been shown to be relatively specific to GAG content(@g).  
Sodium imaging directly images the MR-active sodium nucleus (=ZNa), requiring 
specialist hardware and software for non-proton imaging. Healthy articular cartilage 
contains cations, principally sodium ions, which are electrostatically attracted by the 
aforementioned negatively charged GAG side chains. Therefore, the concentration of 
sodium within articular cartilage is proportional to its GAG content. Sodium imaging 
has demonstrated high sensitivity and specificity for the detection of GAG depletion in 
diseased cartilage, although there are limitations including marked reduction in signal-
to-noise ratio and longer acquisition times when compared to proton imaging(@`). 
3.G.? Rationale for current work 
Previous systematic reviews have assessed the reliability and discriminative validity of 
radiographic and conventional clinical MR imaging assessment of knee 
osteoarthritis(d@,f?,fZ). However, there has been no systematic review which has 
evaluated the reliability or discriminative validity of cartilage compositional 
techniques. This was identified as a gap in the literature in recent Osteoarthritis 
Research Society International (OARSI) guidelines for the use of imaging in the setting 
of OA clinical trials(dd). 
As cartilage compositional MR imaging techniques grow in popularity it is important 
to understand how reliable the techniques are and how well they can distinguish 
cartilage in individuals with OA compared to cartilage in healthy controls. 
Accordingly, the aim of this study was to assess the reliability and discriminative 
validity of cartilage compositional MR imaging in knee osteoarthritis. 
For the purposes of this review, I use the term “reliability” to encompass both 
repeatability (measurement precision with conditions remaining unchanged between 
repeat measurements e.g. same observer, same MR platform) and reproducibility 
(measurement precision with conditions changing between repeat measurements, e.g. 
change in observer, change in MR platform) as defined by the Radiological Society of 
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North America Quantitative Imaging Biomarkers Alliance (RSNA-QIBA) Metrology 
Working Group(`=). 
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=.= METHODS 
This systematic review and meta-analysis was undertaken in accordance with the 
Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 
recommendations(@@). 
3.3.G Protocol & Registration 
The study review protocol was prospectively registered on PROSPERO, the 
international prospective register of systematic reviews (available at 
www.crd.york.ac.uk/prospero/display_record.asp?ID=CRDd=>?b>df=f>). 
3.3.3 Eligibility criteria 
In-vivo studies in human subjects involving at least one cartilage compositional MR 
imaging technique at the knee were considered. The list of compositional techniques 
considered included, but was not limited to, T?rho relaxometry, T= relaxometry, T=* 
relaxometry, dGEMRIC, sodium imaging, glycosaminoglycan chemical exchange 
saturation transfer imaging (gagCEST), diffusion weighted imaging (DWI) and 
diffusion tensor imaging (DTI). For a study to be included, it needed to provide 
reliability data on the technique used (either in subjects with OA or healthy controls or 
both) or provide measurements comparing subjects with OA to a control group (i.e. 
discrimination data) or provide both reliability and discrimination data. Only full-text 
papers reporting original data were included. Conference abstracts, review papers, 
letters to the editor and opinion pieces were excluded. Included studies were limited to 
those published in English. Studies using animal models or human tissues ex-vivo were 
excluded. 
3.3.? Information sources 
MEDLINE (?@db – February =>?g) and EMBASE (?@gd – February =>?g) were searched 
via OVID.  The databases OpenGrey, Clinicaltrials.gov and the World Health 
Organization (WHO) International Clinical Trials Registry were also searched for 
additional studies.  The search strategy for the OVID search is presented in Appendix 
=.?. The reference lists of full-text manuscripts obtained, personal databases and the 
contents Tables of key journals were scrutinised for any omitted studies.  
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3.3.B Study selection 
Two researchers performed initial screening to identify potentially eligible studies per 
inclusion and exclusion criteria. The full-texts of all potentially eligible papers were 
then evaluated to enable a final decision on inclusion. Discrepancies were resolved by 
discussion between the reviewers. 
3.3.V Data extraction and list of items 
Data extraction was performed by a single researcher using a piloted electronic data 
collection form and subsequently verified by a second researcher, with disagreements 
resolved by discussion. Where a study was considered potentially eligible but data 
were not presented in an extractable format (e.g. presented in a figure without raw 
values), the corresponding study author was contacted by email to attempt to obtain 
the relevant data. 
Data extracted for all studies included the following: year of publication, number of 
participants, age and sex of participants, study design, definition of OA used by the 
study (if applicable), details of the MR acquisition protocol, MR field strength, 
experience and training of image analysts, blinding of image analysts to additional 
clinical information (e.g. OA/control status) and type of regional or subregional 
analysis performed.  
Study participants with OA were divided into those with mild OA (Kellgren-Lawrence 
(KL) grades ?-=), severe OA (KL grades Z-d) or OA not otherwise specified (NOS) when 
the study did not provide the information required to stratify(=g). 
3.3.E Risk of bias in primary studies 
The risk of bias for studies of reliability was performed using a modification of the 
Quality Appraisal of Diagnostic Reliability (QAREL) tool relevant to this analysis(?>>).  
Assessment of risk of bias in studies of discriminative validity was performed using a 
modification of the revised Quality Assessment of Diagnostic Accuracy (QUADAS-=) 
tool(?>?). Full details of the modifications made to QAREL and QUADAS-= tools are 
presented in Appendix =.d. 
3.3.W Data analysis 
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The primary endpoint for the reliability assessment was a narrative summary of the 
reliability statistics for intra and inter-observer and test-retest reliability. 
A meta-analysis was not appropriate due to the heterogeneity in methods for 
calculating reliability metrics from the included studies. For example, the coefficient of 
variation (CV) may be presented as a single value, or the root-mean-square average of 
several values (RMSCV). There are numerous approaches to computing the intraclass 
correlation coefficient (ICC) which prevent pooling, and directly comparing ICC across 
different populations could be misleading(?>=,?>Z). For the purposes of this review I 
use an interpretation of ICC values based on Landis and Koch(?>d). 
The primary endpoints for the discriminative validity part of this review were estimates 
of standardised mean difference (average difference between groups divided by the 
pooled standard deviation of the two groups, analogous to effect size) between 
subjects with OA and normal controls for each compositional technique studied. 
Secondary endpoints were estimates of standardised mean difference between subjects 
with OA and normal controls for each compositional technique studied, limited to 
studies where control group participant age had been matched to the OA group. The 
standardised mean difference was used to allow comparison across different 
compositional techniques with values which vary considerably in magnitude. Where 
there were less than two studies available for any given comparison, a narrative 
analysis was conducted. 
The appropriateness for meta-analysis was evaluated by assessing the data extraction 
table for study heterogeneity in cohort characteristics, imaging technique, analysis 
technique and study processes. Where study heterogeneity was evident for one or 
more of these factors, a narrative analysis was undertaken. When this did not occur, a 
meta-analysis was undertaken. In each analysis, statistical heterogeneity was 
calculated through the I= statistic. Fixed effects models were used to pool outcome 
measures with low heterogeneity (I= ≤ ?>%), whereas random effects models were used 
to pool outcome measures with high heterogeneity (I= > ?>%). A strict I= threshold was 
used, wishing to minimise the risk of any ‘unknown’ heterogeneity from influencing 
the interpretation of the analyses, particularly as an emphasis had been placed on 
excluding ‘known’ heterogeneity in the assessment of study characteristics. 
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All meta-analyses were performed using Review Manager version f.Z (The Cochrane 
Collaboration)(?>f). 
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Figure ).+ 
PRISMA flow chart demonstrating process for selection of included studies. 
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=.Z RESULTS 
3.?.G Study selection 
Database searching identified bbf citations, with an additional g@ citations identified 
through other sources (personal databases, reference lists of included studies, contents 
Tables of key journals). The full-text version of ?@= articles was retrieved for detailed 
review. Forty-eight articles were included in the reliability assessment, ?b articles were 
included in the discrimination validity assessment and ?> articles were included in 
both evaluations (Figure =.?)(?>b–?g@). 
3.?.3 Reliability study characteristics 
Characteristics of included studies are reported in Appendix =.=. Data from ?,dgZ 
subjects were included in the reliability analysis. The most commonly used 
compositional technique was T= relaxometry, featuring in Zb of f` (b=%) studies. The 
number of participants in each study ranged from five to =`@ (median =>). The mean 
(standard deviation, SD) age of participants was db.= (?d.f) years. Fifty-three percent of 
included subjects were female.  
Twenty-two studies reported data on intra-observer reliability, =f studies reported 
data on inter-observer reliability and ZZ studies reported data on test-retest reliability. 
Three studies provided multi-centre test-retest reliability data. 
3.?.? Discriminative validity study characteristics 
Characteristics of included studies are reported in Appendix =.Z. Data from gbb 
subjects were included in the discriminative validity analysis. The most commonly 
used compositional technique was T= relaxometry, featuring in ?g of =b (bf%) studies. 
The number of participants in each study ranged from ?f to ?f= (median ZZ). The mean 
(SD) age of OA subjects was f`.Z (d.@) years compared to d>.@ (??.g) years in control 
subjects with females representing fb% of OA subjects compared to f=% of controls.  
Eight studies included subjects with mild OA, three studies included both subjects 
with mild OA and subjects with severe OA and ?f studies did not stratify OA severity 
and were considered as OA (NOS) for these analyses.  
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3.?.B Risk of bias in primary studies 
Full results of quality assessments of reliability and discriminative validity studies are 
presented in Appendix =.d. Overall, the quality of the evidence was moderate for the 
reliability assessment and moderate for the discriminative validity assessment. 
Recurrent weaknesses for the reliability data included the assessment of reliability in 
only healthy volunteer subjects, lack of information regarding image analyst 
experience or training, and lack of information regarding image analyst blinding to 
previous results for studies of intra and inter-observer reliability. Recurrent 
weaknesses for the discrimination validity data included the use of unmatched control 
subjects and the potential lack of blinding of image analysts to subject group. 
3.?.V Reliability outcomes 
A summary of the results of the reliability analysis are presented in Figure =.=, with full 
results in Appendix =.=. 
Figure ).) 
Summary of reliability data (left panel – coefficient of variation (%), right panel – intraclass correlation coefficient) 
for the three most commonly studied compositional techniques. Central point represents median value, lines 
represent interquartile ranges. Where a study provided more than one estimate, a mean value was used. 
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).D.F.+ T) relaxometry 
Intra-observer ICCs ranged from >.Z> to >.@@ and CVs ranged from >.` to d.g%. 
Studies featuring multiple subregional analyses tended to report lower ICC values 
(?fb).  Inter-observer ICCs ranged from >.?g to >.@@ and CVs ranged from ?.> to ?=.=%. 
Again, studies which performed analysis on multiple small subregions and analysis of 
multiple cartilage layers had poorer reproducibility(??g,?fb). CVs for test-retest 
repeatability where analyses were performed on major compartments (e.g. medial 
femur, medial tibia etc) were =.Z to b.f%, with higher values (up to ==%) again seen 
where smaller subregional or laminar analyses were performed(??g). Three studies 
examined test-retest repeatability in a multi-centre setting, reporting CVs between =.Z 
and f.Z% for major compartments and up to ?d% for subregional analyses(?>g,?Z>,?Zb). 
).D.F.) T+rho relaxometry 
One study provided intra-observer reproducibility data, with a CV of Z.`%(?=Z). All 
studies of inter-observer reproducibility reported ICC values in the ‘excellent’ range (> 
>.`). Inter-observer CV values ranged from ?.d to ??.`%. Test-retest repeatability was 
good-to-excellent (ICCs >.gZ to >.@b, CV =.Z to b.?%) when major compartments were 
analysed but poorer (ICCs as low as >.=, CV as high as ?@%) in two studies where 
laminar analysis was performed(???,?Zb). Two studies examined test-retest repeatability 
in a multi-centre setting, reporting CVs of d.@% for major compartments and up to 
?`.`% for subregional analyses(?Z>,?Zb). 
).D.F.D dGEMRIC 
Intra and inter-observer reproducibility data were reported by two studies each, with 
excellent agreement (ICCs > >.@) and CVs of less than Z%(?>b,?Z@,?f`).  Test-retest 
repeatability was excellent (ICCs > >.`f, CV d.= to g.d%) apart from one study 
comparing different T? mapping techniques for dGEMRIC which reported ICC values 
as low as > and a CV of ??% for a variable flip angle (VFA) technique(?f=). 
  
  31 
).D.F.E Others 
Intra- and inter-observer reproducibility data were also reported for sodium imaging, 
gagCEST, T=* relaxometry, T? relaxometry (without contrast), magnetisation transfer 
(MT) imaging and ultrashort TE T=* (UTE-T=*) relaxometry, with excellent 
reproducibility (ICCs > >.`) for gagCEST, T=*, MT and UTE-T=*, CVs of f.? to f.@% for 
T? mapping and CVs of `.? to ??.d% for sodium imaging. 
Test-retest repeatability data were reported for the above techniques as well as DTI. 
Excellent test-retest repeatability ICCs were demonstrated for T=* (>.@Z) and sodium 
imaging (>.@?)(?d>,?d?).  Test-retest CVs were generally less than ?>% except for 
sodium imaging which had test-retest CVs between @.? and ?=.Z%(?=Z,?Zd). 
3.?.E Synthesis of results – discriminative validity 
Results of the meta-analysis of discriminative validity are presented in Table =.? and 
Figure =.Z. Individual forest plots for each method are presented in Appendix =.f. 
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Figure ).D 
Summary forest plot comparing standardised mean differences between subjects with and without OA for each 




).D.Q.+ Mild OA 
Both T= and T?rho relaxometry demonstrated significant discrimination between 
subjects with mild OA and controls (p < >.>>?), with a greater standardised mean 
difference (SMD) for T?rho (>.gZ, @f% CI >.d> to ?.>b) than for T= (>.d@, >.Z> to >.bg). 
dGEMRIC did not show significant discrimination for mild OA with a SMD of >.?Z 
(@f% CI ->.=Z to >.d@, p = >.dg). Single studies evaluating MT imaging in patellar 
cartilage and DTI imaging did discriminate significantly between subjects with mild 
OA and controls in some compartments(?dg,?fZ). 
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).D.Q.) Severe OA 
Pooling of discrimination data was possible for T= relaxometry only, which 
demonstrated significant discrimination between subjects with severe OA and controls 
(p < >.>>?) with, as expected, a greater SMD of ?.=d (>.bZ to ?.`f) when compared to 
the mild OA data. Single studies evaluated discrimination validity for T?rho, dGEMRIC 
and MT, demonstrating significant differences between groups for T?rho and 
dGEMRIC but not MT. 
).D.Q.D OA (Not Otherwise Specified) 
T= relaxometry and T?rho relaxometry demonstrated significant differences between 
subjects with OA (NOS) and controls (p < >.>>?). As for mild OA subjects, T?rho 
relaxometry had a higher SMD (>.b>, >.d? to >.`>) than T= relaxometry (>.d`, >.Zd to 
>.b=). dGEMRIC (p = >.?`, SMD = ->.Z?, ->.g` to >.?f) and sodium imaging (p = >.?g, 
SMD = ->.=>, ->.f> to >.>@) did not significantly discriminate OA subjects from 
controls. Single studies of T=* relaxometry and DTI demonstrated significant 
discrimination in some compartments(?d>,?d`). 
).D.Q.E Additional analyses 
When analysis was restricted to studies that had control groups matched to OA 
subjects for age, data for T= and T?rho relaxometry comparing OA (NOS) subjects with 
controls could be pooled. Both techniques retained significant discrimination between 
subjects with OA and controls (p < >.>>?), but with lower SMD values of >.Z= (>.=> to 
>.dd) for T= and >.Zd (>.?g to >.f?) for T?rho. 
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Table ).+ 
Summary of discrimination between subjects with OA and controls for included compositional techniques. Only 





Standardised Mean Difference (,F% CI) 
Mild OA vs 
controls n 
Severe OA vs 
controls n 
OA (NOS) vs 
controls n 
T= *.E, (*.D*, *.Q/) ` +.)E (*.QD, +.-F) Z *.E- (*.DE, *.Q)) ?> 
T?rho *./D (*.E*, +.*Q) d - - *.Q* (*.E+, *.-*) g 
dGEMRIC >.?Z (->.=Z, >.d@) = - - ->.Z? (->.g`, >.?f) Z 
Sodium - - - - ->.?@ (->.f=, >.?f) Z 
n – number of studies pooled for standardised mean difference estimate 
Pooled comparisons in bold were statistically significant (p < >.>f) 
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=.d DISCUSSION 
This systematic review has shown that cartilage compositional MR imaging techniques 
perform well across the domains of intra-observer, inter-observer and test-retest 
reliability. T= and T?rho relaxometry demonstrated discrimination validity in mild OA 
and non-specific OA populations.  
Reliability values were generally high across all techniques studied with ICC values in 
the ‘excellent’ range (> >.`) and low CVs (< f% in most cases). Reliability was slightly 
poorer for sodium imaging. The reliability values here are commensurate with those 
for established quantitative measures of joint structure such as cartilage volume and 
quantitative imaging biomarkers in other body systems(f?,?`>,?`?). This suggests that 
cartilage compositional MR imaging is suitably reliable for use in the assessment of 
knee OA, particularly for the techniques of T= and T?rho relaxometry where there are 
most data available.  Analyses performed on small cartilage subregions or involving 
laminar analysis (where cartilage is split into = or Z layers from deep to superficial) 
tended to be less reliable than those assessing larger cartilage regions.  This is probably 
due to the effects of noise and partial volume with adjacent synovial fluid and 
subchondral bone which are likely to be exacerbated in small regions of interest 
(ROIs), together with increased scope for subjective positioning differences between 
observers. This should be borne in mind when such analyses are interpreted. Few 
studies examined test-retest reliability in a multi-centre setting. To facilitate use of 
compositional techniques in large-scale clinical trials, more studies in this area are 
needed. 
T?rho and T= relaxometry demonstrated the ability to discriminate between subjects 
with mild OA and controls, and subjects with OA (NOS) and controls. T?rho 
demonstrated larger SMD values in both populations suggesting that it has superior 
discrimination validity, in keeping with the results of previous in vivo and ex vivo 
studies(?fg,?gf,?`=). dGEMRIC and sodium imaging demonstrated smaller and non-
significant SMDs between OA subjects and controls. This contrasts with previous work 
showing better correlation between dGEMRIC and GAG content of articular cartilage 
than between T?rho values and GAG content(@g).  Possible reasons for the poorer 
performance of dGEMRIC in this meta-analysis include variation in imaging protocols 
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between studies which may have affected results(@b), or the fact that dGEMRIC is just 
a poorer technique in vivo.  
For all techniques studied, there was significant statistical heterogeneity between 
different cartilage regions. This concurs with previous work demonstrating significant 
spatial variation in articular cartilage compositional values at the knee, and potentially 
suggests that changes in cartilage composition due to OA also show substantial spatial 
variation(?b?,?bg,?`Z). 
The principal role for cartilage compositional MR imaging is the detection of adverse 
changes in cartilage composition prior to morphological damage. Therefore, they are 
of greatest potential utility in subjects with mild OA and are of questionable value 
once the disease is more advanced(?`d). SMD values for T?rho and T= relaxometry, 
which showed significant discrimination validity for mild OA population, correspond 
to relatively small absolute differences between mild OA subjects and controls of Z.f 
ms (@f% CI ?.@ – f.= ms) for T?rho and ?.@ ms (?.= – =.g ms) for T=. Although 
statistically significant differences have been demonstrated between groups in this 
meta-analysis, it is questionable whether these differences are of clinical significance, 
that is of sufficient magnitude to provide useful clinical discrimination when 
interpreting a single measurement.  Moreover, these small differences may be 
exaggerated because few control groups were matched to OA subjects for important 
characteristics such as age or sex. Given these small overall differences, novel methods 
of enhancing the utility of compositional data are being developed. These include 
novel data-driven analyses such as voxel based relaxometry and cluster analysis which 
give the ability to detect localised changes without the reliability problems associated 
with small manual ROIs, and so-called ‘functional’ cartilage imaging where differences 
between normal and abnormal cartilage may be exacerbated(?db,?`f–?`g). 
This study has some unavoidable limitations. First, I have considered reliability and 
discrimination validity of cartilage compositional MR imaging, but not responsiveness 
to change. This will be an important factor to consider when using cartilage 
compositional MR imaging as an imaging biomarker of response to treatment, and 
from a clinical utility point of view it may be that the magnitude of intra-subject 
change is more important than absolute mean differences between OA and control 
groups. However, at present, there have not been sufficient studies in this area to 
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permit pooled analysis.  Moreover, the majority of studies which have used cartilage 
compositional MR imaging in a longitudinal setting do not report sufficient data to 
allow calculation of standardised response means for pooling. Second, the quality of 
included studies was variable for both reliability and discriminative validity studies. 
The reliability values reported across different studies were consistent suggesting that 
substantial bias affecting the results of this part of the review had not been introduced 
by these factors. However, discriminative validity results did vary between studies, as 
indicated by moderate heterogeneity in the meta-analyses. Third, data extraction was 
performed by a single reviewer only with discussion with a second reviewer in cases of 
doubt, whereas optimal methodology would involve independent data extraction by 
two reviewers. 
In conclusion, this systematic review and meta-analysis has demonstrated that 
cartilage compositional MR imaging techniques are reliable and, in the case of T= and 
T?rho relaxometry, able to discriminate between subjects with OA and controls.  
  
  38 
APPENDIX =.?  
Search strategy for MEDLINE and EMBASE 




f exp knee/ 
b or/d-f 
g exp magnetic resonance imaging/ 
` MRI.ti,ab. 





















Z> exp sensitivity/ 












Characteristics of included reliability studies 






















 mild sev NOS  OA other OA other Number Experience 
Anandacoomarasamy(MNO) - - - )N - NS - NS Q dGEMRIC intraO ICC N.RM M NS 
Balamoody(MNT) - - M) - UR - )V - Q T) TR# RMSCV ).Q – O.Q M NS 
Baum(MNZ) - - - M)O - VN - VN Q T) intraO RMSCV M.TO M NS 
Blumenkrantz(MNR) MQ MT - - OU - QR - M.V T) intraO CV M.V – ) M NS 
Bron(MMN) - - MM MN V) )T OU UN Q dGEMRIC TR ICC N.ZV – N.R M NS 
Carballido-Gamio(MMM) - - - V - )R - )N Q TMrho TR CV Q.Z – M).Q† NS NS 
Dardzinski(MM)) - - V V V) TN Q T) TR RMSCV Q.Q – O.V M NS 








Guha(MMU) - - )N )N VZ VU VN ON Q DTI TR RMSCV O.V – MM.O NS NS 




Hada(MMO) VN - - MR VT )V VU QT Q T) 
intraO ICC N.RM 
) NS 
interO ICC N.ZT 
Hannila )NNR(MMT) - - - )N - )Q - VN M.V T) interO 
RMSCV M.Z – MU.)† 
) NS 
ICC N – N.RZ† 
Hannila )NMV(MMZ) - - - R - QN - UU M.V T) TR 
RMSCV ).V – )).)† 
M NS 
ICC N – N.RZ† 
Hesper(MMR) - - - MN - )R - TN Q T)* intraO ICC N.RT M Z years 
  






















 mild sev NOS  OA other OA other Number Experience 




) At least )V datasets T) U.R 
Hovis )NMM(M)M) - - - MOM - VN - VR Q T) intraO RMSE N.TU – M.VM M NS 





















TR MM.Q – M).R 
Joseph )NMM(M)U) - - - MUV - VN - VR Q T) intraO RMSCV N.R – ).M M NS 
Joseph )NM)(M)V) - - - )ZR - VM - UT Q T) intraO RMSCV N.Z – Q.) M NS 
Juras )NMO(M)O) - - - )Q - QQ - VT Q T) interO CV V.Z – MN.Z† ) MN years/ MV years 
Koli(M)T) ZN - - - VZ - MNN - M.V T) interO RMSCV ) NS NS 
X Li )NNV(M)R) - - R MN V) QN UU UN Q TMrho TR CV U.Z NS NS 
X Li )NMU(M)Z) - - - O - ))-QV - VN Q 
TMrho 
TR RMSCV 
U.) – O 
NS NS 
T) V – O.Q 
X Li )NMV(MQN) - - - MZ - NS - NS Q 
TMrho 
TR# RMSCV 
).Q – V.M 
NS NS 
T) Q.) – V.Q 






Liess(MQ)) - - - )N - )Z - )N M.V T) TR CV M.T NS NS 
Liu(MQQ) - - MU MQ VQ )Z QO )Q Q T) TR CV Q.M - MN M U years 
  






















 mild sev NOS  OA other OA other Number Experience 
Madelin(MQU) - - - O  QT - VN Q, T Sodium TR RMSCV R.M – M).Q NS NS 
Matsubara(MQV) MN - - MR VT QR Q) N Q TMrho interO ICC N.RQ ) Z years/ R years 
Mosher )NMM(MQO) MO MO - MZ VU )T VR OT Q 
TMrho 
TR# 
ICC N.)N – N.RQ† 
NS NS 
TMrho RMSCV T.)Q – MZ.ZQ† 
T) ICC N.OM – N.RZ† 
NS Computer tutorial T) RMSCV U.QO – MU† 
Mosher )NNU(MQT) - - - QN - ))-ZO - MNN Q T) intraO wK N.TT M Z years 




) O years/ M) years dGEMRIC Q 
Multanen )NNR(MQZ) - - - MN - Q) - VN M.V dGEMRIC TR 
ICC N.UV – N.RZ† 
NS NS 
RMSCV U.T – M). R† 
Newbould )NM)(MUN) - - MQ V OU O) TT ZN Q T)* TR 
ICC N.T – N.RU 
NS NS 
CV Q.) – T.T 
Newbould )NM)b(MUM) - - MV V OU O) ZN ZN Q Sodium TR 
ICC N.OT – N.RU 
M NS 
CV Q.O – R.R 





T) < O 












Pan(MUV) - - - RV - VV - OM Q T) intraO RMSCV M.M – M.) M NS 
Pedoia(MUO) UN - - MV VU UZ NS NS Q TMrho TR CV ) ) ) years/ U years 
Raya )NMU(MUT) V - - MN OO QM NS QN T DTI TR RMSCV ).R – V.O NS NS 
Raya )NM)(MUZ) - - MN MO OM QM VN UU T 
DTI 
TR RMSCV 
T.Q – MR.Q† 
M V years 
T) V.V – O.R† 
  






















 mild sev NOS  OA other OA other Number Experience 
Schleich(MUR) - - - )N - )V - UN Q gagCEST 
intraO 
ICC 
N.RV M Z years 
interO N.RV ) V years/ Z years 






Singh(MVM) - - - Z - )N-QV - NS T TMrho TR 
ICC N.TQ – N.RO 
NS NS 
CV ).Q – U.Q 
Siversson(MV)) - - - R - UV - VO M.V dGEMRIC TR 
ICC N – N.OR 
NS NS 
RMSCV O.N – MM.O 
Sritanyaratana(MVQ) MM - - )N VQ Q) QO )V Q MT TR CV N.V – U.O M NS 
Stehling )NMN(MVV) - - - M)N - VM - VN Q T) intraO CV M.) M NS 
Stehling )NMM(MVU) - - - MN - V) - VN Q T) interO RMSCV M.) – ).Z† ) NS 
Surowiec(MVO) - - - MZ - MZ-QV - NS Q T) 
intraO 
ICC 
N.MT – N.ZR 
Q 
V years/ O 
years/ MQ 
years interO N.Q – N.RO 




) M) years / T years T) N.R) 
Tiderius(MVZ) - - - M) - )U - N M.V dGEMRIC 
intraO 
CV 








Van Tiel(MVR) MT - - - VN - UM - Q dGEMRIC TR ICC N.ZT – N.RV M Medical degree 
  






















 mild sev NOS  OA other OA other Number Experience 
Welsch(MON) - - - MT - )O - )U Q, T 
T) 
interO ICC N.RM – N.RV† 
Q 
) years/ MN 
years/ )V 
years 
TR CV T.) – Z.T† 
T)* 
interO ICC N.ZZ – N.RN† 
TR CV O.Z – T.Z† 
MT 
interO ICC N.ZU – N.RM† 
TR CV R.) – MN.Z† 
Wiener(MOM) - - - )V - QM - ON M.V TM TR CV V.M – V.R M NS 
Williams(MO)) - - - MM - )Z - MNN Q UTE-T)* 
intraO ICC N.ZN – N.RT† 
M R years 
TR RMSCV O - MO† 
Zuo(MOQ) - - - O - )T-QN - MT Q 
TMrho 
TR CV 
M.Z – V.O 
NS NS T) ).R – V.T 
Abbreviations: sev  - severe, NS – not specified, intraO – intra-observer, interO – inter-observer, TR – test-retest. 
**Reliability values are presented as ranges when values were provided separately for different cartilage ROIs. RMSCV and CV values are provided as 
percentages. 




Characteristics of included discrimination studies 










Definition of OA 
 mild sev NOS  OA control OA control 
Dunn(MOU) )N )Z - T OQ/OT* QZ OV/VN* UQ M.V T) Radiographs and symptoms 
Eckstein(MOV) - - TT TV VZ VV MNN MNN Q T), dGEMRIC Radiographs only 
Hada(MMO) VN - - MR VT )V VU QT Q T) ACR criteria 
X Li )NNV(M)R) - - R MN V) QN UU UN Q TMrho Radiographs and/or symptoms 
X Li )NNT(MOZ) - - MN MO VO UM QN VN Q TMrho, T) Radiographs and symptoms 
X Li )NNR(MOT) - - MN MN VO UM QN UN Q TMrho, T) Radiographs and symptoms 
W Li )NMN(MOO) - - MU R O) )R TU OU M.V dGEMRIC MRI and/or radiographs and/or symptoms 
Liu )NMV(MQQ) - - MU MQ VQ )Z QO )Q Q T) Radiographs and symptoms 
Madelin(MOR) - - )Z MR OU QV VT U) T Sodium ACR criteria 
Matsubara(MQV) MN - - MR VT QR Q) N Q TMrho Radiographs and symptoms 
Mosher(MQO) MO MO - MZ VM/VT* )T UU/TV* OT Q TMrho, T) Radiographs only 
Multanen(MQR) TZ - - M) VR VZ MNN MNN M.V T), dGEMRIC Radiographs and symptoms 
Newbould )NM)(MUN) - - )N MT OU OM OV TO Q T)* ACR criteria 
  










Definition of OA 
 mild sev NOS  OA control OA control 
Newbould )NMQ(MTZ) - - )Z )Q OQ O) NS NS Q Sodium ACR criteria 
Owman(MTN) - - )T T NS NS NS NS M.V dGEMRIC Radiographs only 
Raya )NM)(MUZ) - - MN MO OM QM VN UU T DTI, T) ACR criteria 
Raya )NMU(MUT) V - - MN OO QM NS QN T DTI ACR criteria 
Souza )NMQ(MT)) - - UU MR VT QR NS NS Q TMrho, T) Radiographs and symptoms 
Souza )NMU(MTM) - - UU RQ VT VN OM VZ Q TMrho, T) Radiographs and symptoms 
Sritanyaratana(MVQ) MM - - )N VQ Q) QO )V Q MT Radiographs and symptoms 
Stahl )NNT(MTQ) - - Z MN VO VZ MNN MNN Q T) Radiographs and symptoms 
Stahl )NNR(MTU) MT - - )N VU QU VQ VN Q TMrho, T) ACR criteria 
Wang(MTV) MN - - MN OV QO )N UN Q TMrho, T) Radiographs only 
Wirth(MTO) Q) - - ZR ON VV VO ON Q T) Radiographs only 
Wyatt(MTT) - - M) T VR VN U) TM Q, T TMrho, T) Radiographs and symptoms 
Yao(MTR) )N )N - MM UZ/VV* QR OV/ON* )T Q T), dGEMRIC, MT Radiographs and symptoms 
Abbreviations: sev - severe, ACR – American College of Rheumatology, NS – not specified. 
*Mean ages and female percentage for mild/severe OA groups provided separately
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APPENDIX +.- 
Quality assessment of included studies 
!. Reliability 
 
Modified QAREL items as follows: 
B. Was the test evaluated in a sample of subjects who were representative of those 
to whom the authors intended the results to be applied? 
+. Was the test interpreted by analysts who were representative of those to whom 
the authors intended the results to be applied? 
K. Were analysts blinded to the findings of other analysts during the study (only 
inter-observer reliability studies)? 
-. Were analysts blinded to their own prior findings of the test under evaluation 
(only intra-observer reliability studies)? 
P. Were analysts blinded to clinical information e.g. age, sex, OA status (only for 
studies featuring both OA subjects and controls)? 
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U. Was the time interval between repeated measurements compatible with the 
stability of the measurement (only test-retest reliability studies)? 
V. Was the MR protocol described reproducibly? 
W. Were appropriate statistical measures of agreement used? 
 
,. Discriminative validity 
 
Modified QUADAS-+ items as follows: 
B.  PATIENT SELECTION 
Risk of bias 
Could the selection of patients have introduced bias? 
Signalling question .: Was an attempt made to match control and OA populations for 
important baseline characteristics (e.g. age, sex)? 
Signalling question 0: Did the study avoid inappropriate exclusions? 
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Applicability 
Are there concerns that the included patients do not match the review question? 
+. INDEX TEST 
Risk of bias 
Could the conduct or interpretation of the index test have introduced bias? 
Signalling question .: Were image analysts blinded to additional clinical cues (e.g. age, 
sex, OA status)? 
Signalling question 0: Is the MR imaging acquisition protocol described in sufficient 
detail for it to be reproduced? 
Signalling question 1: Is the image analysis procedure described in sufficient detail for 
it to be reproduced? 
Applicability 
Is there concern that the index test, its conduct or interpretation differ from the review 
question? 
K. DEFINITION OF OA 
Risk of bias 
Signalling question .: Was the study definition of OA based on clinical symptoms, 
imaging findings or both? Were standard (ACR) criteria applied? 
Applicability 
Is there concern that the definition of OA used differs from the review question? 
-. FLOW AND TIMING 
Risk of bias 
Signalling question .: Were all participants included in the analysis? 
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APPENDIX +.P 
Forest plots for discriminative validity assessment 
T,: mild OA vs controls 
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T,: Severe OA vs controls 
 
  
  51 
T,: OA (NOS) vs controls 
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T!rho: mild OA vs controls 
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T!rho: OA (NOS) vs controls 
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dGEMRIC: mild OA vs controls 
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dGEMRIC: OA (NOS) vs controls 
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Sodium: OA (NOS) vs controls 
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CHAPTER ): 
 
)D CARTILAGE SURFACE MAPPING – 
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Here I describe the development of a novel semi-automatic surface-based 
method for analysing articular cartilage at the knee using clinical MR 
imaging data termed 1D Cartilage Surface Mapping (1D-CaSM). This aims to 
solve some of the problems associated with traditional cartilage analysis 
alluded to in the previous chapter. The method described allows the 
visualisation of the spatial distribution of cartilage thickness and 
compositional parameters, and the performance of spatially corresponded 
surface-based comparisons between individuals and within the same 
individual over time. I present an outline of the steps involved in the analysis 
pipeline and the results of a validation study using cadaveric knees. 
K.B INTRODUCTION 
Improved methods of assessing articular cartilage using magnetic resonance (MR) 
imaging are desirable to enhance understanding of osteoarthritis (OA) onset and 
progression and to assess response to putative disease modifying treatments 
(DMOATs) targeting cartilage. 
Traditional analysis of cartilage using MR data involves manual segmentation of 
articular cartilage surfaces. While this is accurate and reliable, it suffers from two main 
drawbacks. First, manual segmentation is time consuming and represents a 
considerable resource burden for researchers. Second, measurements are often 
averaged over relatively large regions of interest (ROIs). While these measurements 
may be attractively simple, such reductive approaches limit responsiveness and mask 
important focal changes(BWW). 
Several techniques which better respect the spatial distribution of cartilage 
measurements have been described. However, these either rely on combining 
measurements made on individual +D images which do not reflect the true KD 
geometry of the cartilage surfaces, or only permit measurement of morphology and not 
composition(B-U,BWV,BWh,Bhi). 
These drawbacks limit the utility of cartilage imaging biomarkers in clinical trials, 
particularly in early phase clinical trials where sample sizes are small and follow-up 
periods are short. However, with the shift towards biomarker rich experimental 
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medicine study designs, there is potential for imaging to make great impact in these 
trials and contribute to go/no-go decision making(VU). 
Improved responsiveness may be realised by using better analysis methods which both 
reflect the true KD spatial distribution of changes in cartilage over time and can 
analyse multiparametric data (i.e. both morphological and compositional). Here I 
propose a method which fits these criteria, termed KD cartilage surface mapping (KD-
CaSM), a modification of a previously described method termed cortical bone mapping 
(CBM).   
CBM has been validated and used extensively for the measurement of cortical bone 
thickness, predominantly in the setting of osteoporosis (BhB,Bh+). This method can 
overcome inherent inaccuracies in measurement of thin plate-like structures at clinical 
imaging resolutions related to slice thickness and the imaging system’s point spread 
function via model-based deconvolution of the imaging data(BhK). It allows KD 
measurement and visualisation of data, can handle multiparametric input and has 
demonstrated the ability to show targeted treatment-related effects(Bh-–BhU). Visually 
and statistically powerful surface-based comparisons can be made between groups and 
within individuals over time(Bh+). CBM-type analysis can potentially be applied to any 
thin plate-like structure as illustrated by its use to measure KD joint space on CT and 
preliminary work demonstrating its ability to measure cartilage thickness on MR 
imaging(BhV,BhW). 
However, the technique is yet to be validated for measuring individual cartilage 
surfaces at the knee. Here I aimed to validate thickness measurements obtained from 
cadaveric knees imaged at clinically feasible spatial resolution and acquisition times 
with MR imaging against very accurate high resolution peripheral quantitative CT 
(HRpQCT) thickness measurements obtained at a much higher spatial resolution than 
would be possible in vivo.  
The validation of KD-CaSM thickness values is critical for the entire KD-CaSM pipeline, 
as the inner and outer cartilage surfaces generated by the thickness measurement 
process are crucial for downstream cartilage compositional analysis. 
  60 
K.+ METHODS 
1.0.. Study subjects 
Five embalmed human cadaveric knees (+ female, aged WB – Wh years old) were 
obtained from the University of Cambridge Human Anatomy Centre (HAC) for the 
validation work. All cadavers had given ante-mortem consent for post-mortem use of 
specimens for education and research, and the study was approved by the University of 
Cambridge Human Biology Research Ethics Committee. Specimens consisted of intact 
articulated knee joints from distal femoral diaphysis to proximal tibial diaphysis and 
included all periarticular soft tissues. 
1.0.0 MRI acquisition 
Intact cadaveric knees underwent MR imaging on a clinical K Tesla system (MR VPi; 
GE Healthcare, Waukesha, WI) using an W-channel knee coil (Invivo, Gainesville, FL). 
A K-dimensional fat suppressed spoiled gradient echo (KD SPGR) sequence was 
performed, aiming to optimise contrast resolution between articular cartilage and 
adjacent bone and synovial fluid and maximise spatial resolution within a clinically 
feasible acquisition time. Imaging parameters were as follows: field of view, BPi x BPi x 
B-i mmK; matrix size PB+ x KWi (interpolated to PB+ x PB+) with in-plane spatial 
resolution i.K x i.K mm; slice thickness B mm; flip angle +Po; repetition time +U ms; 
echo time in-phase; number of averages i.P; acquisition time approx. V minutes.  
1.0.1 Cadaveric dissection 
Following MR imaging examination, cadaveric knees were dissected (by JM) in the 
HAC to allow disarticulation of the knees into the individual bones (femur, tibia and 
patella). The periarticular soft tissues, ligaments, capsule and menisci were removed to 
leave the bone with the cartilage surface exposed (Figure K.B). To prevent desiccation, 
all specimens remained stored in embalming fluid when not in use. 
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Figure J.! 




Disarticulated specimens were mounted in an acrylic holder (Figure K.+) and secured 
using padding material, ensuring that an air-cartilage interface was maintained and 
that the articular cartilage was not in contact with the holder at any point.  
The disarticulated specimens were then examined with HRpQCT (XtremeCT; Scanco 
Medical, Brüttisellen, Switzerland) with an isotropic voxel size of i.iW+ mm, peak 
voltage of Ph.- kV, tube current of i.BW mAs. 
Figure J., 
Cadaveric femur loaded into acrylic holder for HRpQCT 
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1.0.M Image analysis 
KD SPGR MR images were imported in Digital Imaging and Communications in 
Medicine (DICOM) format into Stradwin version P.-a (University of Cambridge 
Department of Engineering, Cambridge, UK) for KD-CaSM. The initial KD-CaSM 
analysis process is summarised in Figure K.K. 
Figure J.J 
Outline of initial steps in KD-CaSM pipeline, from image acquisition to thickness measurement. Step U results in the 
generation of accurate inner and outer cartilage surfaces between which the thickness measurements have been 
made. Femur used for demonstration purposes – KD-CaSM is also performed for tibial cartilage surfaces. 
 
First, the whole femur and tibia (including the cartilage surfaces) were manually 
segmented by a single observer (JM). This was performed on every Pth sagittal image 
(i.e. at P mm intervals) as the next step accurately creates the intermediate data. This 
step takes approximately BP minutes per knee. Second, KD meshes and corresponding 
isosurfaces were triangulated using the regularised marching tetrahedra method(Bhh). 
Volume-preserving surface smoothing allows creation of an accurate surface even from 
sparse, approximate manual contours. This surface acts as a guide for further 
measurements but does not have to conform to the cartilage border exactly. Third, 
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cartilage ‘patches’ for femur, medial tibia (MT) and lateral tibia (LT) were segmented 
manually directly onto the KD femoral and tibial surfaces. This is aided by the display 
of adjacent signal intensity values onto the KD surface, a process known as 
compounding. Finally, automated cartilage thickness mapping was performed across 
each patch at each vertex on the surface (femoral patch - approximately -iii vertices, 
medial and lateral tibial patches – approximately Biii vertices) using a model-based 
deconvolution of the MR imaging data sampled along a line orthogonal to the cartilage 
surface (i.e. surface normal). As well as thickness measurements, this procedure also 
generates accurate inner and outer surfaces. This process can be prone to error in areas 
of low contrast resolution for the outer cartilage border (e.g. where it contacts an 
adjacent cartilage surface), therefore the outer surface is constrained to lie within K 
pixels (~B mm) of the approximate manually created surface.  Whole bone surfaces, 
inner and outer cartilage surfaces and thickness data were generated for the femur and 
tibia of each cadaveric knee.  
Full manual segmentation of the cartilage was also performed by the same observer. 
Manual thickness values were obtained by taking the distance between the 
intersections of the outer and inner surface on the manual segmentation with a line 
normal to each vertex on the corresponding cartilage patch generated by KD-CaSM, 
ensuring vertexwise correspondence of KD-CaSM and manual thickness values. 
HRpQCT images were downsampled to B mm isotropic resolution and smoothed with a 
KD Gaussian filter to facilitate initial analysis. Surfaces were created for the whole 
femur and tibia from downsampled HRpQCT data. The MR surfaces were then 
registered to the HRpQCT surface for the corresponding whole bone with dedicated 
surface registration software (wxRegSurf version BW; University of Cambridge 
Department of Engineering, Cambridge, UK), using a similarity transform. The 
transformation matrix for registering the MR to the HRpQCT whole bone surface was 
then applied to the corresponding cartilage surface extracted from the MR data. The 
original (i.e. neither downsampled nor blurred) HRpQCT data and transformed 
cartilage surfaces were then loaded into Stradwin.  The transformed surface was used 
as a guide for cartilage thickness measurement of the HRpQCT data as described 
above, meaning that the MR–HRpQCT registration did not have to be exact. Due to 
contrast differences between MR and HRpQCT and the fact that pixel (Hounsfield 
  64 
unit) values on HRpQCT are (unlike MR) not arbitrary, automated thickness 
measurements on the HRpQCT data were performed using a threshold-based full-
width half-maximum (FWHM) technique (Figure K.-). 
Figure J.K 
Outline of HRpQCT thickness measurement process. This results in a set of thickness measurements at each 
HRpQCT cartilage surface vertex which correspond to the measurement at the same vertex on the MR surface. 




1.0.N Statistical analysis 
The thickness value at each vertex on each cadaveric MR surface was compared to the 
thickness value at the identical location on the corresponding HRpQCT surface for 
both KD-CaSM and manual segmentation. Correlation between the two measurements 
was assessed visually using scatter plots. Bland-Altman analysis was performed to 
calculate the mean bias and hP% limits of agreement between MR and HRpQCT 
thickness measurements. The root-mean-square-average-error (RMSE) was also 
calculated to facilitate comparison with the work of others. These analyses were 
performed separately for each cartilage surface and also with data combined from all 
surfaces. By performing appropriate spatial normalisation (surface-to-surface similarity 
and thin-plate spline registration performed in wxRegSurf), the spatial distribution of 
MR-HRpQCT error values across all cadaveric subjects could be displayed on single 
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representative surfaces. Statistical analyses were performed using RStudio version 
B.i.B-K. 
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K.K RESULTS 
1.1.. MR imaging 
All five cadaveric knees were successfully imaged with MR. The measurement 
technique in Stradwin works well and is simple to perform, taking approximately +i 
minutes per knee to analyse all cartilage surfaces. Automated cartilage edge detection 
agrees subjectively with visual assessment of cartilage boundaries.  
1.1.0 HRpQCT validation 
Data from - femoral and - tibial specimens were analysed (one cadaveric knee was 
excluded due to presence of end-stage OA with very little residual cartilage). This gave 
a total of BV,KKP surface vertices for comparison between the two methods. 
Table J.! 
Results of Bland-Altman analyses for comparison of MR and HRpQCT thickness values. Abbreviations: RMSE – 
root mean square error, MT – medial tibia, LT – lateral tibia. 
Surface Method Mean bias MR – HRpQCT (mm) 
OP% limits of 
agreement (mm) RMSE (mm) 
Femur 
KD-CaSM i.iP -i.-i, i.Pi i.+K 
Manual -i.B -i.PW, i.KW i.+U 
MT 
KD-CaSM i.BP -i.+B,i.P+ i.+- 
Manual -i.BV -i.PK, i.Bh i.+P 
LT 
KD-CaSM i.BB -i.U-, i.WP i.-i 
Manual -i.+P -i.hP,i.-P i.-- 
All 
(combined) 
KD-CaSM i.iU -i.-K,i.PU i.+U 
Manual -i.BK -i.U-,i.KW i.+h 
 
Cadaveric validation data are provided in Table K.B. KD-CaSM MR thickness 
measurements demonstrated mean bias (hP% limits of agreement) of +i.iP mm (-i.-i 
to i.Pi mm), +i.BP mm (-i.+B to i.P+ mm) and +i.BB mm (-i.U- to i.WP mm) for 
femur, MT and LT respectively when compared to the reference HRpQCT data. The 
spatial distribution of MR errors was fairly uniform across the cartilage surfaces with 
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the exception of the extreme medial portion of the LT (Figure K.P). Mean bias and hP% 
limits of agreement between manual MR thickness measurements and HRpQCT were -
i.B mm (-i.PW to i.KW mm), -i.BV mm (-i.PK to i.Bh mm) and -i.+P mm (-i.hP to i.-P 
mm) for femur, MT and LT respectively (Figure K.P).  
Figure J.P 
Comparison of agreement between KD-CaSM and HRpQCT and manual segmentation and HRpQCT. Upper panels - 
Bland-Altman plots. Solid lines represent mean bias, dotted lines represent hP% limits of agreement. Lower panels - 




  68 
K.- DISCUSSION 
This study provides evidence for the construct validity of KD-CaSM. Bias and precision 
of KD-CaSM are comparable to that of manual segmentation which is often regarded as 
the ‘gold standard’, but with the added benefits of significant reduction in time taken 
for analysis and the possibility of performing surface-based analyses which may allow 
us to learn more from the data than is obtained from averaging measurements over 
large ROIs. 
For all surfaces analysed, mean bias of KD-CaSM was ≤ i.BP mm with hP% limits of 
agreement less than the largest edge of a voxel in the images analysed (B mm), i.e. sub-
voxel accuracy. The only region with errors that could be considered as unacceptable 
was the extreme medial part of the lateral tibia where the cartilage surface slopes 
caudally to meet the lateral intercondylar eminence, close to the lateral meniscal roots 
(Figure K.U). During dissection, it was difficult to remove the deepest parts of the 
meniscal roots without risking damage to the adjacent cartilage surface (which would 
have invalidated the experiment), therefore a relatively conservative dissection of these 
regions was performed. It is therefore hypothesised that the poor performance of KD-
CaSM vs HRpQCT in this region may be due to residual (undissected) 
ligamentous/fibrous tissue confounding measurement.  
Figure J.R 
Schematic illustration of the tibial plateau (superior view) demonstrating major ligamentous and meniscal 
attachment sites. Reproduced from (+ii). 
 
The results demonstrate a tendency for KD-CaSM to over-estimate cartilage thickness 
by a small amount and for manual segmentation to under-estimate thickness by a 
small amount when compared to the reference method. This is probably because 
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experienced manual segmenters will tend to be cautious when defining the outer 
cartilage edge to avoid partial volume effects, whereas KD-CaSM relies on a signal 
model meaning that voxels adjacent to the outer cartilage edge with similar signal 
intensity will tend to be included, resulting in a small over-estimation. This 
phenomenon has been observed previously with other automated segmentation 
methods(+iB,+i+).  
In this study I have used HRpQCT as a reference method in preference to the more 
commonly used expert manual segmentation in the belief that manual segmentation, 
even if performed by an expert, is prone to observer error and thus is less than ideal as 
a reference method. The result of a small but systematic under-estimation of cartilage 
thickness using expert manual segmentation supports this approach and should be 
considered by others when designing similar validation experiments. 
Obtaining comparable agreement statistics for previously published methods is 
difficult due to the variety of statistical methods used for assessing agreement and the 
different validation methods used. However, bias and precision are broadly similar to 
previously described methods. Methods with narrower limits of agreement with a 
manual segmentation reference method have been described, for example a popular 
active appearance model-based method, but these limits of agreement have been 
derived from measures averaged across large ROIs rather than from individual 
measurement points (+iK). In addition, it should be borne in mind that KD-CaSM 
allows analysis of not only cartilage thickness but also (given the appropriate input) 
cartilage composition, something not achieved by existing methods. 
The clinical importance of KD-CaSM is illustrated by the achievements of CBM in the 
field of osteoporosis, where the method has provided new insights into the efficacy of 
osteoporosis therapies, interaction between therapies and risk factors for disease 
progression and fracture. While the development of KD-CaSM is at an earlier stage, it 
offers the possibility of similar achievements in OA. KD-CaSM also opens up the 
possibility of novel surface-based analysis of cartilage data. In larger datasets, this 
should be performed using statistical parametric mapping (SPM), a well-established 
method in the neuroimaging field which combines linear mixed-effect models with 
Gaussian random field theory to correct for multiple comparisons. In smaller datasets, 
such as in experimental medicine studies which are the focus of this thesis, SPM may 
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be less suitable due to the small sample size. In this setting, alternative descriptive 
analytical approaches, such as applying a threshold considered meaningful to changes 
over time, may be suitable. The opportunity that KD-CaSM offers to detect and localise 
even very focal changes in cartilage morphology or composition may allow early 
assessment of treatment efficacy not accessible to alternative approaches. 
There are several limitations of the current work. First, this validation study featured 
only four cadaveric knees. The number of knees available for this study was limited 
due to the fact that dissection was required, limiting the utility of residual cadaveric 
material for future educational use.  However, these four knees generated over BV,iii 
data points for validation across a clinically meaningful range of cartilage thickness 
values and would be considered ample by conventional sample size calculation.  
Second, one cadaveric knee was excluded due to the presence of end-stage OA with 
extensive full thickness cartilage loss. While the utility of this cadaveric knee for 
validation would have been limited, it should be noted that KD-CaSM may not be valid 
for measurement in end-stage disease. Individuals with such severe OA are highly 
unlikely to be selected for trials of potential DMOATs therefore the lack of utility of 
KD-CaSM in this setting is not of undue concern. Finally, using HRpQCT as a reference 
method required dissection of the knees with removal of any tissues overlying the 
cartilage which could confound measurement yet avoidance of damage or removal of 
any of the cartilage itself. As discussed above, this was challenging at entheseal sites 
close to the cartilage surface such as the meniscal horns, cruciate ligaments, 
gastrocnemius tendons meaning that there is some risk that this may have confounded 
reference measurement. However, the vast majority of measurement points used for 
validation were not affected by this problem. Moreover, there are similar problems at 
the edges of the cartilage surfaces with manual segmentation which has not precluded 
its use as a reference method in previous validation studies. 
In conclusion, this study provides evidence of the construct validity of KD-CaSM. The 
validation of thickness measurement by KD-CaSM is important for the downstream 
sampling of compositional data which relies on the accuracy of the inner and outer 
cartilage surfaces generated by the thickness measurement process. The initial clinical 
application of this work is described in chapter W.
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Subchondral bone is increasingly thought to be at least as important as 
articular cartilage in OA pathogenesis. However, the development of 
quantitative imaging biomarkers of subchondral bone on imaging has lagged 
behind the development of those for cartilage. In this chapter, I use the 
technique of texture analysis for subchondral bone assessment. The promise 
of texture analysis in this setting is in that it will detect alterations in 
trabecular architecture occurring in OA which manifest as changes in the 
heterogeneity and spatial organisation (i.e. ‘texture’) of the subchondral bone 
on an image.  
This chapter involves analysis of .00 participants in the Osteoarthritis 
Initiative, a prospective multicentre observational study. I assess the 
association of subchondral bone texture on MR imaging with the 
radiographic worsening of OA over a 1-year period, as well as the ability of 
subchondral bone texture to predict this worsening. My findings show that 
subchondral bone texture is associated with OA progression, and that 
analysis of subchondral bone texture can discriminate between individuals 
with OA who progress vs those who do not. 
-.B INTRODUCTION 
It is increasingly recognised that subchondral bone plays a critical role in osteoarthritis 
(OA) onset and progression. Subchondral bone is a dynamic tissue, absorbing the 
majority of forces transmitted through the joint and capable of remodelling in 
response to stress(+i-). Therefore, there has been increasing interest in subchondral 
bone as a target for potential disease modifying OA treatments (DMOATs)(+iP).  
Sensitive markers of subchondral bone alterations that occur in OA are required for 
such treatments to be evaluated. Several imaging biomarkers of subchondral bone 
have been described using plain radiographs, dual x-ray absorptiometry (DXA), 
computed tomography (CT) and magnetic resonance (MR) imaging, including direct 
estimation of trabecular microarchitecture and fractal signature analysis (FSA) 
(+iU,+iV). While several established biomarkers have shown cross-sectional 
associations with OA severity, there remains room for improvement with regard to the 
ability to predict OA progression(-i,+iW–+Bi). 
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MR texture analysis (MR TA) has recently been described as a method of quantifying 
subchondral bone changes in OA which may offer superiority over existing 
biomarkers(+BB). MR TA involves the calculation of several statistical descriptors of 
image texture, aiming to characterise the heterogeneity and spatial organisation of the 
subchondral bone. The technique has been shown to be reproducible and able to 
distinguish subjects at different stages of OA from healthy subjects(+BB). Moreover, 
texture features have shown an improved ability to discriminate between knees with 
and without OA when compared to microarchitectural analysis and are significantly 
associated with histomorphometry(+B+,+BK). 
However, MR TA has previously only been used to compare subjects with OA and 
healthy controls. To be useful as a prognostic or treatment evaluation imaging 
biomarker, it should also be able to identify which individuals with OA are likely to 
progress (predictive validity) and demonstrate sensitivity to change for OA progression 
(concurrent validity).  
Therefore, the purpose of this study was to evaluate whether initial (i.e. OAI visit at Ki 
or KU-months) or B+-BW month change (i.e. between OAI visit at Ki/KU-months and -W-
months) in MR subchondral bone texture were predictive of radiographic OA 
progression over KU-months (i.e. between OAI visit at KU-months and V+-months). 
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-.+ METHODS 
The Osteoarthritis Initiative (OAI) has been approved by the institutional review 
boards for the University of California, San Francisco and the four OAI clinical centres 
(University of Pittsburgh, Ohio State University, University of Maryland, Baltimore, 
and Memorial Hospital of Rhode Island). All participants have given informed consent 
to participate in the study. This was a retrospective nested case-control study. The OAI 
datasets are freely available for download at https://oai.epi-ucsf.org.  
K.0.. Participants 
Included participants were participants in the OAI bone ancillary study (BAS). The 
BAS featured U+h participants who underwent MR examination optimised for 
assessment of subchondral bone in addition to the standard OAI MR sequences. All 
BAS participants were members of the progression subcohort, participants with both 
frequent knee symptoms and radiographic OA in at least one knee at OAI inception. 
Initial trabecular bone MRs were performed at either the Ki or KU-month OAI visit, 
with the majority of participants undergoing a repeat MR at the -W-month OAI visit 
(“B+-BW month follow-up”). Study design is summarised in Figure -.B. 
Figure K.! 
Study timeline for image assessments as part of the Osteoarthritis Initiative Bone Ancillary Study. 
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Study cases (“progressors”) were defined as individuals with radiographic progression 
over a KU-month period between the KU-month OAI visit and the V+-month OAI visit, 
according to the definition of the Foundation for the National Institutes of Health 
(FNIH) OA biomarkers consortium: a decrease in minimum medial tibiofemoral joint 
space width (minJSW) of ³ i.V mm, which has a less than Bi% chance of being due to 
measurement error(+B-). The details of the radiographic acquisition and assessments 
have been discussed in detail previously. Briefly, knee radiographs were performed 
using a non-fluoroscopic fixed flexion technique(+BP). Assessments included central 
readings for Kellgren-Lawrence (KL) grading, Osteoarthritis Research Society 
International (OARSI) grading of joint space narrowing (JSN), measurement of 
femorotibial alignment and automated measurement of joint space width(+BU–+BW). 
Progressors were matched to participants who did not have radiographic progression 
between the KU-month OAI visit and V+-month OAI visit (controls) for age, sex, body 
mass index (BMI) and initial medial minJSW in a B:B ratio, using an optimal nearest-
neighbour propensity score algorithm. Although the OAI featured a healthy reference 
subcohort, none of this group underwent dedicated trabecular bone MR imaging and 
therefore were not available to use as a control group in this study. 
Individuals who did not have measurements of minJSW available at the KU-month or 
V+-month OAI visits were excluded, as were individuals with KL grade - knees at the 
KU-month visit (due to ceiling effects on minJSW progression in this group). As this 
study focused on the medial tibiofemoral compartment, any individuals who had 
lateral compartment predominant disease at the KU-month OAI visit were also 
excluded, as defined by greater OARSI JSN grade in the lateral than medial 
compartment.  
K.0.0 MR Acquisition 
Study participants were evaluated with a coronal-oblique K-dimensional fast imaging 
with steady state precession (FISP) MR sequence (field of view B+ x B+ cm, matrix PB+ x 
PB+ (interpolated to Bi+- x Bi+-), slice thickness B mm, repetition time +i ms, echo 
time -.h+ ms, flip angle Pio, number of signal averages B, acquisition time Bi.P 
minutes) optimised for visualisation of subchondral trabecular bone(+Bh). This was 
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performed on one of four identical Siemens Trio KT MR platforms used for the OAI 
using a quadrature transmit-receive knee coil (USA instruments). 
K.0.1 MR Analysis 
The five most central coronal-oblique images through the central medial tibiofemoral 
joint were identified with reference to axial and sagittal reformats and used for 
subsequent analysis.  
The MR images were imported into a dedicated texture analysis program (MazDA vK.K, 
freely available at http://www.eletel.p.lodz.pl/programy/mazda/)(++i). Regions of 
interest (ROIs) were created manually in the medial tibial and medial femoral 
subchondral bone on each coronal image with blinding to case or control status of 
participants. ROIs were defined superiorly and inferiorly by the bone-cartilage 
interface, medially and laterally by the margins of the tibial plateau and femoral 
condyle and extended for a depth of approximately B cm into the subchondral bone, 
ensuring that no part of the physeal plate was included. Illustrative ROI examples are 
provided in Figure -.+. 
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Figure K., 
Example coronal-oblique KD FISP MR image demonstrating ROI placement in the medial tibial (red) and medial 
femoral (green) subchondral bone. 
 
 
Nineteen texture features (listed in Appendix -.B) were calculated for each ROI aiming 
to quantify the heterogeneity and spatial organisation of the subchondral bone, 
according to the method described previously(+BB). These texture features belonged to 
one of four classes: grey-level histogram, absolute gradient, run-length matrix (RLM) 
and grey level co-occurrence matrix (GLCM). Briefly, grey-level histogram features are 
simple descriptors of the distribution of grey levels (i.e. pixel intensity values) in the 
ROI. Gradient, RLM and GLCM features are higher order descriptors of the spatial 
organisation of pixels in the ROI.  Image compression settings of - bits/pixel for 
calculation of gradient features, and U bits/pixel for calculation of GLCM and RLM  
parameters were used. RLM parameters were calculated four times for each pixel (in 
the horizontal, vertical, -Po and BKPo directions) and GLCM parameters were calculated 
+i times for each pixel at a variety of pixel offsets ranging from B to P pixels. The mean 
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value of each RLM and GLCM parameter for each pixel in all possible directions and 
pixel offsets was calculated for each coronal image. The values of each texture 
parameter on each of the five coronal images analysed were then averaged to give 
summary values in each participant for medial tibial and medial femoral ROIs. 
K.0.K Texture analysis reproducibility 
Twenty-three participants were randomly selected using a random number generator 
(www.random.org) and analysed in duplicate by two independent analysts to assess 
reproducibility. Analysts created ROIs independently and were blinded to case or 
control status. The sample size was based on previous data suggesting a mean 
intraclass correlation coefficient (ICC) value of i.h across texture features(+B+,++B). 
Texture features with suboptimal reproducibility metrics (ICCs of < i.W or root-mean-
square average coefficient of variation (RMSCV) of > Bi% for either ROI) were 
excluded from subsequent analyses. 
K.0.M Statistical analysis 
Descriptive statistics for each texture feature were generated. The distribution of 
texture values in progressors and controls was compared visually using boxplots. 
Composite texture scores using linear combinations of texture features were created 
using least absolute shrinkage and selection operator (LASSO) penalised logistic 
regression. This helps to avoid problems associated with overfitting when many 
predictor variables are available by imposing a penalty for including additional 
variables in a model. The LASSO model was chosen based on minimisation of Bi-fold 
cross-validation classification error.  Because the folds for cross-validation are chosen 
at random, the procedure was repeated with Bii iterations. The logistic regression 
equation from a model iteration giving the mean classification error was used to 
calculate a composite texture score.  This was performed separately for tibial, femoral 
and combined (tibial and femoral) texture datasets using initial MR texture features 
and B+-BW month change in MR texture features.   
Odds ratios were calculated for the increase or decrease in odds of radiographic 
progression per one standard deviation (SD) increase in texture score. The mean 
classification accuracy (c-statistic, equivalent to area under the receiver operating 
curve (AUC)) was recorded. 
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Inter-observer reproducibility was assessed using ICC values (single measures, absolute 
agreement) and the RMSCV for each texture feature. 
All statistical analyses were performed using RStudio version B.i.BKU for Mac, using the 
MatchIt package for matching cases to controls, and the glmnet package for 
performing LASSO regression(+++,++K). Statistical significance of the logistic 
regression analyses was assessed using the chi-squared test, with an adjusted P value 
threshold of < i.iiW to maintain an overall type B error rate of i.iP. 
  




Subject characteristics at initial timepoint and B+-BW month follow-up 
Variable 
Initial B+-BW month follow-up 
Cases Controls Cases Controls 
n = UB n = UB n = PK n = P+ 
Age, years* U- (-h – WB) UP (-W – W+) UP (Pi – W+) UU (-h – WK) 
Sex, no. females +P +U +B ++ 
BMI, kg/m+ ** KB.- (-.V) KB.B (-.V) KB.B (-.P) Ki.W (-.U) 
Time between baseline and follow-
up MRI (B+/BW months) - - KP/BW +U/+U 
Initial minJSW, mm** K.WB (B.+i) K.VW (B.Bh) K.WU (B.Bh) K.VP (B.+i) 
Kellgren Lawrence grade (i/B/+/K) V/BB/+B/++ W/h/+-/+i V/BB/BV/BW W/h/+i/BP 
OARSI medial JSN grade (i/B/+) BV/++/++ +K/BW/+i BP/+i/BW +B/BU/BP 
OARSI lateral JSN grade (i/B/+) Ui/B/i PW/K/i P+/B/i Pi/+/i 
Femorotibial alignment, degrees† -U.i (B.h) -P.V (+.B) -U.i (B.W) -P.V(+.B) 
minJSW change, mm** - - -B.+h (i.UK) i (i.--) 
*mean (range) 
**mean (standard deviation) 
†mean (standard deviation), negative values indicate varus alignment 
Of U+h participants in the BAS, KPh were eligible for this study following exclusions. U- 
participants met the criterion for radiographic progression and were selected as cases, 
with U- controls matched for age, sex, BMI and initial minJSW. 
For initial timepoint analyses, B+ participants (K cases) were excluded due to excessive 
motion artefact, defined as preventing the identification of the bone-cartilage interface 
(n = P), unavailable initial MR (n = K) or large subchondral cysts (n = -).  The matched 
controls for excluded cases were also removed from the analysis. For each excluded 
control, a new matched control was selected as the next best match for the 
corresponding case according to the matching algorithm. 
For B+-BW month follow-up analyses, a further BV participants were excluded due to 
excessive motion artefact on follow-up images (n = W), unavailable follow-up MR (n = 
  81 
W), and surgical intervention involving the subchondral bone during the interval 
between initial and follow-up MR (n = B). 
Initial and follow-up characteristics of included cases and controls are presented in 
Table -.B. A flow diagram for selection of study participants is presented in Figure -.K. 
Figure K.J 





  82 
K.1.0 Texture analysis reproducibility 
Data for inter-observer reproducibility are presented in Appendix -.B. The majority of 
texture features demonstrated excellent inter-observer reproducibility. Seven texture 
features were excluded from subsequent analyses at this stage (per criteria in section 
-.+.-), leaving a total of B+ texture features for analysis. 
K.1.1 Association of subchondral bone texture and radiographic progression 
Subchondral bone composite texture score was significantly associated with KU-month 
radiographic progression using the initial timepoint combined data (odds ratio [hP% 
confidence interval] = B.W- [B.+P – +.Wi], P = i.ii+) and the B+-BW month change tibial 
(+.KB [B.-+ – -.B+], P < i.iiB), femoral (B.Wi [B.BV – +.h+], P = i.iiU) and combined (K.VU 
[+.i- – V.W+], P < i.iiB) data. Associations between subchondral bone texture score 
and radiographic progression using initial timepoint tibial (B.-K [i.hh – +.ih], P = 
i.iU) and femoral (B.UK [B.B+ – +.--], P = i.iih) data were not statistically significant. 
Results are summarised in Table -.+ and Figure -.-. Data for each individual texture 
feature are provided in Appendix -.+. Example images are shown in Figure -.P. 
Figure K.K 
Boxplot demonstrating the association between subchondral bone composite texture score and radiographic 
progression status using baseline and B+-BW month change combined tibial and femoral data. Individual datapoints 
are displayed as semi-transparent dots. 
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K.1.K Texture analysis classification 
Combinations of both initial texture features and B+-BW month change in texture 
features were able to predict radiographic progression with statistical significance 
reached for femoral and combined initial data, and tibial, femoral and combined B+-BW 
month change data. The best classification accuracy was demonstrated for combined 
B+-BW month follow-up data with a c statistic of i.UW (hP% confidence interval (CI) i.UW 
– i.UW, P < i.iiB). 
Classification performance is summarised in Table -.+.  
Table K., 
Association between texture features and case vs control status, and classification performance 
Region 






























       













       

















* P < i.iP, ** P < i.iB, ***P < i.iiB 
†Odds ratio of being a progressor for each B standard deviation increase in texture score. 
#Three texture features with largest standardised coefficients (b) in the logistic regression model (note initial tibial 
model only included two texture features).  
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Figure K.P 
Example coronal KD FISP MR images through the medial tibiofemoral compartment of radiographic progressors 
and non-progressors at the initial timepoint. A, non-progressor, texture score (TS) -B.++, B, non-progressor, TS -B.--, 
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-.- DISCUSSION 
This study demonstrates that combinations of initial and B+-BW month change in 
subchondral bone MR texture features are significantly associated with radiographic 
OA progression over KU-months, with better predictive ability for B+-BW month change 
data.  
These results suggest that subchondral bone texture may be a useful quantitative 
imaging biomarker for use in clinical trials, particularly those with interventions 
targeting subchondral bone. Although direct interpretation of the texture scores used 
in this study is difficult, results are consistent with progressors having less spatially 
organized, more homogeneous subchondral bone at the initial timepoint, and B+-BW 
month changes in the same direction. While direct visual assessment of what the 
texture scores are representing is not possible, anecdotally there are cases where visual 
assessment of example images supports this finding (Figure -.P). Combinations of 
texture features were able to predict progressor status using both initial and B+-BW 
month change in texture features. Classification accuracy improved when tibial and 
femoral data were combined. However, the best performing model had only modest 
predictive ability (AUC i.UW), despite the strong associations between texture score 
and radiographic progression.  
Possible explanations for the limited performance of MR subchondral bone texture in 
this study include a bias towards advanced OA in this cohort, and the MR sequence 
used. First, as members of the progression subcohort of the OAI, most participants had 
established OA. The study sample was further biased towards more advanced disease 
by the fact that only individuals with established OA at the -W month OAI visit had 
quantitative JSW measurements performed at the V+-month OAI visit. MR 
subchondral bone texture has previously demonstrated the ability to detect relatively 
early OA-related changes in the subchondral bone, therefore it may be that it is of less 
use in more established disease. Second, the MR sequence used as part of the OAI BAS 
was optimised for analysing trabecular microarchitecture (i.e. direct estimation of 
histomorphometry parameters). While texture analysis has previously been described 
using a similar MR sequence, it has also been demonstrated that alternative MR 
sequences may provide improved texture discrimination between individuals(++-).   
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Nevertheless, the strength of association between texture scores and radiographic 
progression and the AUC values presented here are competitive when compared to 
several alternative OA imaging biomarkers, especially considering the relatively short 
follow-up time and matching of the control cohort in this study for important 
predictive covariates of age, sex and BMI(-i,P+,Ui,++P,++U).  For example, in the FNIH 
OA Biomarkers Consortium studies, central medial tibiofemoral compartment 
cartilage loss over +- months was associated with radiographic progression at +--+W 
months with a similar odds ratio (K.W [hP% CI +.V to P.P]) to that for B+-BW month 
change in combined texture score (K.W [+.i – V.W]) in this study (Ui). In the same FNIH 
cohort, associations between femoral bone shape change (OR +.V [+.i to K.U]) and 
femoral bone area change (+.h [+.B to K.h]) over +- months and radiographic 
progression at +---W months were also of a similar magnitude to those described 
here(++U). Associations between fractal signature analysis (FSA) parameters obtained 
from plain radiographs and radiographic progression in the FNIH OA Biomarkers 
cohort were weaker than those described in this study, as was the predictive ability of 
FSA(-i). 
The results of this study demonstrate that MR TA of subchondral bone can be 
considered a useful addition to the suite of imaging biomarkers available for further 
OA imaging research studies. One advantage over alternative techniques is the 
multidimensional data output of texture analysis, which is well-placed to interact with 
machine learning based approaches to image interpretation.  
One disadvantage of MR TA is that it is not always clear what the biological or 
structural correlates of individual texture features are, despite previous demonstration 
of association with histomorphometry(+BK). However, as has been shown by the use of 
texture analysis in other imaging applications, this lack of correspondence to an 
underlying structural ‘ground-truth’ does not preclude the use of this method to 
improve our understanding of the underlying disease process(++V–++h). In the present 
study, MR TA has usefully quantified the degree of ‘abnormality’ in the appearance of 
the subchondral bone despite limited structural correlation of the texture parameters 
used. Moreover, based on previous work it is possible to speculate as to the biological 
meaning of the alterations in subchondral bone texture seen in this study. For 
example, baseline tibial histogram mean in this study was lower in cases than controls 
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and was one of the most important features in baseline models for predicting 
progression. In a previous study, lower values of this parameter were associated with 
higher bone volume fractions, higher trabecular thickness and lower trabecular 
spacing suggesting that subchondral bone in progressors in this study was more 
sclerotic at baseline than that of non-progressors(+BK). 
Future work could evaluate MR TA of subchondral bone in alternative populations, 
and a head-to-head comparison of different methods for analysing subchondral bone 
would help to determine the optimal imaging biomarker for use in clinical trials. A 
barrier to performing this comparison in the present study was the fact that the 
platforms used for several alternative methods are not freely available, in contrast to 
the method used here. Automation of the time-consuming ROI drawing procedure 
would also encourage wider use of this method. 
There are several limitations to the present study. Structural correlates for texture 
parameters have been assessed in previous studies, but using a different MR sequence. 
Nevertheless, a comparison of texture features between sequences has shown similar 
changes in both, so it is reasonable to assume similar structural correlates for the 
texture features derived from the MR sequence used in this study(++-). This study 
used a retrospective case-control design which is subject to selection bias. However, 
the matching process ensured that cases and controls were well-matched for important 
baseline characteristics. In common with other longitudinal studies using the OAI 
dataset, it is not possible to completely separate concurrent from predictive validity for 
MR subchondral bone texture as the period of follow-up for change in MR texture 
features overlapped with the follow-up period for radiographic progression. There was 
a small sample size for the number of texture features analysed which risks introducing 
bias into any classification procedure. However, this was minimized by excluding 
texture features with poor reproducibility, using cross-validation, and using penalised 
regression to limit the number of texture features incorporated into the classification 
models. Finally, OA progression in this study was defined based on change in 
radiographic joint space width. This measure is established and robust, but captures 
only one aspect of OA progression. Symptomatic progression is also important, but not 
considered in this study due to the low numbers of symptomatic progressors in this 
cohort. 
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In conclusion, initial and B+-BW month change in combinations of MR subchondral 
bone texture features were associated with KU-month radiographic OA progression, 
with better predictive performance of B+-BW month change data.   
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APPENDIX -.B  
Inter-observer reproducibility data 
Parameter ICC (OP% CI)* RMSCV (%) 
Tibia   
Mean V.OP (V.OV, V.OX) P.P 
Skewness i.VW (i.PU, i.hi) +-.- 
Kurtosis i.Uh (i.-i, i.WU) -K.- 
Variance V.OK (V.XY, V.OY) P.P 
Gradient Mean V.OY (V.OK, V.OO) !.X 
Gradient Skewness i.hi (i.VV, i.hP) Bi.h 
Gradient Kurtosis i.UK (i.Ki, i.W+) -+.- 
Gradient Variance V.OX (V.OR, V.OO) !.K 
Gradient NonZeros V.OJ (V.XJ, V.OY) V.O 
Run fraction V.OP (V.XX, V.OX) V.K 
Short run-length emphasis V.OK (V.XY, V.OX) V.J 
Long run-length emphasis V.OJ (V.XP, V.OY) !.! 
Grey-level non-uniformity i.U+ (i.+h, i.W+) Bi.i 
Run-length non-uniformity i.Ph (i.+P, i.Wi) BK.U 
Angular Second Moment V.XX (V.YP, V.OP) X., 
Contrast V.OX (V.OP, V.OO) J.O 
Correlation i.VP (i.-V, i.Wh) -.i 
Entropy V.OK (V.XY, V.OX) !.! 
Inverse difference moment V.OP (V.XX, V.OX) ,., 
Femur   
Mean V.OP (V.XO, V.OX) J.X 
Skewness i.WW (i.VK, i.hP) BW.W 
Kurtosis i.h+ (i.iK, i.hV) -K.B 
Variance V.OY (V.O,, V.OO) P.J 
Gradient Mean V.OX (V.OK, V.OO) !.R 
Gradient Skewness i.hU (i.h+, i.hW) B-.K 
Gradient Kurtosis i.Wh (i.VV, i.hP) BV.P 
Gradient Variance V.OX (V.OR, V.OO) ,.! 
Gradient NonZeros V.OP (V.XX, V.OX) V.Y 
Run fraction V.OR (V.O!, V.OX) V.J 
Short run-length emphasis V.OR (V.O!, V.OX) V., 
Long run-length emphasis V.OP (V.XO, V.OX) !.V 
Grey-level non-uniformity i.Wi (i.PW, i.hB) h.W 
Run-length non-uniformity i.UU (i.KP, i.W-) BB.V 
Angular Second Moment V.OP (V.XX, V.OX) K., 
Contrast V.OX (V.OP, V.OO) J.R 
Correlation i.WB (i.Ui, i.hB) W.i 
Entropy V.OR (V.O,, V.OX) V.X 
Inverse difference moment V.OR (V.O!, V.OX) !.X 
*single measures, absolute agreement  
Texture features in bold were included in subsequent analyses 
Abbreviations: ICC – intraclass correlation coefficient, RMSCV – root mean square average of the coefficients of 
variation, Gradient NonZeros – proportion of pixels with non-zero gradient  
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APPENDIX -.+ 
Initial and B+-BW month change in individual subchondral bone texture features in case 
and control participants 
Texture 
feature 










OR (hP% CI)* 
Tibia       
Mean BVW (-i) BhB (KP) i.VV (i.PK, B.BB) BB.W (-+.-) K.V (-i.P) B.++ (i.WK, B.WV) 
Variance WiUi (+Whi) hiii (KBB+) i.VK (i.Pi, B.i-) hi+ (KBhW) PiB (+UWW) B.BP (i.VW, B.VB) 
GrMean B.UK (i.KU) B.UW (i.KU) i.WW (i.UB, B.+U) i.i- (i.-h) i.B+ (i.-U) i.W- (i.PV, B.+-) 
GrVariance i.hP (i.K-) i.hh (i.KP) i.Wh (i.UB, B.+V) i.iP (i.-W) i.Bi (i.-i) i.Wh (i.Ui, B.KB) 
GrNonZeros i.WW (i.iP) i.WW (i.iU) i.hB (i.UK, B.Ki) i.ii- (i.iU) i.i+ (i.iW) i.Wi (i.PK, B.BW) 
Run Fraction i.WV (i.iK) i.WV (i.iK) i.hi (i.UK, B.+h) i.iiK (i.i-) i.iB (i.i-) i.WB (i.P-, B.Bh) 
SRLE i.hi (i.i+) i.hi (i.i+) i.hi (i.U+, B.+h) i.iiK (i.iK) i.iB (i.iK) i.WB (i.P- i B.Bh) 
LRLE B.P+ (i.BU) B.PB (i.BW) B.iW (i.VU, B.PU) -i.iB (i.+i) -i.iU (i.+K) B.+- (i.W-, B.WV) 
ASM** K.hK (B.hK) K.V+ (+.Bi) B.BB (i.VW, B.UB) -i.+P (+.BV) -i.h+ (+.UW) B.KK (i.hi, +.iK) 
Contrast KW.K (BW.i) -i.P (BV.h) i.WW (i.UB, B.+U) +.K (+P.K) P.W (+B.U) i.WU (i.PW, B.+U) 
Entropy +.PW (i.+i) +.UB (i.+i) i.WW (i.UB, B.+P) i.iK (i.+P) i.ih (i.+P) i.Wi (i.P-, B.BW) 
Inv Df Mom i.++ (i.i-) i.+B (i.i-) B.BK (i.Vh, B.UK) -i.iiP (i.iP) -i.i+ (i.iU) B.+P (i.WP, B.WU) 
Femur       
Mean BVU (K-) BWV (KK) i.Vi (i.-V, B.ii) BK.W (KU.P) W.K (+W.-) B.BW (i.Wi, B.VW) 
Variance Uh-i (+UVV) V-KK (+B++) i.WV (i.Ui, B.+-) BiWU (+--i) PPB (+++B) B.+V (i.WU, B.hK) 
GrMean B.UV (i.KU) B.V+ (i.KW) i.Wh (i.U+, B.+V) i.iV (i.-P) i.BV (i.-W) i.Wi (i.PK, B.BW) 
GrVariance i.hV (i.KP) B.ii (i.KU) i.h+ (i.U-, B.KB) i.iU (i.-W) i.B- (i.-P) i.W+ (i.PP, B.++) 
GrNonZeros i.Wh (i.iP) i.Wh (i.iU) i.h- (i.UP, B.K-) i.iih (i.iP) i.iK (i.iV) i.VW (i.PB, B.BP) 
Run Fraction i.WV (i.iK) i.WW (i.iK) i.h+ (i.U-, B.KB) i.iiU (i.iK) i.iiK (i.i-) i.VW (i.P+, B.BP) 
SRLE i.hi (i.i+) i.hB (i.iK) i.h+ (i.U-, B.KB) i.ii- (i.i+) i.iiK (i.iK) i.VV (i.PB, B.B-) 
LRLE B.PB (i.BP) B.Pi (i.BW) B.iU (i.V-, B.PK) -i.iK (i.BU) -i.iW (i.+K) B.+h (i.WV, B.hU) 
ASM** -.+V (+.KP) -.+V (+.Vi) B.ii (i.Vi, B.--) -i.-P (+.+-) -B.KB (K.K-) B.KV (i.h+, +.B+) 
Contrast KW.U (BV.P) -i.P (BW.U) i.hi (i.U+, B.+h) K.i (+K.W) W.B (++.W) i.Wi (i.PK, B.BW) 
Entropy +.PP (i.+i) +.PU (i.++) i.hK (i.UP, B.K-) i.iP (i.+-) i.BB (i.+W) i.VW (i.P+, B.BP) 
Inv Df Mom i.+B (i.i-) i.+B (i.iP) B.Bi (i.VV, B.Ph) -i.iih (i.iP) -i.iiP (i.iP) B.Ki (i.WW, B.hV) 
*odds ratio (OR) and hP% confidence interval (hP% CI) of being a case for a B standard deviation increase in texture 
feature              
**values as given xBi-K 
Abbreviations: Gr – Gradient, GrNonZeros – proportion of pixels with non-zero gradient, SRLE – short run-length 
emphasis, LRLE – long run length emphasis, ASM – angular second moment, Inv Df Mom – inverse difference 
moment.
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The AMROA study was a prospective longitudinal observational study 
conducted with the aim of assessing the potential utility of quantitative 
imaging biomarkers (QIBs) of bone, cartilage and synovium in the setting of 
experimental medicine studies. Candidate QIBs were compared across the 
domains of test-retest repeatability, ability to discriminate between 
participants with osteoarthritis (OA) and age-matched healthy controls, and 
responsiveness to change over N months and . year. 
This chapter describes the core background, methodology and results of the 
study, including the results of radiographic and semi-quantitative MR 
analyses. Subsequent chapters will discuss the different QIB methods and 
results in detail. 
P.B INTRODUCTION 
As discussed in previous chapters, multiple quantitative imaging biomarkers (QIBs) of 
OA have been described which have the potential to be of use in early phase clinical 
studies. However, the implementation of QIBs in this type of study remains limited. 
One of the possible reasons for their limited uptake is a relative paucity of data on the 
performance characteristics of candidate QIBs in this setting.  
This chapter describes the Advanced Magnetic Resonance imaging of Osteoarthritis 
(AMROA) study which was designed to help address this shortcoming. AMROA was a 
prospective longitudinal observational study aiming to evaluate the performance 
characteristics of a selection of QIBs in conditions similar to an early phase 
‘experimental medicine’ study. Experimental medicine studies are typically biomarker-
rich studies occurring early in the drug development process(VU). They aim to 
establish early proof-of-concept or proof-of-mechanism, thus de-risking subsequent 
development and contributing to the decision of whether to progress a novel 
therapeutic entity into later stage development (so-called ‘go/no-go’ decision making) 
with the entailed resource implications(VP). Experimental medicine studies overlap 
with phases B and +a of the traditional drug development paradigm and are typically of 
short duration with small numbers of participants. This poses particular challenges for 
imaging biomarkers in OA, traditionally considered to be a slowly progressive disorder.  
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The AMROA study included candidate QIBs which both reflected the multi-tissue 
nature of OA and had also demonstrated potential in larger studies (Table P.B). For 
synovitis QIBs, evidence of potential principally comes from studies evaluating 
response to intra-articular steroids using similar methodology(VB,V+,+Ki). For cartilage 
QIBs, evidence of promise of the approach outlined in chapter K comes from previous 
work in larger observational datasets(B-U,BWV,BWW). Bone QIBs similar to those 
employed in this study have been shown to be useful in the Osteoarthritis Initiative 
dataset, including the analysis described in Chapter -(U-,++U). 
Table P.! 
Description of QIBs included in AMROA study 





CE-MRI Synovial tissue volume 






KD-CaSM (chapter K) Bone area* 
Texture analysis (chapter -) Bone texture 
Abbreviations: DCE-MRI – dynamic contrast-enhanced MR imaging, CE-MRI – contrast-enhanced MR imaging, 
KD-CaSM – KD-cartilage surface mapping, dGEMRIC – delayed gadolinium enhanced MR imaging of cartilage. 
*tAB including osteophytes per Eckstein nomenclature(+KB) 
The purpose of the AMROA study was to evaluate the likely performance of candidate 
QIBs in the setting of experimental medicine studies. Specifically, I aimed to assess 
QIBs across the domains of test-retest repeatability, ability to discriminate between 
OA and healthy controls, and responsiveness to change over U-months. This chapter 
outlines the core (non-QIB) methodology and results for the study. Subsequent 
chapters discuss the methods and results for specific QIBs of each joint tissue. 
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P.+ METHODS 
M.0.. Ethical approval 
Ethical approval for the study was granted by the Cambridge Central Local Research 
Ethics Committee (ref: BU/EE/i-i+). All participants gave written, informed consent. 
M.0.0. Participants 
Participants with knee OA and healthy volunteers (HV) were recruited. OA 
participants were recruited from specialist orthopaedic knee clinics at Addenbrooke’s 
Hospital. HVs were recruited either via a register of healthy individuals who had 
expressed an interest in taking part in clinical studies, or via poster advertisements 
placed in the University of Cambridge Department of Radiology. 
Inclusion criteria for both groups were age -i-Ui years, in good general health, body 
mass index ≤ KP kg/m+ and the imaged knee able to fit within the knee MR coil 
(diameter approximately BW cm). Additional inclusion criteria for OA participants were 
a clinical diagnosis of OA per American College of Rheumatology criteria as assessed 
by a consultant orthopaedic surgeon and medial compartment predominant disease 
with a Kellgren-Lawrence grade of +-K as assessed on standing AP knee radiographs by 
an orthopaedic surgeon and musculoskeletal radiologist in consensus(+V,+K+). 
Exclusion criteria for both groups were a history of previous ipsilateral lower limb 
fracture or surgery (including arthroscopy), history of metabolic bone disease or 
inflammatory arthritis or contraindication to MR imaging or gadolinium-based 
contrast agent (gdCA) administration.  
M.0.1 Study Procedures 
Participants had four scheduled study visits: baseline, B-month, U-months and B-year. 
Each participant had an MR examination according to the protocol described below at 
each visit. OA participants also had radiographs performed at baseline and at B-year. 
These were performed posteroanterior (PA) in fixed flexion with the use of a 
SynaFlexer (BioClinica, Newtown, PA) positioning device to ensure a consistent degree 
of knee flexion between examinations(+KK). For baseline radiographs, the x-ray beam 
was initially angled Bio caudally (Figure P.B). Images were immediately reviewed to 
ensure adequate superimposition of the anterior and posterior margins of the tibial 
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plateau, defined as less than i.P mm difference between the two. If superimposition 
was unsatisfactory, the radiograph was repeated with a change in the caudal 
angulation of the x-ray beam in +o increments in the direction of the perceived 
discrepancy. Up to four radiographic exposures were permitted at each visit. Each 
participant had their baseline x-ray beam angulation recorded which was used as the 
initial angulation for the B-year follow-up radiograph. 
Figure P.! 
Fixed flexion radiographic technique using SynaFlexer frame. Reproduced from (+KK). 
 
The Knee Injury and Osteoarthritis Outcome Score (KOOS) questionnaire was 
completed by OA participants at each visit(+K-). HV participants completed the KOOS 
questionnaire at the baseline visit only. The KOOS questionnaire used for the study is 
provided in Appendix P.B. At each visit, a whole blood sample was taken from 
participants to enable measurement of haematocrit for DCE-MR analyses. Serum 
samples were also taken and frozen to enable future measurement of exploratory 
serum biomarkers (e.g. cartilage turnover markers) and assess their correlation to 
imaging findings. 
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MR examinations were scheduled consistently at the same time of day for each visit of 
each participant to minimise the confounding effect of diurnal changes in cartilage 
thickness and composition measurements(B+W,+KP). In addition, all participants had a 
period of unloading of the knee of at least -P minutes prior to imaging to minimise 
effects on the same measures related to recent weight-bearing(+KU,+KV). 
All MR examinations were performed on a KT platform (GE VPi; GE Healthcare, 
Waukesha, WI) using an W-channel transmit/receive knee coil (Invivo, Gainesville, FL). 
Careful immobilisation of the target knee was performed to minimise motion artefact. 
OA participants had the symptomatic knee imaged. HV participants had a knee 
selected at random using a random number generator (www.random.org) by the 
supervising radiologist immediately prior to the baseline visit. 
The MR protocol was divided into two sessions, the first lasting approximately -P 
minutes and the second lasting approximately five minutes (Table P.+). Towards the 
end of the first session, the DCE-MR sequences were performed. GdCA (Dotarem®, 
Guerbet, Paris, France) was administered via a pump injector at a rate of K mL/s 
followed by Pi mL saline administered at the same rate. The dose of gdCA was i.+ 
mM/kg, double the normal dose for the purposes of subsequent dGEMRIC. The 
additional steps for dGEMRIC included participants leaving the scanner after the first 
MR session and performing Bi minutes of cycling at an easy pace on a stationary cycle 
in a room adjacent to the MR control room. There was then a rest period of 
approximately Vi minutes, followed by the second MR session. 
  
Table '.) 
AMROA study MR protocol 
 








NEX Acquisition time (min:s) Notes 
SESSION G 
Standard clinical 
assessment & MOAKS 
scoring 
Sag IW FS FSE GKLL/MN OL MPQ x RKN** GNL  M/G M LM:LL  
Cor IW FS FSE RKLL/MN OL MPQ x RKN** GNL M/G M LM:ML  
Cor TG FSE NLL/GR OL KGR x KGR GRL R.K/R.K G LR:ML Used for subchondral bone texture analysis 
Cartilage morphology MD SPGR FS RN/in-phase RK KGR x MPL** GKL G/L L.K LN:KL  
Cartilage composition 
MD FSE FS 
CubeQuant TGr GKLL/G,GL,RL,MK* OL MRL x RKN**
 GNL M/L L.K LK:LL Spin lock frequency  KLL Hz 
MD FSE FS 
CubeQuant TR MD 
FSE FS 
GKLL/`,GM,R`,QL OL MRL x RKN** GNL M/L L.K LK:LL  
Synovial segmentation  MD SPGR FS GR/in-phase GK MPQ x MPQ** MRL R#/L L.K LQ:ML  
TG map for DCE-MRI MD SPGR Q/in-phase R,N,GQ GRP x GRP† MRL Q‡/L L.K LQ:LL N phases per flip angle 
***IV Dotarem administered during next sequence after first K phases*** 
DCE-MRI MD SPGR Q/in-phase GQ GRP x GRP† MRL Q‡/L L.K LP:GL MK phases, GQ s/phase 
Synovial segmentation  MD SPGR FS GR/in-phase GK MPQ x MPQ** MRL R#/L L.K LQ:ML  
SESSION R 
Cartilage composition 
(dGEMRIC) MD SPGR K/in-phase R,N,GQ MRL x RKN** GNL M/L G LM:ML  
Abbreviations: TR – repetition time, TE – echo time, FOV – field-of-view, NEX – number of excitations (signal averages), IW – intermediate-weighted, FS – fat saturated (spectral), FSE – 
fast spin echo, SPGR – spoiled gradient echo, IV – intravenous 
* Time of spin lock (TSL) values.  
** Interpolated to KGR x KGR with zero-filling † Interpolated to RKN x RKN with zero-filling # Interpolated to G mm with zero-filling ‡ Interpolated to R mm with zero-filling 
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!.#.$ Non-imaging assessments 
Demographic data were acquired for each participant at baseline including age, sex 
and body mass index (BMI). KOOS scores were recorded for each individual subscale 
(pain, symptoms, activities of daily living, sports & recreation and knee-related quality 
of life) as well as the average score across all five subscales, KOOS-I. 
Whole blood samples were processed by the Cambridge University Hospitals NHS 
Foundation Trust laboratories. Haematocrit values were recorded and used for 
subsequent DCE-MR analyses(STU). Serum blood samples were centrifuged with 
subsequent aliquoting and freezing of the serum fraction at -UWo Celsius. 
!.#.! Core imaging assessments 
Fixed-flexion radiographs were graded according to the Kellgren-Lawrence scale, with 
additional grading of joint space narrowing and osteophytes according to the 
Osteoarthritis Research Society International (OARSI) scale(S[,SU). Fixed location 
joint space width was measured manually at SS.I% of the total width of the 
tibiofemoral joint (JSWSSI), defined by lines tangent to the most medial/lateral point 
on the femoral condyles on the PA radiograph (Figure `.S). Measurement at this 
position has been demonstrated to be the most repeatable and sensitive to change 
when using the fixed-flexion technique(TT). 
The standard clinical sequences from the MR protocol (sagittal intermediate weighted 
(IW) fat-saturated (FS), coronal IW FS and coronal T`) plus the high spatial resolution 
TD spoiled gradient echo (SPGR) sequence were used to grade participants according 
to the MRI osteoarthritis knee score (MOAKS) system(bc). Whether semi-quantitative 
reading should be blinded to timepoint is a matter of ongoing debate. Blinding to 
timepoint reduces bias but also reduces sensitivity to change(STd,SbW). The general 
consensus in OA imaging is that not performing blinding to timepoint is probably 
preferable, therefore blinding was not performed in this study (Sb`). Quantitative MR 
assessments will be discussed in detail in subsequent chapters, but, in brief, these 
included measurement of Ktrans, IAUCcW and synovial tissue volume, cartilage thickness 
and composition (T`rho, TS and dGEMRIC) and subchondral bone area and texture. 
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!.#.4 Statistical analysis 
Demographic, clinical (KOOS), radiographic and semiquantitative MR imaging data 
were analysed descriptively, using means (standard deviations) or medians 
(interquartile ranges) as appropriate. Formal hypothesis testing was not performed (a) 
as these variables were not the primary outcome measures of interest and (b) due to 
the exploratory nature of the study. 
For KOOS scores, test-retest repeatability was assessed by calculating the root-mean-
square average coefficient of variation (RMSCV) between baseline and `-month 
measurements in OA participants. The proportion of OA participants with significant 
improvement or worsening of symptoms over c-months and `-year was calculated 
using thresholds of the smallest detectable difference (SDD, SW points) and also 
OMERACT-OARSI responder criteria (SbS,SbT).  
The proportion of OA participants with radiographic progression over `-year was 
calculated. For qualitative grading scales (Kellgren-Lawrence and OARSI), progression 
was defined as any increase in grade on the corresponding scale. For JSWSSI 
measurement, progression was defined as a reduction in JSW of ³ W.[ mm based on 
criteria developed by the Foundation of the National Institutes of Health (FNIH) OA 
biomarkers consortium as having a less than `W% chance of being due to measurement 
error(SSc). 
Participants were assessed for improvements or worsening in their MOAKS score over 
c-months and `-year using previously published criteria(Sbb). This assessment was 
performed separately for each tissue type scored by MOAKS for which a change 
definition was available (bone marrow lesions, cartilage defects, synovitis, osteophytes 
meniscal pathology and meniscal extrusion). 
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I.T RESULTS 
!.9.: Participants 
An original cohort of `W OA participants and six HVs were recruited. All original 
cohort participants completed the baseline study visit, nine OA/six HV participants 
completed the `-month study visit, nine/five completed the c-month study visit, and 
nine/four completed the `-year study visit. An informal review by the study team of the 
`-month test-retest repeatability data recommended the recruitment of up to five 
additional participants with OA to be imaged at baseline and six months. This was due 
to the smallest detectable difference (SDD) values for QIBs calculated from these data 
being smaller than anticipated, increasing the likelihood of detecting meaningful 
changes at six months. Additional participants were therefore sought to increase the 
confidence in estimates of magnitude and standard deviation of change at this 
timepoint. Consequently, an additional cohort of four OA participants were recruited 
and imaged at baseline and six months (Figure I.S). All additional cohort participants 
completed both study visits. 
Figure (.* 
Study visit schedule. All participants in each group completed each visit unless otherwise stated in grey. 
 
Baseline demographic data are provided in Table I.T. Nine OA participants underwent 
arthroscopy during the study follow-up period (eight in the original cohort, one in the 
additional cohort). No participants were treated with any investigational therapeutic 
agents, and none underwent administration of any intra-articular medication.  
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Table (./ 
Baseline demographic characteristics of included study participants 
 OA (n = 56) HV (n = :) 
Age (years)* I`(I) II(b) 
Sex (M:F) U:c S:b 
BMI(kg/mS)* Sd.S (b.`) Sd.[ (T.W) 
*mean (SD) 
!.9.# Non-imaging assessments 
KOOS scores for OA and HV participants are provided in Table I.b. All HV 
participants had KOOS scores above the population mean for their age and sex strata, 
supporting their use as control participants in the study(SbI).  
Table (.6 
KOOS scores for OA and HV participants. Values provided are means (SDs). 
 OA HV 
 Baseline  (n = `b) 
`-month  
(n = d) 
c-month  
(n = `T) 
`-year  
(n = U) 
Baseline  
(n = c) 
Pain cW (SW) Ic (`d) [b (`I) cb (`d) dd (S) 
Symptoms Ic (`d) cS (SS) [[ (`U) c[ (`d) dc (I) 
ADL c[ (S`) cW (SS) US (`c) [` (`U) dd (`) 
Sports/Rec Tc (ST) T[ (Sc) Ic (Sb) b` (S[) dI (c) 
QoL TT (ST) SU (SW) IW (SW) TI (SS) dc (U) 
KOOS-I IW (`U) bU (`d) cU (`I) Ic (`d) d[ (b) 
Abbreviations: ADL – activities of daily living, QoL – knee-related quality of life, Sports/Rec – sports & recreation, 
KOOS-I – average KOOS score across all I subscales. 
One-month test-retest RMSCV for the KOOS subscales of pain, symptoms, activities of 
daily living, sports and recreation and quality of life were `W%, `U%, c%, TI% and SI% 
with a RMSCV for the KOOS-I average score of `S%. These are commensurate with 
previously published values for the KOOS(SbS).  
The number of improvers based on the SDD and OMERACT-OARSI responder 
thresholds are provided in Table I.I. No participants demonstrated worsening of 
KOOS values greater than the SDD. 
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Table (.( 
Number (%) of OA participants with symptomatic improvement at c-months and `-year visits per SDD and 
OMERACT-OARSI criteria.  
 c-month follow-up (n = `b) `-year follow-up (n = U) 
Change criterion SDD O-O SDD O-O 




Symptoms c (bT%) S (SI%) 
ADL I (Tc%) T (TU%) 
Sports/Rec c (bT%) b (IW%) 
QoL [ (IW%) b (IW%) 
KOOS-I I (Tc%) T (TU%) 
Values provided are participant numbers. Note that the O-O criterion uses a composite of different measurement 
scales, more details in (SbT). Abbreviations: SDD – smallest detectable difference, O-O – OMERACT-OARSI 
!.9.$ Core Imaging Assessments 
All of the original OA cohort participants had baseline radiographs, with seven out of 
`W also completing `-year follow-up radiographs. One participant did not attend their 
final visit, with the other two participants missing their final radiograph due to 
scheduling difficulties. Individual participant qualitative and quantitative radiographic 
assessments are provided in Table I.c for both original and additional cohort 
participants. Additional cohort participants did not have dedicated fixed-flexion 
radiographs making measurement of JSW unreliable, therefore only qualitative 
assessments were performed. 
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Table (.: 
Results of radiographic analyses in OA participants 




osteophytes JSW**( (mm) 
Baseline `-year Baseline `-year Baseline `-year Baseline `-year 
Original cohort 
5 S S ` ` ` ` I.S b.[ 
* T T S S ` ` T.I S.I* 
/ S S ` ` ` ` b.I b.` 
6 S - S - ` - T.d - 
( T T T T S S T.T T.T 
: S S ` ` ` ` I.b b.U 
Q T T S S ` ` b.W T.U 
R T T T T S S T.` T.c 
S S - W - ` - c - 
5T S - W - ` - c.T - 
Additional cohort 
55 S - W - ` - - - 
5* S - ` - ` - - - 
5/ S - ` - ` - - - 
56 S - ` - S - - - 
* JSW progression per criteria in section I.S.d 
One out of seven analysable original cohort participants had `-year JSW loss greater 
than the specified W.[ mm threshold. There was no change in K-L or OARSI grades 
over `-year in analysable original cohort participants. 
Semi-quantitative assessment using MOAKS was possible for each participant at each 
completed study visit. Baseline MOAKS data are summarised in Table I.[. MOAKS 
progression data are presented in Figure I.T. 
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Table (.Q 
Summary of baseline MOAKS data 
MOAKS domain OA (n = 56) HV (n = :) 
Bone marrow lesion   
- Any `S ` 
- ³ grade S U W 
Cartilage defect   
- Any  `S S 
- ³ grade S (size) `S ` 
- Any full-thickness  d ` 
Osteophyte   
- Any  `S S 
- ³ grade S I W 
Meniscal damage   
- Any medial tear* `W ` 
- Any lateral tear* U ` 
Meniscal extrusion   
- Any medial `T b 
- ³ grade S medial `S b 
- Any lateral ` ` 
- ³ grade S lateral ` W 
Effusion-synovitis   
- Any `` ` 
- ³ grade S I W 
Hoffa-synovitis   
- Any c ` 
- ³ grade S ` W 
* not including intrameniscal signal without discrete tear 
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Figure (./ 
Percentage of subregions in each group with worsening, improvement or no change in MOAKS score over c-months 
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I.b DISCUSSION 
This chapter has described the core methodology and results of non-QIB analyses in 
the AMROA study. Meaningful changes in semi-quantitative MR grading scores, 
radiographic JSW measurement and symptoms were observed during the study period. 
Participants with OA demonstrated a greater number of MOAKS abnormalities at 
baseline and an increased proportion of subregions demonstrating progression at c-
months and `-year when compared to HV participants. Given that one would expect 
QIBs to be at least as sensitive to change as semi-quantitative or qualitative 
measurements, this finding suggests that QIBs will also demonstrate meaningful 
changes in some individuals over the study period. Only one participant demonstrated 
meaningful radiographic changes over one year, in keeping with previous studies over 
similar time periods and highlighting the limited utility of JSW measurement in the 
experimental medicine setting(Sbc).  
Not all HV participants had structurally normal knees at MR imaging. Abnormalities 
such as those detected are common in the asymptomatic population and become 
increasingly common with age(bS). The AMROA study was designed to match HV 
participants as closely as possible to OA participants for age given that one of the 
desirable criteria for a candidate QIBs in OA is that it should be able to discriminate 
between true disease and normal ageing(Sb[). 
The number of OA participants demonstrating symptomatic improvement over the 
study period is likely a result of several factors. The natural waxing and waning nature 
of symptoms in OA is well-described, although if this was the sole explanation one 
might expect to see individuals with worsening of symptoms as well. Regression to the 
mean may also play a role. The local pathway for referral to an orthopaedic knee clinic 
requires the patient to have persistent, severe symptoms which have not responded to 
conventional treatments. Therefore, patients are likely to have been referred to 
orthopaedic clinic at a time when their symptoms were severe, with regression to the 
mean making an improvement in symptoms likely at subsequent visits. No treatment 
with known disease-modifying benefit was administered to participants during the 
study, however symptomatic benefit from treatments such as arthroscopy and simple 
analgesia are feasible. The improvement in symptoms demonstrated in this study in 
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the absence of any disease-modifying intervention highlights the difficulties faced 
when designing trials comparing active treatment vs placebo using patient reported 
outcome measures alone. 
The proportion of participants demonstrating MOAKS progression or improvement is 
similar to what has been observed in previous studies using the same definitions of 
change(SbU,Sbd). Synovitis and meniscal extrusion measures had the greatest 
proportion of subregions demonstrating change. Synovitis is known to fluctuate over 
time in knee OA(SIW,SI`). Fluctuation in meniscal extrusion is less well-described. 
However, extrusion of the meniscus is known both to occur in both healthy and 
abnormal knees and to be influenced by multiple factors including anatomic variation 
in the site of meniscal root attachment, recent loading and volume of joint effusion, 
providing a rationale for why fluctuation in measures of meniscal extrusion may have 
occurred in this study(SIS–SIb).  
The fact that d out of `b OA participants underwent knee arthroscopy during the study 
follow-up period is somewhat surprising, given that this procedure is no longer 
recommended in the setting of knee OA(U). However, this recommendation remains 
contested with the suggestion that the evidence it is based on is not generalisable to 
the typical population seen in orthopaedic clinics(d,`W). Recently published British 
Association for Surgery of the Knee (BASK) guidelines on the appropriateness of 
arthroscopic meniscal surgery in the presence of OA would support the use of this 
treatment in the patient group enrolled in this study – symptomatic mild-to-moderate 
OA who have not responded to conservative treatment(``). This uncertainty may 
explain the fact that a large proportion of participants underwent this procedure and 
highlights the paucity of effective treatments on offer for the study demographic(`S). 
There are several strengths of the AMROA study design. A standardised protocol was 
used to minimise common measurement confounds, including the use of a positioning 
device for knee radiographs, scheduling MR examinations at a consistent time of day 
and allowing for a period of unloading prior to compositional knee MR sequences. In 
addition, all studies were performed at a single centre under direct radiologist 
supervision. Another strength is the use of an age-matched control cohort. Chapter S 
of this thesis illustrates the fact that the discriminative performance of imaging 
biomarkers may be inflated when non-age-matched control cohorts are used. 
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There are several study limitations. Only a small number of participants were included 
with a short follow-up period. This was intentional in order to mimic the conditions of 
an experimental medicine study; however, this does limit study power. Due to this 
constraint, study statistical analyses are predominantly descriptive rather than 
inferential. While the study had an observational design, several participants had 
surgical interventions as part of ongoing care during the study period so the 
responsiveness of different QIBs observed in the study may be different to what would 
be observed in an interventional trial population. This limitation was unavoidable due 
to ethical concerns regarding asking participants to forego treatment for a purely 
observational study without direct benefit. Finally, the careful standardisation of study 
procedures previously described as a strength is also a potential weakness as it limits 
the extrapolation of results to less controlled settings such as multi-centre studies. 
In conclusion, this chapter has described the core methodology and results of the 
AMROA study. Future chapters will discuss the methodology and results of QIBs 
employed in this study in detail.  
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APPENDIX I. `  
KOOS questionnaire 
 
Knee injury and Osteoarthritis Outcome Score (KOOS), English version LK1.0  1 
KOOS KNEE SURVEY 
 
 
Today’s date: _____/______/______ Date of birth: _____/______/______ 
 
 
Name: ____________________________________________________  
 
INSTRUCTIONS: This survey asks for your view about your knee. This 
information will help us keep track of how you feel about your knee and how 
well you are able to perform your usual activities. 
Answer every question by ticking the appropriate box, only one box for each 
question. If you are unsure about how to answer a question, please give the 
best answer you can. 
 
Symptoms 
These questions should be answered thinking of your knee symptoms during 
the last week. 
 












S2. Do you feel grinding, hear clicking or any other type of noise when your knee 

















































The following questions concern the amount of joint stiffness you have 
experienced during the last week in your knee. Stiffness is a sensation of 
restriction or slowness in the ease with which you move your knee joint. 
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Knee injury and Osteoarthritis Outcome Score (KOOS), English version LK1.0  2 
Pain 












What amount of knee pain have you experienced the last week during the 
following activities? 
 
































































































Function, daily living 
The following questions concern your physical function. By this we mean your 
ability to move around and to look after yourself. For each of the following 
activities please indicate the degree of difficulty you have experienced in the 
last week due to your knee. 
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Knee injury and Osteoarthritis Outcome Score (KOOS), English version LK1.0  3 
For each of the following activities please indicate the degree of difficulty you 
have experienced in the last week due to your knee. 
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Knee injury and Osteoarthritis Outcome Score (KOOS), English version LK1.0  4 
For each of the following activities please indicate the degree of difficulty you 
have experienced in the last week due to your knee. 
 
























Function, sports and recreational activities 
The following questions concern your physical function when being active on a 
higher level. The questions should be answered thinking of what degree of 





























































Quality of Life 












Q2. Have you modified your life style to avoid potentially damaging activities 
       to your knee? 











Q3. How much are you troubled with lack of confidence in your knee? 






















Thank you very much for completing all the questions in this questionnaire. 
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CHAPTER ): 
 
DYNAMIC CONTRAST ENHANCED MAGNETIC 
RESONANCE IMAGING OF SYNOVITIS IN THE 
AMROA STUDY 
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Synovial inflammation is common in knee OA. Dynamic contrast enhanced 
(DCE) MR imaging provides a method of quantifying synovitis. DCE-MR is 
well established in rheumatoid arthritis and has shown initial promise in OA.  
In this chapter I describe the use of DCE-MR quantitative imaging biomarkers 
(QIBs) of synovitis in the AMROA study. No prior description of test-retest 
repeatability of DCE-MR QIBs in knee OA or comparison of DCE-MR QIB 
values between OA participants and age-matched healthy controls exists in 
the published literature. The results suggest that the DCE-MR QIB with the 
best performance characteristics for experimental medicine studies is Ktrans, 
the transfer coefficient between plasma and the extracellular extravascular 
space.  
c.` INTRODUCTION 
Synovial inflammation is common in OA, with MR-detected synovitis occurring in up 
to dW% of OA knees(SII). It can be detected both histologically and on imaging from 
the early stages of the disease process(SIc). Strong cross-sectional associations exist 
between the presence of synovitis and the severity of knee pain(SI[). Longitudinal 
associations have been demonstrated between the presence and severity of synovitis 
and OA progression from both a symptomatic and a structural point of 
view(SIW,SIU,SId). There is therefore a strong rationale for therapeutic targeting of 
synovitis to provide disease modification(Sb). 
Dynamic contrast enhanced (DCE) MR imaging aims to characterise the uptake and 
washout of gadolinium-based contrast agents (gdCA) in tissues of interest, providing 
measures of tissue perfusion, capillary permeability and blood and interstitial volume. 
These parameters are known to change in the synovium in OA(ScW). DCE-MR has 
been used to assess synovitis in early phase clinical trials of rheumatoid arthritis (RhA) 
and has demonstrated superiority over semi-quantitative assessments in this 
setting(Sc`,ScS). The promise of DCE-MR in OA has been illustrated by several studies 
demonstrating the response of DCE-MR biomarkers to intra-articular corticosteroid 
treatment with improved responsiveness compared to alternative semi-quantitative 
and qualitative assessments of synovitis([`,[S). 
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However, to increase confidence in the utility of DCE-MR QIBs in experimental 
medicine (EM) studies of knee OA more information is desirable. This includes 
assessment of test-retest repeatability, ability to discriminate between knee OA and 
normal ageing, and expected changes over relevant follow-up periods.  
Therefore, the purpose of this study was to assess the performance characteristics of 
DCE-MR QIBs of synovitis for use in EM studies. 
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c.S METHODS 
4.#.: Participants & Ethical Approval 
Ethical approval, participant recruitment and eligibility criteria are provided in chapter 
I (sections I.S.` and I.S.S). 
4.#.# Image acquisition 
General details on the acquisition of MR data for the AMROA study are described in 
chapter I (section I.S.T, Table I.S). Sequences used for DCE-MR included pre-contrast 
variable flip angle T` mapping sequences and a multi-phase dynamic sequence 
(temporal resolution for entire volume `bs).  At the end of the sixth phase of the 
dynamic sequence, gdCA (Dotarem®, Guerbet, Paris, France) was administered at a 
dose of W.S mM/kg and a rate of T mL/s followed by a IW mL saline chaser at the same 
rate. Imaging continued for a further Sd phases (TI phases total, acquisition time U 
min `W s) following the gdCA administration. Pre and post gdCA TD fat-saturated 
SPGR sequences were also obtained for synovial segmentation purposes. The total time 
taken for all sequences used for DCE-MR analysis was approximately S` minutes. 
4.#.9 Image analysis – region of interest definition 
Initial rough manual segmentation of the synovium was performed on the post-
contrast TD FS SPGR sequence by a radiologist, with definition of seven synovial 
regions of interest (ROIs): suprapatellar, Hoffa’s fat pad, medial and lateral 
perimeniscal, intercondylar notch, medial and lateral posterior medial femoral 
condyles (Figure c.`). Anatomical definitions of synovial ROIs are provided in Table 
c.`.  
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Figure :.5 
TD rendering of synovial regions of interest with anterior (A), posterior (B), medial (C) and lateral (D) views. TD 
rendering of femur, tibia and patella (grey) provided for reference. ROI Key: green – suprapatellar, yellow – Hoffa 
fat pad, red – medial perimeniscal, blue – lateral perimeniscal, purple – intercondylar notch, pink – posterior medial 
femoral condyle, orange – posterior lateral femoral condyle. 
 
Next, enhancing voxels were defined by subtracting the pre-contrast TD FS SPGR 
sequence from the matching post-contrast sequence using a shuffle transform(ScT). 
For a given voxel in the post-contrast image, the shuffle transform minimises the 
absolute difference between the signal intensity of that voxel and the corresponding 
voxel plus a defined neighbourhood (for this study the adjacent T x T voxels) in the pre-
contrast image. This improves the quality of the subtracted images and is also robust 
to residual motion artefact following image registration (Figure c.S).  
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Table :.5 
Anatomical definition of synovial regions of interest. 
Region Definition 
Suprapatellar 
From mid pole of patella to superior extent of suprapatellar bursa, 
including medial and lateral peripatellar recesses 
Hoffa fat pad 
From junction of patellar tendon/tibial tuberosity to mid pole of 
patella superiorly. Posteriorly extends to anterior aspect of 




Wraps around medial meniscus. Extends superiorly deep to 
medial collateral ligament (MCL) to level of femoral MCL origin. 
Extends inferiorly deep to MCL to tibial MCL attachment. 
Lateral 
perimeniscal 
Wraps around lateral meniscus. Extends superiorly deep to lateral 
collateral ligament complex to fibular collateral ligament femoral 
origin. Extends inferiorly to level of tibiofibular joint. Includes 
popliteus recess, if present. 
Intercondylar 
notch 
From superior aspect of anterior cruciate ligament (ACL) femoral 
origin to floor of intercondylar notch at intercondylar eminences. 
Posterior margin tangential to most posterior margin of posterior 
cruciate ligament, anterior margin at anterior aspect of ACL. 
Posterior medial 
femoral condyle 
From most proximal aspect of medial head of gastrocnemius 
tendon to superior border of posterior horn of medial meniscus. 
Extends to meet intercondylar notch region laterally and medial 
perimeniscal region medially. Includes semimembranosus/medial 
head of gastrocnemius bursa, if present. 
Posterior lateral 
femoral condyle 
From most proximal aspect of lateral head of gastrocnemius 
tendon to superior border of posterior horn of lateral meniscus. 
Extends to meet intercondylar notch region medially and lateral 
perimeniscal region laterally. 
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Figure :.* 
Example of the use of shuffle transform to improve quality of subtracted image compared to simple subtraction of 
registered images. A – pre-contrast TD FS SPGR, B – post-contrast TD FS SPGR, C – simple subtraction (following 
intensity-based registration), D – shuffle subtraction. Improved subtraction quality is seen when the shuffle 
transform is used. 
 
The shuffle subtracted images were then converted to binary enhancing masks using 
Otsu thresholding(Scb). The intersection between this binary mask and the rough 
manual segmentation for each ROI was termed the ‘volume of enhancing pannus’ 
(VEP) following the naming convention established in RhA(ScT).  The VEP mask was 
used for the extraction of DCE-MR QIB values for each synovial ROI and for the whole 
joint (all ROIs combined). In addition, the VEP mask was used to create an estimate of 
volume of synovial tissue (VEP volume, measured in mL) by multiplying the number of 
voxels included in the VEP mask by the voxel size. Similar pipelines have previously 
been used for estimating synovial volume in knee OA(ScI). 
4.#.$ Image analysis – pharmacokinetic modelling 
All DCE-MR images were registered using intensity-based registration to the post-
contrast TD SPGR FS sequence for the purpose of motion correction. This used an 
initial rigid transformation to bring images into approximate alignment followed by a 
window-limited deformable registration, performed using the Advanced 
Normalization Tools(Scc). The accuracy of this registration procedure was confirmed 
visually for every case. 
A pre-contrast T` map was created using a variable flip angle approach. The T` value at 
each voxel was estimated from the signal at each flip angle !: 
  120 
 " = $% sin(!) +,	.+,/01(2). where 3	 = exp ,787+  (c.`) 
 
Where MW is proportional to the estimated proton density of the tissue and MR gain 
settings and is also estimated during the fitting process. There was no correction for B` 
(transmit field) inhomogeneity given that a local transmit coil was used, meaning that 
any effect was likely to be minimal. 
The signal intensity data S from each voxel at each timepoint in the dynamic series was 
converted into a T` value via rearrangement of equation c.`. This was in turn converted 
into a concentration of gdCA C by comparing the observed T` value to the native T` 
value T`W given the known relaxivity r: of the gdCA (Dotarem®: T.b s-`.mM-` at T T) by 
rearrangement of equation c.S 
 
1:+ = 1:+% +	<+=		 (c.S) 
 
This creates a time-concentration curve for each voxel in the dynamic series, which is 
used as an input to equation c.T, the extended Tofts-Kety model(Sc[): 
 =>(?) = @A=A(?) + B>CDEF G=A(?H) exp−B>CDEF(?H)@J K?′>%  (c.T) 
 
Where Ct(t) is the time-concentration curve for the voxel, Cp(t) is the arterial input 
function (AIF), Ktrans is the volume transfer coefficient between plasma and the 
extracellular extravascular space (units min-`), ve is the proportion of extracellular 
extravascular space, and vp is the proportion of plasma. 
A population AIF was used due to technical difficulties in creating an individual AIF at 
the knee, including small artery size and the achievable temporal resolution(ScU). All 
AIFs were corrected for individual haematocrit values(STU). 
The initial area under the time-concentration curve at cWs following the 
administration of gdCA (IAUCcW, units mM.s) was also considered as a candidate QIB. 
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4.#.! Statistical analysis 
Test-retest repeatability was assessed using baseline and `-month whole joint data. 
Root-mean-square average coefficients of variation (RMSCV) were calculated for each 
QIB. The smallest detectable difference (SDD) was calculated for each QIB, 
representing the magnitude of change that would give dI% confidence of a change 
being genuine rather than due to measurement noise(Scd). To derive the SDD, 
correlation between the difference between the baseline and `-month measurements 
and the mean value was assessed visually and quantified using Kendall’s t. If significant 
correlation was detected, this indicates that variability depends on the QIB value in 
which case SDD is expressed as a percentage change. In this case, the within subject 
coefficient of variation was used: 
"MM =	N∑ PQRSRTUVRW+X × 1.96 × √2 × 100% (c.b) 
 
If no significant correlation was detected, this implies that variability is independent of 
QIB value in which case SDD is expressed as an absolute value. In this case, the within 
subject variance was used: 
"MM = 	a∑ QRUVRW+X × 1.96	 × √2 (c.I) 
 
Discrimination between OA and HV participants was assessed using baseline data. 
Descriptive statistics were calculated for each group, and the standardised mean 
difference (with dW% confidence intervals) was estimated for each QIB. 
Six-month and `-year changes in each QIB were assessed using descriptive statistics. 
ANCOVA was used to estimate the adjusted mean c-month and `-year change in each 
QIB in each group using baseline measurement as a covariate to account for regression 
to the mean(S[W). The number of participants with changes in each DCE-MR QIB 
greater than the SDD was calculated. 
All statistical analyses were performed in RStudio version `.W.`bT. 
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c.T RESULTS 
4.9.: Participants 
Participant characteristics are as described in chapter I (section I.T.`). One original 
cohort OA participant declined gdCA administration at the six-month visit and did not 
attend the `-year visit, therefore was not included in c-month or `-year change 
analyses. 
4.9.# Test-retest repeatability 
RMSCV and SDD values for each parameter are provided in Table c.S. The variability 
of Ktrans, IAUCcW, VEP volume was not significantly correlated with the value of the 
parameter, so absolute SDD values were calculated. Variability of ve was significantly 
correlated with parameter values, so percentage SDD values were calculated. There 
were a large number of W values for vp, meaning calculation of RMSCV and SDD values 
were not possible. This parameter was not used for further analyses. Due to the very 
high RMSCV for ve and the presence of implausible values (e.g. ve greater than `), this 
parameter was also not used for further analyses. 
Table :.* 
Root-mean-square average coefficients of variation and smallest detectable changes for DCE-MR QIBs. The mean 
baseline value of each biomare in OA participants is also given to provide context to the SDD. 
Parameter RMSCV(%) SDD* OA mean (SDD as %) 
Ktrans (min-`) `[.U W.W`T W.Wb` (TS) 
IAUCcW (mM.s) TS.T c.[b U.dU ([I) 
VEP volume (mL) Tb.U [`.I cd.S (`WT) 
vp NA NA W.WW`I (NA) 
ve c`.S `cd.I% W.dT (NA) 
*provided as absolute values unless otherwise stated. Abbreviations: NA – not applicable 
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4.9.9 Baseline between-group differences 
Baseline between group differences for the whole joint are illustrated in Figure c.T. 
Plots for individual ROIs are provided in Appendix c.`. One HV participant had much 
higher values of Ktrans and IAUCcW when compared to other HV participants across all 
ROIs. On further investigation, it was determined that this HV had taken part in 
karate practice the night before each study visit, and also had an undisclosed history of 
gout (never having affected the knee). Possible explanations considered for this value 
were that this represented part of the normal range of healthy values, or that the 
presence of gout or recent intense physical activity had confounded measurement.  
Figure :./ 
Baseline DCE-MR QIB values. Black dots are median values, with interquartile range error bars. 
 
The standardised mean difference (SMD) between OA and HV groups was W.db (dW% 
confidence interval W.`` to `.[[), W.Ib (-W.Sc to `.TI) and W.IW (-W.T` to `.TW) for Ktrans, 
IAUCcW and VEP volume respectively. Excluding the outlier HV case, SMDs were `.Tb 
(W.bS to S.SI) for Ktrans and `.`S (W.ST to S.WS) for IAUCcW. Analysis of synovial ROIs 
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revealed the highest between group differences for the intercondylar notch and medial 
and lateral perimeniscal ROIs for Ktrans and IAUCcW (Appendix c.`). Between group 
differences were smaller for VEP volume for all synovial ROIs, with the largest 
difference for the suprapatellar ROI. 
4.9.$ 4-month and :-year changes 
Changes in DCE-MR QIBs over the duration of the AMROA study are summarised in 
Figure c.b, with data for all synovial ROIs provided in Appendix c.S. The mean c-
month and `-year changes in DCE-MR QIBs, adjusted for baseline value, are provided 
in Table c.T. All dW% confidence intervals for c-month and `-year mean changes in 
QIBs included W (no change) for both groups with the exception of `-year change in 
VEP volume in HV. 
Table :./ 
Adjusted mean c-month and `-year changes in DCE-MR QIBs.  
Parameter 
:-month LSmean D (ST% CI) 5-year LSmean D (ST% CI) 
OA (n = 5*) HV (n = () OA (n = S) HV (n = 6) 
Ktrans (min-`) W (-W.W``, W.W`W) W (-W.W`c, W.W`b) W (-W.W`, W.W`) W.W` (-W.W`, W.WT) 
IAUCcW (mM.s) W.T (-`.U, S.b) -`.I (-b.I, `.b) ` (-S.W, b.W) `.[ (-S.U, c.S) 
VEP volume (mL) Sc (-S, Ib) SU (-`S, c[) `c (-S, TI) Tb (c, cS) 
Abbreviations: LS mean – least-squares mean, i.e. mean change value adjusted for baseline value via ANCOVA 
For Ktrans, I out of `S OA and ` out of I HV participants had changes greater in 
magnitude (regardless of direction) than the SDD at c-months. One out of d OA and S 
out of b HV participants had changes greater than the SDD at `-year. Corresponding 
values for IAUCcW and VEP volume are provided in Table c.b. 
Table :.6 
Number of participants with c-month and `-year changes greater in magnitude than the SDD. 
Parameter 
Number of participants with changes > SDD 
At c-months At `-year 
OA (n = `S) HV (n = I) OA (n = d) HV (n = b) 
Ktrans (min-`) I ` ` S 
IAUCcW (mM.s) ` W ` W 
VEP volume (mL) ` W W W 
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Figure :.6 
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A comparison of c-month changes in Ktrans and MOAKS synovitis score (sum of 
effusion synovitis and Hoffa synovitis scores, see chapter I for detail) is provided in 
Figure c.I.  
Figure :.( 
Individual participant c-month changes in Ktrans and MOAKS synovitis score. Dotted lines for Ktrans are ±SDD values. 
 
There was little concordance between participants with changes in Ktrans and 
participants with changes in MOAKS synovitis score (Table c.I). For example, one 
participant had an increase in Ktrans but a reduction in MOAKS synovitis, and one 
participant had a decrease in Ktrans but an increase in MOAKS synovitis. 
Table :.( 
Confusion matrix demonstrating concordance between changes in Ktrans and MOAKS synovitis score. Note total 
values are not provided (bottom right) due to different numbers of participants being assessed by each method (one 
OA participant declined contrast at c-month visit). 
  MOAKS synovitis 
  Increase Decrease No D Total 
Ktrans 
Increase W ` ` S 
Decrease ` ` S b 
No D b ` - - 
Total I T - - 
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Example images of participants with significant changes at c-months are provided in 
Figure c.c. 
Figure :.: 
Example images from participant with significant increase (A) and decrease (B) in Ktrans at c-months. In (A), note 
extruded medial meniscus with cuff of surrounding synovitis (white arrow). At c-months, the synovitis has 
increased both in amount and intensity. In (B), not distention of suprapatellar pouch (arrow) and synovitis adjacent 
to anterior horn of lateral meniscus (arrowhead) at baseline, with marked reduction at c-months. 
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c.b DISCUSSION 
This study suggests that Ktrans is the optimum DCE-MR QIB for use in experimental 
medicine studies, with the best test-retest reproducibility, best discrimination between 
OA and HV participants, and greatest responsiveness as judged by the number of 
participants showing detectable changes from baseline over c-months and `-year.  
Data on test-retest repeatability of DCE-MR QIBs in OA have not previously been 
published. Coefficients of variation are similar to previous DCE-MR studies in both 
musculoskeletal and non-musculoskeletal applications(Sc`,S[`,S[S). Repeatability 
appears to be acceptable for experimental medicine studies given the finding of 
participants with changes exceeding the SDD at c-months and `-year. The test-retest 
repeatability interval chosen for the AMROA study (`-month) is relatively long when 
compared to the time over which fluctuations in synovitis are known to occur in OA. 
Therefore, ‘true’ methodological test-retest variability, excluding biological variation, is 
likely to be lower than the variability described here.  
DCE-MR has also not previously been used to compare individuals with knee OA with 
healthy controls in the published literature. Higher values of Ktrans, IAUCcW and VEP 
volume were found in OA participants as would be expected. The highest point 
estimate for between-group SMD was for Ktrans, albeit with overlapping confidence 
intervals with other QIB estimates. The results suggest that IAUCcW is providing similar 
information to Ktrans, which would be expected as both are driven by the initial gdCA 
uptake curve. However, Ktrans seems to offer reduced variability, improved 
discrimination and improved responsiveness. One possible explanation for the 
observed superiority of Ktrans is its improved physiological specificity when compared 
with IAUCcW. VEP volume differences between groups were also relatively large. It 
should be noted that no adjustment was performed for joint size. OA and HV groups 
were well matched for height and weight although not for sex (Chapter I, section 
I.T.`). More detailed adjustment for joint size via, for example, articular surface area is 
also possible but is difficult to interpret as surface area is also affected by the OA 
disease process. 
One HV participant had much higher values of Ktrans and IAUCcW than did other HVs. 
As mentioned above, potential explanations for this outlier are the influence of 
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physical exercise the previous evening or subclinical synovitis due to gout or calcium 
pyrophosphate deposition arthropathy. The influence of prior exercise on DCE-MR 
parameters remains unknown and warrants further investigation given that this is a 
potential confound. If prior exercise is indeed a source of unwanted variation, then it 
should be noted that the observation of unloading protocol (~bI minutes rest) for 
cartilage compositional imaging in the AMROA study has not removed the effect in 
this study. This suggests a longer period of prior rest may be required for DCE-MR. 
There was a wide range of c-month changes in DCE-MR QIBs in both positive and 
negative directions in OA participants. MOAKS synovitis scores also demonstrated 
greater changes at six months than did other semiquantitative parameters. This may 
reflect the fluctuating nature of synovitis in OA, which is well recognised clinically 
with the concept of OA flares(S[T). The variation described in this observational study 
should be borne in mind if using DCE-MR QIBs in further interventional studies, 
where it seems reasonable to assume that some participants will demonstrate 
‘significant’ reductions in Ktrans and IAUCcW as part of the natural variation in these 
parameters rather than due to treatment effects. At a group level, adjusted mean 
changes for each QIB were close to W at six months and `-year. An effective treatment 
targeting synovitis may be expected to reduce the adjusted mean difference at a group 
level. Using the standard deviation of change observed in this study, a reduction in 
mean Ktrans of W.W`I min-` over c-months could be detected with UW% power with a 
sample size of `c participants per group, assuming an active treatment vs placebo 
design and a type ` error rate of W.WI. This would represent a reduction of about TI% 
from the OA baseline mean, and is a clinically feasible reduction based on previous 
studies of response to intra-articular corticosteroid administration([`). 
Results of DCE-MR QIBs were relatively consistent between different synovial ROIs. 
However, baseline SMDs for Ktrans and IAUCcW were highest in the perimeniscal and 
intercondylar notch regions. These are not areas which are scored by MOAKS or other 
commonly used whole joint scoring systems, highlighting a possible shortcoming. 
Alternative semiquantitative scoring systems for synovitis do take these locations into 
account, although are less widely used(S[b). 
The use of DCE-MR QIBs obtained from analysis of dynamic data provides substantial 
additional information for assessment of synovitis by quantifying intensity of 
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inflammation. Morphological measures (such as VEP volume) can quantify the amount 
of synovial tissue, but not the intensity of inflammation. As well as playing a role in 
assessing response to treatment, ‘intensive’ (vs ‘extensive’) biomarkers of synovitis may 
have an important role to play in gaining better insight into the OA disease process. 
Evidence from animal and ex-vivo studies suggests that synovitis plays an important 
role in promoting adjacent cartilage degradation and stimulating marginal osteophyte 
formation(SI,S[I). QIBs such as Ktrans may offer a novel way of examining such 
hypotheses in in-vivo human studies of OA onset and progression. 
The extended Tofts model used for pharmacokinetic modelling in this study was 
originally developed for DCE-MR of solid tumours. This study agrees with previous 
work highlighting the shortcomings of this model for synovitis(Sc`). The model 
assumes that the contrast agent concentration within a voxel of interest will reach a 
plateau with possible wash-out phase. Voxel-wise analysis of uptake curves in this 
study’s data demonstrate that in synovium, the plateau phase is not reached during the 
dynamic acquisition (approx. U minutes) which can lead to implausible estimates for 
ve.  The model also allows each voxel to contain a proportion of blood plasma volume 
(vp), which is a sensible assumption in highly vascular tumours but perhaps less so in 
synovium where the vascular channels are much smaller. The DCE-MR parameters 
showing best performance in this study, Ktrans and IAUCcW, are driven primarily by the 
initial uptake curve and therefore are unaffected by these assumptions. 
The main study limitation is the use of a `-month test-retest repeatability interval for 
DCE-MR QIBs which does not allow the isolation of methodological vs biological 
variability. The interval was chosen to assess test-retest repeatability for all QIBs 
included in the AMROA study, but this may have unfairly advantaged cartilage and 
bone QIBs which are less likely to show biological variability over this time. Recent 
concerns regarding deposition of gdCA in several tissues including the brain and bone 
marrow have reduced the ethical acceptability of repeat gdCA administrations over a 
short period of time, but a test-retest interval in the order of one week would likely be 
achievable(S[c). A second limitation is that the results presented are from a single 
centre and obtained with meticulous quality control, therefore extrapolation to multi-
centre studies should be done with caution. However, previous work in other disease 
suggests that DCE-MR QIBs can be used in such a setting with appropriate training, 
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calibration and central image quality control(S[[). In particular, the use of a semi-
automated pipeline as described in this study for defining the synovial ROI is likely to 
improve reliability in the multi-centre setting compared with alternative manual 
methods(S[U). A population-based arterial input function (AIF) was used for 
pharmacokinetic analysis of the DCE data. Such approaches improve reproducibility 
but may be less sensitive to change(ScU). The use of a population-based AIF was 
preferred as the temporal resolution of this study’s volumetric acquisition (`b s/phase) 
precluded the accurate construction of individual AIFs. 
In conclusion, this chapter has provided data on test-retest repeatability, 
discrimination between OA and ‘normal’ ageing and responsiveness for DCE-MR QIBs. 
Ktrans appears to have the best performance across these domains and is therefore most 
likely to be useful in EM studies.  
  132 
APPENDIX c.`  
Baseline DCE-MR QIB values in each synovial region of interest. Black dots are median 
values, with interquartile range error bars. 
`. Ktrans (min-`) 
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S. IAUCcW (mM.s) 
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T. VEP volume (mL) 
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APPENDIX c.S 
Change in DCE-MR QIBs over study duration for each synovial ROI. Black dots are 
median values, with interquartile range error bars. 
`. Ktrans 
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S. IAUCcW 
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T. VEP volume 
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CHAPTER 6: 
 
MAGNETIC RESONANCE IMAGING OF 
SUBCHONDRAL BONE IN THE AMROA STUDY 
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 Subchondral bone plays a critical role in OA onset and progression. Bone is a 
dynamic tissue, capable of remodelling in response to different loading 
conditions and endocrine and paracrine signalling. To evaluate the response 
of novel therapeutic agents on bone, sensitive imaging biomarkers of bone are 
desirable. 
In this chapter I apply the texture analysis methodology described in chapter 
$ to the AMROA study. I also analyse subchondral bone area which has been 
shown to be a sensitive marker of OA progression in previous studies. The 
results show that subchondral bone area measurement and subchondral bone 
texture analysis are highly repeatable with multiple participants 
demonstrating detectable changes at 4-months and :-year. Subchondral bone 
texture is more responsive than subchondral bone area, but is more difficult 
to interpret from a biological or structural point of view.  
[.` INTRODUCTION 
Subchondral bone plays an important role in OA development and progression(SWb). 
Because bone is a dynamic tissue, capable of remodelling in response to both 
mechanical and biological stimuli, there has been increasing interest in targeting 
potential disease modifying treatments (DMOATs) to this tissue(SWI,S[d). Sensitive 
imaging biomarkers of subchondral bone could help assess patient suitability for and 
response to putative DMOATs. 
As discussed in chapter b, multiple candidate quantitative imaging biomarkers (QIBs) 
for subchondral bone have been described using plain radiography, dual energy x-ray 
absorptiometry, computed tomography (CT), nuclear medicine and MR 
imaging(Td,SWd,SUW,SU`). There are several reasons for preferring MR-based QIBs 
including the lack of ionising radiation and the ability to assess other tissues involved 
in the disease process in the same examination and determine the spatial relationship 
of changes in these tissues to changes in bone. 
Two of the most promising MR QIBs for bone are subchondral bone area (SBA) and 
MR texture analysis (MR TA). SBA for both femur and tibia increases in OA(SUS,SUT). 
Change in SBA has been shown to discriminate patients with OA from controls and 
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has been associated with structural and symptomatic progression of OA in analyses of 
the Osteoarthritis Initiative (OAI)(cT,SSc). Changes in SBA were detected over T-
months in a small OA cohort (n = S[) where there was no detectable change in 
cartilage thickness, demonstrating its potential utility as a QIB in experimental 
medicine studies(cb). MR TA has been described previously in chapter b of this thesis. 
It has also shown the ability to discriminate patients with OA from healthy controls, 
and both baseline and change in MR TA are associated with structural OA 
progression(S``,SUb). However, the test-retest repeatability and responsiveness to 
short-term change of MR TA remains uncertain. There has not been a previous head-
to-head comparison of MR TA and SBA measurement to determine which has the most 
desirable QIB profile for use in experimental medicine studies. 
Therefore, the purpose of this study was to evaluate the performance characteristics of 
two candidate MR QIBs of subchondral bone, subchondral bone area and subchondral 
bone texture, for use in experimental medicine (EM) studies. 
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[.S METHODS 
V.#.: Participants & Ethical Approval 
Ethical approval, participant recruitment and eligibility criteria are described in 
chapter I (sections I.S.` and I.S.S). 
V.#.# Image Acquisition 
Details on the acquisition of MR data for the AMROA study are described in chapter I 
(section I.S.T, Table I.S). The coronal SD T`-weighted fast spin echo (T`w FSE) 
sequence was used for subchondral bone texture analysis (Figure [.`).  The high spatial 
resolution pre-contrast sagittal TD fat suppressed (FS) spoiled gradient echo (SPGR) 
sequence was used for segmentation of bone and cartilage from which SBA 
measurements were derived. 
V.#.9 Image analysis – subchondral bone texture 
The texture analysis methodology follows that described in chapter b (section b.S.T). 
The three most central coronal-oblique images through the central medial 
tibiofemoral joint were identified with reference to localiser images and other sagittal 
sequences and used for subsequent analysis. Three central images were used here 
(compared to five central images used in chapter b) as a SD vs TD sequence with 
thicker slices (S.I mm vs ` mm) and interslice gaps (S.I mm vs W mm) was being used. 
The SD T`w FSE sequence was chosen over the TD gradient echo sequence used in the 
OAI bone ancillary study as previous work has demonstrated that it provides improved 
differentiation of osteoarthritic vs healthy bone, and also a fourfold shorter acquisition 
time(SSb). 
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Figure Q.5 
Coronal SD T`w FSE image through the central tibial plateau with example ROIs for tibial (red) and femoral (green) 
subchondral bone MR TA 
 
The MR images were imported into a dedicated texture analysis program (MazDA vT.T, 
freely available at http://www.eletel.p.lodz.pl/programy/mazda/)(SSW). Regions of 
interest (ROIs) were created manually in the medial tibial and medial femoral 
subchondral bone on each coronal image. As in chapter b, ROIs were defined 
superiorly and inferiorly by the bone-cartilage interface, medially and laterally by the 
margins of the tibial plateau and femoral condyle and extended for a depth of ` cm into 
the subchondral bone (Figure [.`). 
The same `d texture features as used in chapter b were calculated for each ROI with 
the same image compression settings and averaging of parameters across pixel offsets 
used. The values of each texture parameter on each of the three coronal images were 
averaged to give summary values for each parameter in each participant for medial 
tibial and medial femoral ROIs. 
V.#.$ Image analysis – subchondral bone area 
The TD cartilage surface mapping (TD-CaSM) methodology described in chapters T & U 
yields measures of articular surface area for femur, medial tibia and lateral tibia. This is 
achieved via calculating the surface area of the inner cartilage surface mesh generated 
by the semi-automated thickness measurement process (Figure [.S). The surface area 
calculation is performed in wxRegSurf (University of Cambridge Department of 
  143 
Engineering, Cambridge, UK). In standard cartilage/bone morphology nomenclature, 
this would be defined as tAB (total area of subchondral bone) including 
osteophytes(ST`). 
Figure Q.* 
Subchondral bone area measurement pipeline. The cartilage thickness measurement pipeline described in chapters 
T & U generates accurate inner and outer cartilage surfaces. By definition, the inner surface corresponds to the 
subchondral bone contour. SBA is therefore simply the surface area of the generated inner surface meshes. 
 
V.#.! Statistical analysis 
Test-retest repeatability was assessed using baseline and `-month data. Root-mean-
square average coefficients of variation (RMSCV) were calculated for SBA and MR TA 
features. The smallest detectable difference (SDD) was calculated for SBA for each 
surface as described in chapter c (section c.S.I). 
Due to the large number of MR TA features calculated (`d), reduction in the 
dimensionality of the data was achieved via feature elimination. This involved 
excluding any texture features with suboptimal test-retest repeatability (RMSCV > 
`W%) from subsequent analyses. Individual texture features were then analysed 
separately in contrast to the composite texture score used in chapter b. The reason for 
the different approach is the lower number of participants in AMROA which prevents 
reliable cross-validation and increases the likelihood of overfitting of any regression 
model. Simply using the same model as developed in chapter b to calculate texture 
score was also not appropriate as texture feature values will vary considerably between 
different MR sequences(SUI).  
Discrimination between OA and healthy volunteer (HV) participants was assessed 
using baseline data. Descriptive statistics were calculated for each group, and the 
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standardised mean difference (with dW% confidence intervals) was estimated for SBA 
and MR TA features. 
Six-month and `-year changes in SBA and MR TA features were assessed using 
descriptive statistics. ANCOVA was used to estimate the adjusted mean c-month and 
`-year change in each QIB in each group using baseline measurement as a covariate. 
The number and proportion of participants with changes in each subchondral bone 
QIB greater than the SDC was calculated. 
All statistical analyses were performed in RStudio version `.W.`bT. 
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[.T RESULTS 
V.9.: Participants 
Participant characteristics are as described in chapter I (section I.T.`). Two 
participants had `-year visit images which were unsuitable for calculation of bone 
surface area due to motion artefact (` participant) and radiographer error in scan 
prescription (`). Out of a total of cc study visits across all participants, `` visits were 
excluded from MR TA analysis. The two reasons for exclusion were poor image quality 
due to the tibial plateau being close to the inferior boundary of the knee coil sensitivity 
region - positioning of the knee in the coil for this study was lower than the 
positioning used in standard clinical practice so as to include the entirety of the 
suprapatellar region for DCE-MR analyses of synovitis (chapter c) – and radiographer 
error in prescribing a standard clinical T`w sequence which has lower in-plane spatial 
resolution than the sequence used for MR TA. This meant that a total of `S ([ OA/I 
HV) participants contributed to test-retest assessment, `c (``/I) contributed to c-
month change assessment, and `S (U/b) contributed to `-year change assessment of MR 
TA. 
V.9.# Test-retest repeatability 
RMSCV and SDD values for SBA and MR TA features are provided in Table [.`.  Nine 
out of `d MR TA features had RMSCV > `W% and were excluded from subsequent 
analyses. 
V.9.9 Baseline between-group differences 
Baseline between group differences in SBA and MR TA features are summarised in 
Figures [.T and [.b. Mean SBA values were higher for all surfaces in the OA group with 
SMD (dW% CI) of W.IS (-W.Sd, `.Tb), W.IT (-W.Sd, `.Tb) and W.II (-W.S[, `.Tc) for femur, 
medial tibia and lateral tibia respectively. The three tibial subchondral bone texture 
features demonstrating the best differentiation between OA and HV participants were 
the grey-level co-occurrence matrix (GLCM) parameters correlation (SMD [dW% CI] = 
`.Sc [W.T`, S.SW]) and entropy (W.IT [-W.Tc, `.bS]) and the grey-level histogram mean (-
W.[U [-`.cd, W.`S]). GLCM correlation (W.cc [-W.Sb, `.II]) and entropy (W.IW [-W.Td, 
`.Td]) were also two of the best three femoral subchondral texture features for 
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differentiating between OA and HV bone, the other being the run-length matrix 
(RLM) parameter run-length non-uniformity (W.TU [-W.IW, `.S[]). 
Table Q.5 
Root-mean-square average coefficients of variation and smallest detectable changes for subchondral bone QIBs. The 
mean baseline value of each QIB in OA participants is also given to provide context to the SDD. For brevity, texture 
features which had RMSCVs > `W% (and were therefore not included in subsequent analyses) are not included. 
Parameter RMSCV(%) SDD OA mean (SDD as %) 
Subchondral bone area    
Femur S.` Sbd mmS bdUc mmS (I.W) 
Medial Tibia T.T dT mmS `Wdd mmS (U.b) 
Lateral Tibia I.I `IS mmS `WIS mmS (`b.b) 
Subchondral bone texture – tibia    
Mean U.d c`U SISU (Sb.b) 
Gr Mean [.T W.TW `.b` (S`.T) 
Gr NonZeros S.S W.WI W.Uc (I.U) 
Run fraction `.` W.WT W.UU (T.W) 
SRLE W.U W.WS W.d` (S.S) 
LRLE T.T W.`T `.bI (d.S) 
RLNU c.d I[[ TbWb (`[.W) 
Correlation I.U W.`W W.cb (`I.W) 
Entropy S.c W.`U S.I` ([.b) 
Inv Df Mom c.T W.Wb W.SI (`c.U) 
Subchondral bone texture – femur    
Mean U.S IU[ S[bU (S`.T) 
Gr Mean [.S W.SI `.SIc (SW.S) 
Gr NonZeros T.W W.W[ W.Ub (U.S) 
Run fraction `.I W.Wb W.U[ (b.W) 
SRLE `.` W.WT W.dW (T.W) 
LRLE b.T W.`U `.bU (`S.S) 
RLNU d.b cTT S[dT (SS.c) 
Correlation S.I W.Wb W.cS (I.U) 
Entropy S.U W.`U S.bW ([.b) 
Inv Df Mom [.W W.WI W.S[ (`d.U) 
Abbreviations: Gr – gradient, SRLE – short run length emphasis, LRLE – long run length emphasis, RLNU – run-
length non-uniformity, Inv Df Mom – inverse difference moment. 
  147 
Figure Q./ 
Baseline SBA values in each group. Black dots are median values, with interquartile range error bars. 
 
Figure Q.6 
Baseline MR TA values in each group, limited to the three tibial and three femoral texture features which 
demonstrated the greatest standardised mean differences between OA and HV participants for brevity. Black dots 
are median values, with interquartile range error bars. Abbreviations: RLNU – run length non-uniformity 
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V.9.$ 4-month and :-year changes 
The mean c-month and `-year changes in subchondral bone QIBs adjusted for baseline 
value are provided in Table [.S. The lower dW% CI for mean femoral bone area increase 
over `-year in the OA group was greater than W. The lower dW% CI for mean medial 
tibial area increase in the HV group was also greater than W.  
Multiple MR TA features had mean c-month and `-year changes with dW% CIs 
excluding W. The number of OA participants with c-month and `-year changes greater 
in magnitude than the SDD for subchondral bone QIBs is provided in Table [.T. The 
parameters with most participants showing changes greater than the SDD at c-months 
were the tibial texture features RLM short-run-length emphasis (SRLE) and long-run-
length-emphasis (LRLE) and the femoral texture feature GCLM inverse difference 
moment (I out of `` OA participants and S out of I HV participants). At `-year the 
femoral texture feature GLCM correlation had the highest number of participants 
demonstrating change greater than the SDD ([ out of U OA and S out of b HV 
participants) (Figure [.I). Plots of individual changes for all SBA and MR TA 
parameters are provided in Appendix [.`. 
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Figure Q.( 
Dot plots and example images for most responsive subchondral bone QIBs at c-months and `-year. Dotted lines on 
dot plots represent +/- smallest detectable difference (SDD) limits. Images on left hand panel for participant with c-
month increase in tibial RLM long-run-length-emphasis (LRLE). Note focal area of homogeneous low signal (black 
arrowhead) in the tibial subchondral bone at both visits which represents a bone marrow lesion (BML). At the c-
month follow-up visit, the bone adjacent to this BML is of lower signal and is more homogeneous (black void 
arrowhead) which will lead to an increase in RLM LRLE. Images on right hand panel are for a participant with a `-
year decrease in femoral GLCM correlation. Note area of subchondral sclerosis present on both images (white 
arrowhead) but covering a larger area at the `-year follow-up visit (white void arrowhead). More adjacent pixels 
having similar signal intensity will lead to an increase in GLCM correlation. 
 
 
  150 
Table Q.* 
Adjusted mean c-month and `-year changes in subchondral bone QIBs. 
Parameter 
:-month LSmean D (ST% CI) 5-year LSmean D (ST% CI) 
OA HV OA HV 
Subchondral bone area (mm#) 
 n = `T n = I n = [ n = b 
Femur bc (-Tc, `SU) TI (-d[U, `cU) `[S (``c, SSU) -Tb (-`Wd, bW) 
Medial Tibia b (-SW, Sd) `d (-SS, Id) ST (-U, Ib) I` (d, dS) 
Lateral Tibia S (-TT, T[) TU (-SW, dI) I (-SS, T`) Sd (-c, cI) 
Subchondral bone texture - Tibia 
 n = `` n = I n = U n = b 
Mean -``[ (-TUS, `b[) -c` (-bbS, TSW) -IT (-TII, Sbd) -UU (-IS[, TIW) 
Gr Mean -W.S (-W.T, -W.`) -W.` (-W.S, W) -W.T (-W.b, -W.S) -W.S (-W.T, W) 
Gr NonZeros -W.Wb (-W.Wc, -W.WT) -W.WT (-W.WI, W) -W.Wc (-W.Wd, -W.Wb) -W.WT(-W.Wc, W) 
Run Fraction -W.WS (-W.WT,-W.W`) -W.WS (-W.WT, W) -W.WT (-W.WI, -W.WS) -W.WS (-W.Wb, W) 
SRLE -W.WS (-W.WT, -W.W`) -W.W` (-W.WS, W) -W.WT (-W.Wb, -W.WS) -W.W` (-W.WT, W) 
LRLE W.`S (W.Wc, W.`U) W.Wd (W, W.`c) W.`U (W.``, W.SI) W.`W (W, W.SW) 
RLNU -bS` (-c[I, -`cc) -T (-TcT, TI[) -cc` (-U``, -I`W) -`SSS (-`bTb, -I`W) 
Correlation W.WI (W, W.`W) -W.WS (-W.Wd, W.Wc) W.W[ (W.WS, W.`S) -W.WS (-W.Wd, .Wc) 
Entropy -W.WU (-W.`b, -W.WS) -W.`` (-W.`d, -W.WS) -W.`T (-W.SS, -W.WT) -W.`S (-W.SI, W.WS) 
Inv Df Mom W.WT (W.WS, W.Wb) W.WS (W.W`, W.Wb) W.WI (W.WT, W.W[) W.WS (W.W`, W.Wc) 
Subchondral bone texture – Femur 
 n = `` n = I n = U n = b 
Mean -`UU (-TbU, -Sd) -[I (-TWT, `IS) -SWI (-bdT, UT) -`[c (-IU[, STI)_ 
Gr Mean -W.`U (-W.ST, -W.`S) -W.`b (-W.SS, -W.Wc) -W.Sd (-W.Tb, -W.Sb) -W.SI (-W.TT, W.`U) 
Gr NonZeros -W.WI (-W.W[, -W.WT) -W.WT (-W.Wc, -W.W`) -W.WU (-W.`W, -W.Wc) -W.Wc (-W.Wd, -W.WT) 
Run Fraction -W.WT (-W.Wb, -W.WS) -W.WS (-W.WT, -W.W`) -W.Wb (-W.Wc, -W.WT) -W.WT (-W.WI, -W.WS) 
SRLE -W.WS (-W.WT, -W.W`) -W.WS (-W.WT, W) -W.Wb (-W.Wb, -W.WT) -W.WS (-W.Wb, -W.W`) 
LRLE W.`b (W.WU, W.SW) W.`W (W.WS, W.`U) W.Sb (W.`U, W.TW) W.`I (W.W[, .Sb) 
RLNU -bTb (-I[I, -Sdb) -[d (-S[d, `S`) -III (-[Sb, -TUc) -UIT (-`WdT, -c`T) 
Correlation W (-W.WS, W.WS) W.WI (W.W`, W.WU) W.Wc (W.WS, W.``) -W.W` (-W.W[,  W.Wc) 
Entropy -W.`T (-W.`U, -W.WU) -W.WU (-W.`I, -W.W`) -W.`[ (-W.SS, -W.``) -W.SW (-W.SU, -W.``) 
Inv Df Mom W.Wb (W.WT, W.WI) W.WT (W.W`, W.WI) W.Wc (W.WI, W.WU) W.WI (W.WT, W.W[) 
Abbreviations: LS mean – least-squares mean, i.e. mean change value adjusted for baseline value via ANCOVA,  
otherwise as for Table `
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Table Q./ 
Number of participants with c-month and `-year changes greater in magnitude than the SDD. 
Parameter Number of participants with changes > SDD at : months 
Number of participants with 
changes > SDD at 5 year  
Subchondral bone area 
 n = `T n = I n = [ n = b 
Femur T W S W 
Medial Tibia I W ` ` 
Lateral Tibia W W W W 
Subchondral bone texture - Tibia 
 n = `` n = I n = U n = b 
Mean ` S ` S 
Gr Mean S ` I ` 
Gr NonZeros b ` I ` 
Run Fraction ` ` T ` 
SRLE I S b S 
LRLE I S b S 
RLNU b S I T 
Correlation T W S ` 
Entropy S S T ` 
Inv Df Mom b S b ` 
Subchondral bone texture – Femur 
 n = `` n = I n = U n = b 
Mean W ` ` ` 
Gr Mean T ` I ` 
Gr NonZeros S ` I S 
Run Fraction ` ` b ` 
SRLE S ` b ` 
LRLE T ` T ` 
RLNU T W I T 
Correlation b S [ S 
Entropy b ` b S 
Inv Df Mom I S c S 
Abbreviations: As for Table [.`
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[.b DISCUSSION 
Results from the AMROA study demonstrate that both SBA and MR TA have the 
potential to be useful QIBs of subchondral bone in experimental medicine studies. 
There are advantages and disadvantages to both. SBA is repeatable and demonstrates 
significant group level changes at `-year, but is less responsive at an individual level. 
MR TA is both repeatable and responsive to change, but requires analysis of a number 
of different parameters whose relationship to the image being analysed can be difficult 
to interpret. 
Repeatability of SBA assessment was good, particularly for femur and medial tibia 
which is where the majority of changes would be expected to occur in a medial OA 
population. The repeatability of SBA assessment in this study is comparable to most 
other previously published methods although worse than for a commercially available 
method which uses active appearance models (AAMs) and has test-retest coefficients 
of variation of less than `% (cb,SUS,SUT). One possible explanation for the better 
performance of the AAM-based method is that area is calculated for the central medial 
femoral area alone which has perhaps less potential for error than measuring the whole 
femoral area as performed in this study. Baseline between-group differences in SBA 
were in the direction that would be expected given previously described shape changes 
in OA(SUc). It should be noted that due to the small sample size, and to maintain 
consistency with other AMROA analyses, confounding variables such as sex and height 
were not adjusted for in the between group comparisons. At a group level, the average 
femoral SBA increased significantly in OA compared to HV participants over `-year 
which is in keeping with previous work describing femoral area as more responsive 
than tibial area (``,SW). At the individual level, relatively few participants demonstrated 
c-month and `-year changes greater than the SDC. Given the good test-retest 
repeatability demonstrated in the current work and previous studies, the main limiting 
factor in terms of responsiveness may be that the changes in bone area take place over 
a relatively long time period compared to other candidate QIBs. 
MR TA features had variable repeatability, with the majority of features having test-
retest RMSCVs of less than `W%. Interestingly, previous studies of MR TA (including 
chapter b of this thesis) have shown that the inter-observer reproducibility of MR TA 
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features is also variable(S``,SUb). Clearly some texture features are very sensitive to 
small changes in the image or in ROI delineation making them less suitable for 
longitudinal analyses. Discrimination between groups was generally good, with the 
direction of difference in texture features between OA and HV groups in agreement 
with previous studies and generally in keeping with OA participants having more 
heterogeneous, less spatially organised subchondral bone. This was the first study to 
use MR TA in a prospective longitudinal setting. At an individual level, texture features 
had high responsiveness with multiple participants demonstrating changes greater 
than the SDC. At a group level, there were few differences between groups in average 
c-month and `-year changes.  
One of the main disadvantages of MR TA is the limited interpretability of texture 
features. It is possible to describe approximately what texture features mean in terms 
of image heterogeneity and spatial organisation, but a more nuanced understanding of 
what parts of the image or ROI are driving the texture feature calculation is not 
possible.  In this respect MR TA is something of a ‘black box’ methodology. While this 
does not prevent it from detecting and quantifying abnormality in subchondral bone, 
in the setting of EM studies it would be desirable to understand not just if a potential 
DMOAT is working but also some understanding of the underlying mechanism at a 
tissue level. MR TA does not provide an easy way to gain this understanding. 
Conversely, SBA is much easier to interpret and links directly to the underlying OA 
disease process. There is also a much larger body of work linking it to meaningful 
future clinical and structural outcomes(SSc,SU[). However, this has to be balanced 
against the reduced responsiveness compared to MR TA demonstrated in this study. 
Both SBA and MR TA have the advantage over some other QIBs used in the AMROA 
study of requiring standard MR acquisitions (TD SPGR and SD T`w FSE) which should 
be more easily translatable to the multi-centre setting when compared to QIBs which 
require more advanced acquisition methods such as DCE-MR (chapter c) and cartilage 
compositional assessment (chapter U). In addition, some of the most promising 
putative DMOAT data is for treatments targeting subchondral bone. For example, 
while large clinical trials of bisphosphonates have failed to demonstrate significant 
effects on patient reported outcome measures there has been some evidence of a 
slowing in structural progression particularly in certain subgroups(SUU,SUd). In 
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smaller trials, other therapeutics targeting subchondral bone such as oral salmon 
calcitonin and cathepsin K inhibitors have also shown promise(cc,SdW). QIBs such as 
those used in this study may provide a way to both identify suitable participants for 
assessment of potential DMOATs targeting subchondral bone and provide surrogate 
endpoints for these studies. 
As well as being useful in EM studies, QIBs of subchondral bone could provide novel 
insights into OA pathophysiology. For example, measurement of SBA has led to the 
report of the so-called ‘pie-crust’ effect where there is a gradual spreading out of 
subchondral bone at the margins of the articular surface as OA develops. This is 
essentially describing osteophytosis in TD and has debunked previous theories that 
osteophytes were only seen in weight bearing areas of the joint(cT,SWb).  
There are several study limitations. First, a relatively large number of coronal T`w 
images were not suitable for MR TA due to need to position knee lower than usual for 
DCE-MR acquisition and analysis. A study with a dedicated texture analysis acquisition 
protocol may yield improved repeatability, discrimination and responsiveness data 
meaning that the values provided here could be regarded as conservative. Second, so-
called ‘scanner drift’ – the tendency for quantitative values to change with MR system 
software updates etc – cannot be excluded as a cause for change in texture features 
during the study. Quantitative metrics such as TS and T`rho relaxometry can be 
adjusted for this using phantom based measurements. However, no standardised 
phantom for texture measurements exists and so this was not possible here. Finally, 
the assessment of SBA in this study required some manual interaction whereas some 
alternative methods (e.g. those using AAMs) are fully automatic. Although the test-
retest repeatability and inter-observer reproducibility reported in this study are very 
good, it is likely that automation may improve this even further and therefore offer 
slightly improved responsiveness. 
In conclusion, in this chapter I have assessed the likely utility of MR QIBs of 
subchondral bone in EM studies. Both MR TA and SBA are repeatable and able to 
distinguish between OA and HV subchondral bone. MR TA may have superior 
responsiveness to SBA, but is less interpretable in terms of how it relates to the OA 
disease process which may hinder its uptake.  
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APPENDIX [. `  
c-month and `-year changes in subchondral bone QIBs. Each dot represents an 
individual participant. Dotted lines are ±SDD values. Abbreviations: GLCM – grey-
level co-occurrence matrix, RLM – run-length matrix, IDM – inverse difference 
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CHAPTER 9: 
 
:D CARTILAGE SURFACE MAPPING – 
IMPLEMENTATION IN THE AMROA STUDY 
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Breakdown of articular cartilage is a characteristic feature of OA, and 
prevention of this breakdown is an important target for potential disease 
modifying treatments. MR imaging methods can characterise cartilage 
morphology and composition, but conventional approaches are limited in 
their ability to detect short term changes. 
Here I implement the 9D Cartilage Surface Mapping pipeline, described in 
chapter 9, in the AMROA study. This method is able to detect focal changes in 
nearly all participants at 4-months and :-year of follow-up. By demonstrating 
the spatial heterogeneity and bidirectional nature of changes in cartilage 
morphology and composition, the method may also offer new insights into 
OA pathogenesis. 
U.` INTRODUCTION 
Despite recent criticism of an over-emphasis on cartilage in OA research, cartilage 
breakdown is nevertheless a hallmark of the disease and remains very much a 
therapeutic target of interest(S[d,Sd`,SdS). Therefore, the development and 
optimisation of quantitative imaging biomarkers (QIBs) of cartilage biology and health 
continues to be desirable. 
Quantification of cartilage morphology (volume and thickness) using MR imaging with 
expert manual segmentation is well-established, and has been implemented in several 
clinical trials to date(SdT). However, it has been shown that such methods are unlikely 
to be sufficiently responsive over timeframes relevant to experimental medicine 
studies  with c-months or less follow-up (Sdb–Sdc). Methods for quantification of 
cartilage composition using MR imaging are also well-described (see chapter S of this 
thesis) and have been implemented in large observational studies with several years 
follow-up(Sd[,SdU). However, their utility in studies with shorter follow-up periods 
remains uncertain. 
The TD Cartilage Surface Mapping (TD-CaSM) pipeline described and validated in 
chapter T of this thesis offers some potential advantages over existing methods as 
discussed previously (sections T.` and T.b). However, before it can be confidently 
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implemented in an interventional setting, in-vivo evidence of its utility in an 
observational setting is desirable. 
Therefore, the purpose of this chapter is to describe the implementation of TD-CaSM 
for the analysis of cartilage morphology and composition in the AMROA study. In 
common with other candidate QIBs in this study, I include assessment of test-retest 
repeatability, ability to discriminate between OA participants and healthy controls and 
responsiveness to change over c-months and `-year. 
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U.S METHODS 
Y.#.: Participants & Ethical Approval 
Ethical approval, participant recruitment and eligibility criteria are described in 
chapter I (sections I.S.` and I.S.S). 
Y.#.# Image acquisition 
Details on the acquisition of MR data for the AMROA study are described in chapter I 
(section I.S.T, Table I.S). The high spatial resolution T-dimensional fat suppressed 
spoiled gradient echo (TD SPGR) was used for assessment of cartilage morphology and 
for the initial steps of the TD-CaSM pipeline. This sequence had near-identical 
acquisition parameters to the sequence used for validation of TD-CaSM in chapter T.  
For assessment of cartilage composition, three complementary methods were used. 
Quantitative T`rho (longitudinal relaxation in the presence of a radiofrequency field) is 
sensitive to alterations in the proteoglycan content of cartilage, quantitative TS 
(transverse relaxation) is sensitive to alterations in collagen content, collagen 
orientation and water content of cartilage, and delayed gadolinium-enhanced MRI of 
cartilage (dGEMRIC) is sensitive to alterations in glycosaminoglycan (GAG) content. 
Quantitative T`rho and TS mapping were performed using T`rho/TS magnetisation 
prepared pseudo-steady-state TD fast spin echo (FSE) sequences, performed after a 
period of unloading of at least bI minutes to minimise effects related to recent weight-
bearing (Sdd).  dGEMRIC was performed by administering intravenous gadolinium-
based contrast agent (gdCA – Dotarem; Guerbet, Paris, France) at a dose of W.S mM/kg 
the end of the first imaging session. After leaving the scanner room, participants 
performed ten minutes of cycling on a stationary cycle to promote gdCA penetration 
into the knee joint followed by an UW-minute rest period to allow distribution of gdCA 
within the cartilage. Participants then returned for a second imaging session consisting 
of quantitative T` (longitudinal relaxation) mapping using a variable flip angle (VFA) 
approach.  
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Y.#.9 Image analysis 
TD SPGR images were used for TD-CaSM thickness measurement as described in 
chapter T (section T.S.I).  
For analysis of cartilage composition, source images for T`rho mapping, TS mapping 
and dGEMRIC were rigidly registered to TD SPGR images for motion correction using 
elastix(TWW). The femur and tibia were registered separately using masking to allow for 
different degrees of knee flexion between sequences, as has been described 
previously(``W). Parameter maps were then generated for each compositional 
measurement by fitting the observed signal for each pixel to the appropriate equation 
(Table U.`) using a linear least-squares approach. Goodness-of-fit statistics were 
extracted for each pixel, and pixels with poor fits (RS < W.d) or implausible values 
(Table U.`) were excluded from subsequent analysis. The inner and outer cartilage 
surfaces created from the TD SPGR images were then imported into the parameter 
maps using the relevant rigid transform. Measurement of each parameter at each 
vertex on the cartilage surface was obtained by sampling the compositional data (i.e. 
pixel values) along the line connecting each vertex on the inner surface to its 
correspondent on the outer surface and taking the mean value (Figure U.`). 
Table R.5 
Signal equations and thresholds for implausible values for cartilage compositional methods in this study 
Parameter Signal equation Exclusion threshold 
T`rho "7bc = d	 × exp −:"e:1f  > `TW ms 
TS "7g = d	 × exp−:h:2  > `WW ms 
T`GD (dGEMRIC) " = $% sin(!) +,	.+,/01(2).	where 3	 = exp ,787+  > `WWW ms* 
*following correction for BMI: (:1ij(klCCJk>Jm) = :1ij(nJDFoCJm) + 3(q$r − 20)) 
MW is proportional to tissue proton density and MR system gain, and is also estimated during the fitting process. 
A is a constant which is estimated during the fitting process 
a is the flip angle
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Figure R.5 
Outline of cartilage composition measurement process. In this example, a T`rho map is used. Note focal area of 
increased T`rho values on the medial femoral condyle (black arrowhead) corresponding to an area of partial 
thickness cartilage loss on the TD SPGR images (white arrowhead). Femoral T`rho data used for demonstration 
purposes, same process used for tibial, TS and dGEMRIC data. 
 
Cartilage surfaces from each timepoint from each participant were spatially 
normalized to a template (canonical) surface. This was carried out in wxRegSurf using 
a combined similarity and thin-plate-spline transformation. All surface data could then 
be mapped to this template surface to facilitate further spatially-corresponded analysis 
(Figure U.S). 
Two independent observers (JM and TT, a musculoskeletal radiologist with `W years’ 
experience) performed TD-CaSM on `W randomly selected knees for assessment of 
inter-observer reproducibility.  Both observers also performed full manual 
segmentation of the femoral and tibial cartilage (time taken T-b hours per knee) to 
allow comparison of inter-observer reproducibility between TD-CaSM and traditional 
manual segmentation. Manual thickness values were obtained as described for the 
validation study in chapter T (section T.S.I).  
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Figure R.* 
Overview of spatial normalisation procedure. Individual cartilage surfaces are registered to a canonical surface using 
a combined similarity/thin-plate-spline transform. Each individual’s data for each timepoint can then be ‘mapped’ 
to this canonical surface facilitating further spatially corresponded analysis. Here femur thickness data are used for 
demonstration – the same procedure applies for tibial and compositional data. 
  
Y.#.$ Statistical analysis 
In the description of the statistical methods for this study I draw the distinction 
between vertexwise analyses where the values from all surface vertices (~IWWW per 
participant) are used, and surfacewise analyses where a surface-averaged value is used. 
For analysis of inter-observer reproducibility, vertexwise and surfacewise comparisons 
between the two observers’ measurements were performed with calculation of root 
mean squared average coefficients of variation (RMSCVs). This was done for both TD-
CaSM and manual segmentation, and for both thickness and compositional 
measurements.  
For analysis of test-retest repeatability, RMSCVs were calculated for surfacewise and 
vertexwise differences between baseline and one month repeat data. In addition, 
vertexwise and surfacewise smallest detectable differences (SDD) were calculated as 
described in chapter c (section c.S.I). 
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To assess discrimination between OA and healthy knees, surfacewise data were used to 
estimate standardised mean differences (SMDs) between OA and healthy volunteer 
(HV) participants at baseline. The mean vertexwise difference between the two groups 
for each parameter was visualised using baseline data mapped to the canonical surfaces 
and subtracting the mean HV value at each vertex from the mean OA value. 
To assess individual c-month and `-year changes, vertexwise comparison was 
performed between baseline and c-month/`-year data mapped to the template surface 
allowing creation of an individual ‘change surface’ for each parameter at each 
timepoint (Figure U.T). I then defined areas of significant change by applying 
magnitude (change greater than SDD calculated from the test-retest repeatability data 
for that surface/parameter combination) and area (occurring across a cluster of at least 
`W vertices) thresholds to these change surfaces. The percentage of each surface with 
areas of significant change was calculated and used to define three summary metrics: 
%SCpos, %SCneg, %SCtotal, defined respectively as the percentage of the surface with 
areas of positive significant change, negative significant change and any significant 
change (regardless of sign). These metrics were compared between OA and HV groups 
using descriptive statistics. 
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Figure R./ 
Illustration of vertexwise assessment of change at c-months. Baseline and follow-up data are mapped to the same 
canonical surface, enabling vertexwise comparison of data and creation of a c-month change surface. Thresholding 
is then applied to this surface to highlight regions of significant change. TS measurements used in this example; the 
same process was used for thickness, T`rho and dGEMRIC measurements and `-year follow-up data. 
 
As well as analysing surface-based changes at an individual level, the fact that all data 
are registered to a canonical surface permits group-averaged analysis of localised c-
month and `-year changes and performance of statistical parametric mapping (SPM) to 
determine the statistical significance of these changes. SPM was performed in the OA 
group using SurfStat (http://www.math.mcgill.ca/keith/surfstat/), a MATLAB 
(MathWorks, Natick, MA, USA) toolbox for the statistical analysis of univariate and 
multivariate surface data using linear mixed effects models and random field theory. 
Linear mixed models were constructed with timepoint as a fixed effect and subject as a 
random effect (to account for paired data). A p value of < W.` was considered to be 
statistically significant given the exploratory nature of this analysis. 
Statistical analyses other than SPM were performed using RStudio version `.W.`bT. 
Surface-based analyses were performed using Stradwin, wxRegSurf and MATLAB 











6 month Δ (masked)
Apply thresholds based on
• Magnitude (SDD)
• Area (clustering)
↓ > threshold (SCneg)
↑ > threshold (SCpos)
No meaningful change
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U.T RESULTS 
Y.9.: Participants 
Participant characteristics are as described in chapter I (section I.T.`). The number of 
analysable participants at each timepoint for each parameter are provided in Table U.S. 
Compositional datasets were more commonly excluded than morphological images, 
with the commonest reason being unacceptable image artefact which was often due to 
phase wrap in the medial-lateral direction or signal drop-off inferiorly affecting 
quantitation of tibial cartilage. The latter links back to the issue described in chapter [ 
(section [.T.`) for quantitation of tibial subchondral bone texture, namely the 
compromise that had to be reached between including as much of the suprapatellar 
region as possible for dynamic contrast enhanced (DCE) evaluation of synovitis while 
avoiding positioning the tibia out of the coil sensitivity region.  
Table R.* 
Number of analysable participants at each timepoint for each parameter 
Parameter 
Number of analysable participants at visit 
Baseline  
(n = SW*) 
`-month  
(n = `I) 
c-month  
(n = `U**) 
`-year  
(n = `T) 
Thickness SW `I `U `` 
T`rho `U `T `[ U 
TS `U `S `c U 
dGEMRIC `b `b `T d 
*potential total n = `c for dGEMRIC as this was not included in the protocol for all participants at this visit 
**potential total n = `T for dGEMRIC as this was not included in the protocol for all participants at this visit 
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Y.9.# Inter-observer reproducibility 
Inter-observer reproducibility data are provided in Table U.T. Surfacewise inter-
observer RMSCVs were similar for measurements performed using TD-CaSM and those 
performed using manual segmentation. However, vertexwise inter-observer RMSCVs 
were lower for TD-CaSM for all but one measurement (medial tibial thickness) than for 
manual segmentation. 
Table R./ 
Inter-observer reproducibility data for TD-CaSM and conventional manual segmentation 
Surface Parameter 
Inter-observer RMSCV (%) 
Surfacewise Vertexwise 
TD-CaSM Manual TD-CaSM Manual 
Femur 
Thickness `.c `.d U.[ `T.[ 
T`rho S.W `.c [.[ ``.b 
TS S.` `.W c.I `S.S 
dGEMRIC T.` `.b d.[ `S.W 
      
Medial 
Tibia 
Thickness I.S I.` `I.d `b.[ 
T`rho S.[ [.[ [.T ST.S 
TS T.c U.b U.S SU.b 
dGEMRIC `.T T.S b.S Sb.W 
      
Lateral 
Tibia 
Thickness T.d b.I `S.d `T.b 
T`rho I.S `.b `W.` `b.b 
TS b.b S.c d.W `I.W 
dGEMRIC S.S S.[ b.d `b.[ 
Abbreviations: RMSCV – root-mean-square average coefficient of variation 
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Y.9.9 Test-retest repeatability 
One-month test-retest TD-CaSM repeatability data and SDD values are provided in 
Table U.b. Thickness measurements had better surfacewise repeatability than 
compositional measurements, but similar vertexwise repeatability.  
Table R.6 
One month test-retest repeatability data for TD-CaSM. 
Surface Parameter Surfacewise RMSCV (%) 
Vertexwise 
RMSCV (%) Vertexwise SDD 
Femur 
Thickness T.U ``.S W.cS mm 
T`rho b.U ``.W `[.T ms 
TS b.T d.d `S.b ms 
dGEMRIC U.` `W.W `IS.T ms 
     
Medial Tibia 
Thickness I.S `b.` W.[W mm 
T`rho c.d `S.c S`.W ms 
TS c.[ ``.[ `b.I ms 
dGEMRIC [.U [.[ `Sb.W ms 
     
Lateral 
Tibia 
Thickness T.d `W.b W.c` mm 
T`rho [.[ `S.[ `U.S ms 
TS c.W `W.d `S.I ms 
dGEMRIC U.c U.[ `TT.c ms 
Abbreviations: SDD – smallest detectable difference (repeatability coefficient from Bland-Altman analysis), 
otherwise as for Table U.T 
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Y.9.$ Baseline between-group differences 
Surfacewise standardised mean differences (SMD) with dW% confidence intervals (CI) 
are provided for each parameter in Table U.I. Average vertexwise differences are 
displayed in Figure U.b, illustrating that between group differences are spatially 
heterogeneous. 
Figure R.6 
Average vertexwise differences between OA and HV groups at baseline for each parameter. Red areas indicate that 
the parameter was on average lower in OA participants than in HV participants, whereas blue areas indicate that 
the parameter was on average higher in OA participants than in HV participants. 
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Table R.( 
Baseline surfacewise standardised mean difference values for each parameter at each surface. Positive values 
indicate that the parameter is higher in the OA group than the HV group. 
Surface Parameter Surfacewise SMD (dW% CI) 
Femur 
Thickness W.bT (-W.TU, `.Sb) 
T`rho W.bU (-W.bW, `.TI) 
TS W.bI (-W.bT, `.TS) 
dGEMRIC W.TT (-W.Ib, `.S`) 
   
Medial Tibia 
Thickness -W.bc (-`.SU, W.TI) 
T`rho W.Ib (-W.Tb, `.b`) 
TS W.TU (-W.bd, `.SI) 
dGEMRIC W.WU (-W.Uc, `.WS) 
   
Lateral Tibia 
Thickness -W.`T (-W.db, W.c[) 
T`rho -W.WU (-W.dI, W.[U) 
TS -W.WS (-W.Ud, W.Ub) 
dGEMRIC W.WS (-W.d`, .dc) 
 
Y.9.! Individual-level 4-month and :-year changes 
Mapping of c-month and `-year changes in cartilage thickness and composition 
revealed substantial spatial heterogeneity between participants, with areas of 
concurrent increase and decrease (e.g. cartilage thickening and thinning) visible in 
some participants (Figure U.I). Individual %SC values for each parameter are displayed 
in Figure U.c. The parameter with the highest total %SC value at c-months and `-year 
in OA participants was TS, with median (IQR) total %SC of U.U (I.I, `S.c) at c-months 
and d.b (b.[, `c.[) at `-year. Interestingly at both timepoints this total %SC value was 
driven mostly by positive rather than negative changes in TS.  
Y.9.4 Group-averaged 4-month and :-year changes 
The only statistically significant group-averaged change in the OA group was 
demonstrated for c-month dGEMRIC change in the femur, where a focal area of 
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significant increase in dGEMRIC was demonstrated close to the medial terminal sulcus 
(Figure U.[). No other statistically significant group-averaged changes were detected by 
SPM at c-months or `-year. 
Figure R.( 
Baseline and c-month follow-up thickness and compositional data for a single representative OA participant 
displayed on canonical femoral and tibial surfaces. Note spatial heterogeneity of changes and the co-occurrence of 
both significant positive and significant negative changes in thickness, T`rho and TS. 
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Figure R.: 
Individual c-month and `-year %SC data for each parameter. The dotted line represents a proposed I% threshold 
above which %SC values could be considered significant within an individual. This is a relatively stringent threshold 
given that all areas of significant change have already passed magnitude (SDD) and area criteria. 
       
Figure R.Q 
Average OA group c-month change in femoral dGEMRIC, with focal region of statistical significance (p < W.`) 
demonstrated close to the medial femoral sulcus. Scale for masked surface is the same as for the unmasked, but 
with areas without statistical significance washed out. 
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U.b DISCUSSION 
This chapter has described the implementation of TD-CaSM in the AMROA study. This 
method of analysis allows detection of changes in cartilage morphology and 
composition over c-months and `-year which are spatially heterogeneous between 
individuals and often bidirectional in nature. 
Inter-observer reproducibility of TD-CaSM is similar to expert manual segmentation 
when values are averaged across the entire cartilage surface. However, when 
measurement at each individual vertex is considered, reproducibility is better for TD-
CaSM for all but one surface/parameter combination. This is unsurprising given that 
the automated cartilage thickness measurement algorithm uses only sparse manual 
contours as a guide, whereas manual thickness measurement is entirely dependent on 
these manual contours and therefore more subject to operator bias. Test-retest 
repeatability values are also commensurate with those reported for alternative 
methods(I`,TW`). Previous work involving averaging of values across subregions has 
reported smallest detectable change (SDC) values for cartilage thickness lower than 
the SDD values provided here(SdI). There are two explanations proposed for this 
discrepancy. First, vertexwise SDD values are provided here which would be expected 
to be higher than SDD or SDC values averaged over a larger region of interest. Second, 
the SDC is calculated slightly differently to the SDD and will tend to be lower(TWS). 
Despite the higher SDD values reported here, the finding of c-month changes 
exceeding this threshold suggests adequate sensitivity to change of TD-CaSM 
nonetheless. 
The potential advantage of performing vertexwise vs surfacewise analysis is illustrated 
by the results of baseline between-group comparisons using the two approaches 
(Figure U.b and Table U.I). For example, average surfacewise femoral thickness 
measurement is counterintuitively higher in the OA than the HV group. On 
examination of the mapped average vertexwise differences, the reason for this becomes 
clear. Cartilage thickness values in the weight-bearing medial femoral condyle are 
lower in the OA group as would be expected given this group had been selected for 
having medial compartment predominant OA. However, thickness values elsewhere 
(lateral & patellofemoral compartments) are higher in the OA group. The phenomenon 
  175 
of cartilage being simultaneously thinner in certain regions and thicker in others in OA 
when compared to healthy controls has been described previously, and is not always 
adequately reflected by ROI based approaches(TWT). The same is also true of 
compositional parameters, where cartilage regions with average values higher in the 
OA than the HV group and vice versa are present. These may reflect differing 
biomechanical loads in different areas. 
This advantage of vertexwise analysis is further demonstrated when analysing c-month 
change data. Areas of significant change are spatially heterogeneous between 
participants. Therefore, metrics such as %SC which are location agnostic may be more 
useful than group averaged (SPM) analyses which assume that regions of change are 
spatially consistent between individuals. However, this makes the implicit assumption 
that change in one location is as meaningful as change in any other which may not be 
the case. Moreover, the predictive and concurrent validity of metrics such as %SC is 
unknown, in contrast to conventional manual segmentation/ROI based approaches for 
which a large amount of literature exists(cW). 
Despite these potential shortcomings, the results of previous studies using similar 
approaches to TD-CaSM are encouraging. Williams et al described a similar method 
termed ACRAC (Anatomically Corresponded Regional Analysis of Cartilage) for 
analysing cartilage thickness and produced individual change maps(TWb). Although 
detailed measurements were then averaged across relatively large ROIs (an approach I 
have deliberately sought to avoid here), the authors were nonetheless able to use this 
method to detect significant decreases in cartilage thickness in some regions in a 
cohort of T` individuals with OA over c-months(`Ud). Monu et al implemented a 
similar pipeline (termed ‘cluster analysis’) in a post anterior cruciate ligament (ACL) 
injury population and demonstrated greater areas of increase in T`rho and TS values in 
ACL injured knees compared to the healthy volunteers at c-months and `-year post 
injury(`U[). Although not a focus of Monu’s initial analysis, analysis of the ‘cluster 
maps’ provided demonstrates similarly spatial heterogeneous and bidirectional 
changes to those seen in the present work. Pedoia et al described ‘voxel-based 
relaxometry’ (VBR) which performs voxelwise analysis of compositional (T`rho and TS) 
data. VBR was able to depict significant changes in cartilage composition which were 
not detected by conventional ROI based approaches(`bc). The location agnostic 
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‘ordered value’ approach of Eckstein et al for analysis of manually segmented cartilage 
data has been used in several studies to demonstrate concurrent greater thickening 
and greater thinning of cartilage in knees with and at-risk for OA(TWI). This involves 
ordering each subregion of cartilage analysed according to where the greatest changes 
have occurred, then using the region of greatest change (regardless of location) to 
compare between groups or associate with an outcome. The use of the %SC metric 
takes the ‘ordered value’ approach to its logical conclusion by applying a similar 
concept but removing the need for arbitrary subregion definition. 
Data from existing surface-based and voxel-based methods are promising, and it 
should be noted that TD-CaSM has the additional advantage of being able to 
simultaneously analyse compositional and morphological data. This may be of 
particular interest in interventional studies. For example, sprifermin (intra-articular 
recombinant human fibroblast growth factor `U) has been shown to cause average 
increases in cartilage thickness and volume in clinical trials(SdT). While these results 
are encouraging, the question has arisen as to whether this represents genuine 
cartilage growth or just cartilage swelling, which may in fact represent disease 
worsening(TWc). With conventional analysis, it has been difficult to assess the quality 
of this cartilage as precise localisation of the area of thickening is challenging with 
ROI-based approaches. However, TD-CaSM could delineate in each individual knee 
exactly where any cartilage thickening had occurred. Because the thickness and 
compositional data are registered to the same surface, assessment of compositional 
values in the precise region of cartilage thickening could then be performed. This may 
allow some assessment of the quality of the cartilage in areas of thickening and 
differentiation of cartilage regeneration vs swelling (`SW). 
The previously limited use of analytical approaches taking into account bidirectional 
changes in cartilage provides a speculative explanation as to why previous studies of 
short-term changes in cartilage morphology have failed to detect significant 
unidirectional changes, and clinical trials using only cartilage loss in a single subregion 
as an endpoint have failed to demonstrate a significant effect(cI,Sdc). Moreover, it 
supports the paradigm of OA as a disorder characterised by abnormal cartilage 
turnover rather than simply a disorder of cartilage loss, for which there is considerable 
biological and imaging evidence(TW[,TWU). For example, in early osteoarthritis the 
  177 
synthesis of proteoglycans and type II collagen actually increases (TWd,T`W). In 
addition, disruption of the normal cartilage structure may cause a counterintuitive 
increase in the amount of bound water molecules by increasing the number of 
accessible hydrophilic binding sites(T``). Therefore, when considering changes in 
quantitative imaging biomarkers reflective of these tissue components, one would 
expect to see changes reflective of this (e.g. decreases in T`rho, TS, increases in 
dGEMRIC) in some patients rather than only changes in the traditionally expected 
direction. In order to investigate this further, future work should explore the clinical 
meaning of MR imaging-defined cartilage turnover in terms of association with patient 
symptoms and other measures of structural deterioration. 
The main limitation of this study is the lack of longitudinal validation of TD-CaSM and 
the metrics derived from it (e.g. %SC). While the method may offer improved 
responsiveness to conventional ROI-based methods, it should be borne in mind that 
changes detected by these conventional methods have been linked to longer term 
clinical and radiological outcomes whereas changes detected by TD-CaSM have not. 
Implementation of TD-CaSM in larger cohorts with longer term follow-up is planned to 
help establish the clinical meaning of metrics such as %SC. Another limitation is the 
lack of histological or biological validation of the findings. Therefore, the suggestion 
made in preceding paragraphs that TD-CaSM may be able to depict abnormal ‘cartilage 
turnover’ should be regarded as somewhat speculative. Finally, SPM was used to assess 
the significance of group-averaged changes over c-months and `-year. While this 
approach is valid and has been used extensively in the neuroimaging community, 
larger group sizes are usual. Power calculations for SPM are difficult, but it is likely 
that this study was underpowered in its ability to detect group-averaged changes. 
However, as mentioned above it should also be noted that SPM may not be the optimal 
analysis method for TD-CaSM data given the spatial heterogeneity of the changes 
demonstrated. Location agnostic measures such as %SC may provide better 
responsiveness. 
In conclusion, this chapter has described the implementation of TD-CaSM in the 
AMROA study. This analysis method is able to detect and map significant changes in 
cartilage morphology and composition at c-months and demonstrates test-retest 
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repeatability and inter-observer reproducibility comparable to existing gold-standard 
methods.
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d.` CONTRIBUTIONS TO KNOWLEDGE 
This thesis has investigated the role of quantitative imaging biomarkers (QIBs) in the 
assessment of knee OA with a focus on their role in experimental medicine (EM) 
studies. The major contributions to knowledge of this thesis include an extension of 
the evidence base behind several existing MR QIBs, the development of a novel 
analysis pipeline (TD-CaSM) for analysis of articular cartilage morphology and 
composition and an assessment of the performance characteristics of candidate MR 
QIBs for EM studies. 
The systematic review and meta-analysis of the reliability and discriminative validity of 
cartilage compositional MR imaging (chapter S) has been acknowledged by the 
Radiological Society of North America (RSNA) Quantitative Imaging Biomarkers 
Alliance (QIBA) as an important contribution to the validation of these QIBs(TW`,T`S). 
The resultant publication will form part of an upcoming QIBA profile for cartilage 
compositional MR imaging. QIBA profiles are developed using published data to 
generate evidence-based performance claims on the magnitude of change required for 
the biomarker within an individual for that change to be considered significant. For 
example, the QIBA profile for tumour volume change with computed tomography (CT) 
for advanced malignancy states that “A true change in a tumor volume has occurred 
with dI% confidence if the measured change is larger than Sb%, Sd% or Td% when the 
longest in-plane diameter is initially IW-`WW mm, TI-bd mm or `W-Tb mm, 
respectively”(T`T). Detailed knowledge of the repeatability and reproducibility of QIBs, 
as provided by chapter S of this thesis, is a key piece of information used to derive such 
claims. 
The development and validation of TD cartilage surface mapping (TD-CaSM) has 
allowed the detection and localisation of focal changes in cartilage thickness and 
composition over as little as c-months in the AMROA study. TD-CaSM has 
demonstrated that changes in cartilage in OA participants are spatially heterogeneous 
and are bidirectional in nature. This work will contribute to a growing literature 
challenging the concept of OA as characterised by only loss of cartilage over time. The 
analysis pipeline will next be applied to the Foundation for the National Institutes of 
Health (FNIH) Biomarkers Consortium PROGRESS-OA cohort to establish the 
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predictive and concurrent validity of TD-CaSM for clinically meaningful 
outcomes(T`b).  
The predictive and concurrent validity of subchondral bone texture for knee OA 
progression were established in chapter b in the Osteoarthritis Initiative Bone 
Ancillary Study cohort. Previous work had demonstrated the utility of subchondral 
bone texture analysis in a cross-sectional setting and had established construct 
validity. The work presented in this thesis is an important step in promoting the use of 
this QIB in longitudinal and interventional studies(SUb). 
The AMROA study has established the important performance characteristics of 
candidate QIBs for bone, synovium and cartilage for EM studies. The results enable 
head-to-head comparison of the QIBs studied across the domains of test-retest 
repeatability, discriminative validity and responsiveness to change at both c-months 
and `-year (Table d.`). While such comparison can be informative, it should be noted 
that choice of QIB for interventional studies will ultimately depend most on the 
anticipated mechanism of action of the treatment being tested. 
Table S.5 
Comparison of QIBs included in AMROA study across domains of interest. For each domain, the QIB from each 






Discrimination OA vs 
HV (SMD) 
Responsiveness to 
change at c-months 
(% OA participants 
with D > SDD) 
       
Synovium Ktrans 
 
`[.U Ktrans W.db Ktrans bS 
       





`.Sc RLM SRLE 
(tibia)# 
bI 
       
Cartilage Thickness b.T* T`rho W.Ib* TS U`** 
       
*surfacewise analysis **vertexwise analysis 
#tied with Tibial RLM LRLE & Femoral GLCM inverse difference moment 
Abbreviations: RMSCV – root mean square average coefficient of variation, SMD – standardised mean difference, 
SDD – smallest detectable difference, RLM – run-length-matrix, GLCM – grey-level-co-occurrence matrix, SRLE – 
short run length emphasis, LRLE – long run length emphasis 
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The findings from the AMROA study can also inform sample size calculation for future 
studies. In particular, the within-subject standard deviation estimated from test-retest 
data is an important parameter for such calculations. An example is provided in 
Chapter c (Section c.b). However, such sample size calculations assumes a frequentist 
approach which is rarely used in the analysis of EM studies where Bayesian approaches 
are preferred(T`I). The reason for preferring Bayesian approaches is that the goal of EM 
studies is not necessarily to establish definitive evidence of effect, rather to establish 
the level of confidence in any efficacy signal detected. The data from the AMROA 
study can also be helpful in this regard. Taking again the example of synovial Ktrans, the 
number of OA participants demonstrating significant reductions in this parameter at 
c-months in this observational study (b/`T or TW%) can be used to create an 
informative prior distribution of predicted ‘response’ in the absence of any treatment 
effect. This information can then be used to determine the probability that a response 
rate observed in an interventional study was due to treatment effect using Markov-
Chain-Monte-Carlo sampling from the prior distribution (Figure d.`). 
Figure S.5 
Use of AMROA data to inform Bayesian analysis of EM study data. Given number of participants showing a 
reduction in Ktrans in the observational setting (a), an informative prior distribution (b) can be derived to summarise 
the probability of response in the absence of disease modifying treatment. This can then be used (c) to assess the 
likelihood of a response rate observed in a small single-arm EM study (n = `I used as an example here) of a putative 
anti-inflammatory DMOAD being due to treatment effect.
 
The limitations of individual components of the AMROA study are discussed in 
chapters I-U. The major overarching limitation is the small sample size. As discussed 
previously, this was to some extent intentional. However, the small sample size does 
still reduce the precision of estimates of QIB performance characteristics derived from 
the study data. Nevertheless, the AMROA study has still provided important data to 
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enable the use of QIBs in interventional EM studies where similar uncertainty is likely 
to exist. 
d.S FUTURE DIRECTIONS 
A recent imaging biomarker roadmap published by oncology researchers outlines two 
“translational gaps” in the development of QIBs(U`). This study represents an effort to 
cross translational gap ` (Figure d.S). The next step is to achieve incorporation of a 
selection of the QIBs into ongoing interventional studies. 
Figure S.* 
Translational gaps in imaging biomarker development. The AMROA study results will help enable the QIBs 
evaluated to cross translational gap ` by providing technical and clinical validation. Adapted from (U`). 
 
The QIBs studied in this thesis also have the potential to enter more widespread 
clinical use. However, this is a longer-term aim and will require several additional 
studies, including the demonstration of multicentre feasibility and robustness and cost 
efficacy. As with all OA imaging, the widespread uptake of the QIBs will be limited 
until a treatment which demonstrates disease modifying capability is available and 
advanced imaging has a demonstrable influence on patient management, whether for 
assessing eligibility for or monitoring response to treatment. 
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d.T CONCLUSIONS 
`. Cartilage compositional MR methods are reliable and, in the case of T`rho and 
TS mapping, are able to discriminate individuals with knee OA and controls. 
S. TD Cartilage Surface Mapping (TD-CaSM) is as accurate as manual 
segmentation for measurement of cartilage thickness when compared to the 
reference standard and also reduces time taken for analysis with better inter-
observer reproducibility. 
T. Baseline and `-year change in subchondral bone texture are associated with 
radiographic knee OA progression at T years, with modest predictive ability. 
b. For dynamic contrast enhanced (DCE) MR assessment of synovitis, the QIB 
with the best performance characteristics for experimental medicine studies is 
Ktrans, suggesting that full pharmacokinetic modelling of DCE data is worth the 
additional effort. 
I. Subchondral bone area and subchondral bone texture demonstrate significant 
changes in some individuals over c-months. Subchondral bone texture features 
are more responsive than subchondral bone area, but are less interpretable. 
c. TD-CaSM can detect and localise significant changes in cartilage morphology 
and composition over c-months in some individuals. 
Changes in cartilage morphology and composition in OA are spatially 
heterogeneous between participants and bidirectional in nature. Location 
agnostic analytical approaches may therefore have some advantages.
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